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ZUSAMMENFASSUNG 
Mit jeder Zellteilung muss das Genom exakt dupliziert werden. Zehntausende 
Replikationsinitiationsstellen sind bei der Replikation des gesamten humanen Genoms 
beteiligt. Die Aktivierung der Initiationsstellen ist präzise reguliert und umfassende 
Genom-weite Studien haben verschiedene genomische Faktoren identifiziert, die die 
Aktivierung der Replikationsinitiationsstellen beeinflussen. Der Prä-
Replikationskomplex (pre-RC) bildet die Grundlage der Replikationsinitiation und 
besteht aus zwei Hauptuntereinheiten: der „origin recognition complex“ (ORC) 
bindet DNS und wird zum Laden der zweiten Untereinheit, den Mcm2-7 Helikasen 
benötigt, die die eigentliche Replikationsinitiation veranlassen. Während die 
Regulation des pre-RC Aufbaus vielfach untersucht wurde und mittlerweile gut 
verstanden wird, sind die Chromatinkomponenten, welche die Positionierung der pre-
RCs regulieren, weitgehend unbekannt. Die wenigen Genom-weiten pre-RC 
Chromatin Immunopräzipitations- und Sequenzierungsstudien (ChIP-seq), 
behandeln bis heute nur ORC. Da sich Mcm2-7 allerdings von seiner initialen 
Ladeposition fortbewegen kann, werden vor allem die Genom-weiten Positionen von 
Mcm2-7 benötigt, um die Regulation der DNS Replikation vollständig zu verstehen.         
Diese Arbeit umfasst die erste Genom-weite pre-RC ChIP-seq Analyse der zwei 
pre-RC Hauptkomponenten ORC und Mcm2-7 in der Epstein-Barr Virus (EBV) 
infizierten Burkitt-Lymphom Zelllinie Raji. Als Qualitätskontrolle für erfolgreiche 
ChIPs wurden die aus den vorliegenden Experimenten bestimmten pre-RC 
Positionen auf dem EBV-Genom mit bereits bekannten pre-RC Positionen 
verglichen. Auf dem humanen Genom korrelierten die pre-RC ChIP Ergebnisse mit 
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aktiven Replikationszonen, während Replikationsterminationszonen eine spezifische 
Abnahme der pre-RC Komponenten, besonders von Mcm2-7, aufzeigten. Es ist 
bereits bekannt, dass aktive Replikation mit aktiver Transkription korreliert. Starke 
pre-RC Bindung war in der Tat hauptsächlich an Regulationsstellen der aktiven 
Transkription zu finden, was vermutlich durch die Zugänglichkeit des Chromatins 
determiniert wird. Starke Mcm2-7 Bindung variierte dabei in Abhängigkeit des 
Zellzyklus, was für Mcm2-7 Translokationen während der G1 Phase spricht, die 
vermutlich von der aktiven Transkriptionsmaschinerie beeinflusst werden. Diese 
Ergebnisse deuten darauf hin, dass ORC und Mcm2-7 Positionen in der aktiven 
Chromatinumgebung hauptsächlich von der Zugänglichkeit des Chromatins 
abhängen und Mcm2-7 die Hauptkomponente der Bestimmung der 
Replikationsinitiationsstellen darstellt.        
In Heterochromatin assoziierte vorwiegend ORC mit der heterochromatischen 
Histonmodifikation H4K20me3, während Mcm2-7 weniger Anreicherung zeigte. 
Unter Verwendung eines Plasmid-basierten Replikationssystems wurde bestätigt, dass 
diese ORC-Chromatin Assoziation einen essentiellen Einfluss auf die Regulation der 
pre-RC Positionierung und Aktivierung ausübt. Dieses Ergebnis zeigt, dass ORC-
Chromatin Interaktionen einen entscheidenden Faktor für die Regulation der 
Replikation in Heterochromatin darstellen. Zusammenfassed schlägt diese Studie zwei 
verschiedene Modi der pre-RC Positionierung vor, welche jeweils vom 
Chromatinkontext abhängen.    
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RÉSUMÉ 
Chaque division cellulaire requiert une duplication précise du génome. Des dizaines 
de milliers de sites d’initiation de la réplication d’ADN (origines de réplication) sont 
impliqués dans la réplication complète du génome humain. L’activation des origines 
de réplication est régulée précisément et des études génomiques extensives ont 
démontré la présence de caractéristiques génomiques associées à l’activation des 
origines de réplication. Le complexe de pré-réplication (pre-RC) est la base de 
l’initiation de la réplication et consiste en deux sous-complexes majeurs : l’ « origin 
recognition complex » (ORC) qui interagit directement avec l'ADN et est nécessaire 
pour recruter le second sous-complexe, les hélicases Mcm2-7, qui sont responsables 
de l'initiation de la réplication. La régulation de l’assemblage du pre-RC est bien 
étudiée, mais les caractéristiques de la chromatine qui déterminent le positionnement 
du pre-RC sur le génome restent peu connues. Les études génomiques par immuno-
précipitation de la chromatine et séquençage à haut débit (ChIP-seq) des pre-RCs sont 
rares et jusqu’à aujourd’hui seulement disponibles pour ORC. Du fait que Mcm2-7 
migre de son site de chargement initial, il est crucial d'obtenir des informations sur le 
positionnement des Mcm2-7 pour la compréhension complète de la régulation de la 
réplication.        
Ce travail présente la première analyse génomique par méthode ChIP-seq des deux 
sous-unités majeures du pre-RC, ORC et Mcm2-7, dans la lignée cellulaire de 
lymphome de Burkitt Raji infectée par le virus d’Epstein-Barr (EBV). La présence du 
génome d’EBV permet d'avoir un contrôle interne de la qualité de nos expériences, 
en comparant les positions de pre-RC déterminées avec des positions du pre-RC 
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précédemment publiées. Sur le génome humain, les résultats de séquençage du pre-
RC corrèlent bien avec des zones de réplication active. De façon intéressante, les zones 
de terminaison de la réplication étaient spécifiquement bas en pre-RC, spécialement 
en Mcm2-7. La localisation des sites d'initiation de la réplication identifiés est 
généralement bien corrélée avec les sites de transcription active. En effet, des sites 
d’assemblage du pre-RC de haute affinité sont localisés préférentiellement en 
voisinage de sites de transcription active, ce qui est possiblement dû à l’accessibilité de 
la chromatine dans ces régions. La fixation de Mcm2-7 fluctuait de façon dépendante 
du cycle cellulaire, ce qui suggère des translocations de Mcm2-7 en G1, probablement 
dépendantes de la machinerie active de la transcription. Ces résultats indiquent que les 
positions de ORC et Mcm2-7 sont principalement dépendantes de l’accessibilité de la 
chromatine avec un accès privilégié dans la chromatine active et Mcm2-7 étant le 
déterminant majeur de l’initiation de la réplication.         
Au sein de l'hétérochromatine, ORC était enrichi dans des zones associées avec 
l'histone modifié H4K20me3. Cependant, cet enrichissement était moins important 
pour les Mcm2-7. En utilisant un système de réplication basé sur des plasmides, nous 
avons démontré que l’association d'ORC et H4K20me3 favorise l’assemblage du pre-
RC et l’initiation de la réplication. Cette observation suggère que l’interaction ORC-
chromatine est le déterminant majeur de la régulation de la réplication d’ADN au sein 
de l’hétérochromatine. En conclusion, cette étude propose deux mécanismes 
différents de la régulation de l'assemblage du pre-RC dépendants de l’environnement 
de la chromatine. 
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ABSTRACT 
With every cell division, the genome needs to be faithfully duplicated. Tens of 
thousands of DNA replication initiation sites (origins of replication) are invoved in 
replicating the human genome. Origin activation is precisely regulated and extensive 
genome-wide studies found association of origin activation to several different 
genomic features. The pre-replication complex (pre-RC) is the basis for replication 
initiation and consists of two major subcomponents: the origin recognition complex 
(ORC) binds DNA and is required for loading of the second component, Mcm2-7 
helicases, which initiate DNA replication. Regulation of pre-RC assembly is well 
studied, however, chromatin features driving pre-RC positioning on the human 
genome remain largely unknown. Genome-wide pre-RC chromatin 
immunoprecipitation experiments followed by sequencing (ChIP-seq) studies are rare 
and so far only performed for ORC. As Mcm2-7 can translocate from their initial 
loading site, information about Mcm2-7 positioning are required for full 
understanding of DNA replication regulation. 
This work presents the first genome-wide ChIP-seq analysis of the two major pre-RC 
subcomponents ORC and Mcm2-7 in the Epstein-Barr virus (EBV) infected Burkitt’s 
lymphoma cell line Raji. Successful ChIPs were validated on the EBV genome by 
comparing obtained pre-RC positions with already existing pre-RC ChIP-on chip data. 
On the human genome, pre-RC sequencing results nicely correlated with zones of 
active replication. Interestingly, zones of replication termination were specifically 
depleted from pre-RC components, especially from Mcm2-7. Active DNA replication 
is known to correlate with active transcription. Indeed, strong pre-RC assembly 
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preferentially occurred at sites of active transcriptional regulation, presumably 
determined by chromatin accessibility. Strong Mcm2-7 binding thereby fluctuated cell 
cycle-dependently, arguing for Mcm2-7 translocations during G1, possibly depending 
on the active transcriptional machinery. These results indicate ORC and Mcm2-7 
positions being mainly dependent on chromatin accessibility in active chromatin, with 
Mcm2-7 being the major determinant of replication initiation.     
In heterochromatin, ORC was enriched at H4K20me3 sites, while Mcm2-7 
enrichment was less prominent. Employing a plasmid-based replication system, ORC 
association to H4K20me3 was proven to promote successful pre-RC assembly and 
replication initiation, situating direct ORC-chromatin interactions being the major 
determinant for DNA replication regulation in heterochromatin. Taken together, this 
study proposes two different modes of pre-RC assembly regulation depending on 
chromatin environment.  
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1. INTRODUCTION 
DNA replication is the process of precisely copying the complete genetic information, 
which assures faithful inheritance of the genome during each cell division. Thereby, 
DNA replication initiates only once per cell cycle. Misregulation during this process 
leads to genetic instability, which might have fatal consequences on organs and tissues 
and can cause cancer or other genetic disorders in humans (Abbas, Keaton, and Dutta 
2013). Sites of DNA replication initiation are called origins of replication. While 
bacteria initiate genome replication at one specific origin (Mott and Berger 2007), 
replication regulation in Saccharomyces cerevisiae is already more complex. In S. cerevisiae, 
DNA replication origins were initially identified as autonomous replication sequences 
(ARS), which contain a 11-17 bp AT-rich consensus sequence. However, only a small 
part of all ARS consensus sequences are used as replication origins, suggesting that 
other features also contribute to origin recognition and activation (Fragkos et al. 2015). 
In higher eukaryotes, origins do not exhibit sequence specificities and DNA 
replication can initiate at any DNA sequence (Vashee et al. 2003). In humans, 30000-
50000 origins are activated in each cell at each cell cycle. Numerous studies during the 
recent years revealed that origins exhibit a preference for specific features, although 
none of these features alone are predictive for replication origins (Méchali 2010).  In 
the following, I will detail the regulation of DNA replication in higher eukaryotes and 
the impact of chromatin, histone modifications, and structural arrangements within 
the nucleus. 
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 DNA REPLICATION IS TIGHTLY REGULATED – AND 
STOCHASTIC 
DNA replication is spatio-temporally separated to ensure correct duplication of the 
genome. During each S-phase of the cell cycle, 30000-50000 origins are activated per 
cell. These origins are chosen from an exceeding pool of possible origins. For an origin 
to be activated, proper loading of the pre-replication complex (pre-RC) during 
preceding G1 is required.  
1.1.1 ASSEMBLY OF THE PRE-REPLICATION COMPLEX IN LATE MITOSIS/ EARLY G1 
The process of pre-RC assembly is called origin licensing and is restricted from late 
mitosis to the restriction point in G1-phase of the cell cycle. All possible origins need 
to be properly licensed, while only a subset is activated during S-phase. Origin 
licensing consists of the sequential loading of pre-RC proteins and starts with the 
binding of the origin recognition complex (ORC, Figure 1.1).  
 
FIGURE 1.1: SCHEMATIC REPRESENTATION OF SEQUENTIAL PRE-RC ASSEMBLY. Licensing consists 
of the sequential loading of pre-RC components and is restricted to G1-phase. First ORC binds 
DNA as hexameric complex. Cdc6 recruitment traps DNA in the center of the circle and initiates 
Cdt1-dependent Mcm2-7 helicase loading. Cdt1 dissociates from Mcm2-7 after loading. Another 
Mcm2-7 hexamer is subsequently loaded in head-to-head conformation (Model template from 
Bleichert, Botchan, and Berger 2015).  
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ORC is a hexameric complex with ATPase activity and ATP-dependent DNA contact 
(Bleichert, Botchan, and Berger 2015). After ORC binding, the ATPase Cdc6 is 
recruited and DNA-bound ORC-Cdc6 initiates Cdt1 association. Cdt1 chaperones 
Mcm2-7 (for Minichromosome Maintenance) loading, the ring-structured core of the 
replicative helicase (Remus et al. 2009; Bell and Kaguni 2013). Cdc6 hydrolyses ATP 
only when bound to ORC and is required for proper Mcm2-7 loading. Mcm2-7 
helicases are sequentially loaded as head-to-head double-hexamer (Remus et al. 2009). 
Interestingly, once Mcm2-7 double-hexamers are loaded, ORC, Cdc6, and Cdt1 are 
no longer required for replication initiation (Hua and Newport 1998; Yeeles et al. 
2015). Pre-RC assembly is restricted to G1-phase when cyclin-dependent kinase 
(CDK) activity is low. Licensed origins are then competent for replication activation.  
1.1.2 REPLICATION ACTIVATION IN S-PHASE: FROM PRE-REPLICATION COMPLEX TO 
PRE-INITIATION COMPLEX 
With the onset of DBF4-dependent kinase (DDK) and CDK activity during the 
G1/S-phase transition (for kinase activities, see also Figure 1.2, chapter 1.1.4, p. 5), 
pre-RCs are converted into the pre-initiation complexes (pre-ICs). Pre-IC formation 
involves the binding of further proteins, such as Mcm10, Cdc45, Dbp11 and the 
GINS (Sld5, Psf1, Psf2, Psf3) complex (Gambus et al. 2006). During origin activation, 
several pre-IC proteins, including Mcm2-7, are phosphorylated by CDK and DDK to 
initiate replication (Francis et al. 2009). Cdc45-Mcm2-7-GINS (CMG) represent the 
active replicative helicase, which unwinds the DNA and DNA polymerase loads on 
single-stranded DNA (Ilves et al. 2010). Replication activation involves the 
dissociation of the Mcm2-7 double-hexamer into two active hexamers that originate 
the two replisomes consisting of about 150 proteins replicating DNA bidirectionally 
(Herrera et al. 2015).  
Bidirectional DNA replication involves one strand to be replicated continuously 
(leading strand), while the other strand is synthesized in discontinuous fragments 
(Okazaki fragments), which are subsequently ligated (lagging strand). RNA primase de 
novo generates RNA primers, which are extended by DNA polymerases in 5’ to 3’ 
direction and removed during a maturation process (see also Figure 1.6, p. 14). DNA 
polymerases duplicate several hundreds of kb before replication forks collapse 
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(Fragkos et al. 2015; Petryk et al. 2016). Replication termination happens e.g. when two 
replisomes converge.      
1.1.3 TERMINATING DNA REPLICATION  
Although initiation of DNA replication is well characterized, replication termination 
remains poorly understood. Replication termination mainly occurs when two opposite 
replication forks (from two adjacent origins of replication) collide. Also, termination 
needs to be tightly regulated to prevent premature termination without completing 
replication. The process involves the disassembly of converging replisomes and 
resolution of replication-induced DNA catenated intertwines by topoisomerases 
(Fachinetti et al. 2010). Recent work has shown that the polyubiquitination of the 
Mcm2-7 subunit Mcm7 at the end of S-phase leads to CMG disassembly (Moreno et 
al. 2014; Maric et al. 2014). However, this ubiquitination is necessary but not sufficient, 
suggesting additional factors being involved in replication termination (Lengronne and 
Pasero 2014).  
1.1.4 CELL CYCLE REGULATION OF DNA REPLICATION: PREVENTING RE-REPLICATION 
AND INCOMPLETE REPLICATION 
It is crucial for genetic stability, that the genome is completely replicated only once per 
cell cycle. The proteins that regulate cell cycle progression (amongst others cyclins, 
CDKs, and ubiquitin ligases) are also tightly linked with the control of DNA 
replication (DePamphilis et al. 2006). Origin licensing only happens in absence of 
DDK and CDKs (Figure 1.2). Existing pre-RCs are inactivated during S, G2 and M, 
preventing repeated licensing and activation (Blow and Dutta 2005; DePamphilis 
2005). As already mentioned in chapter 1.1.2, DDK and CDK phosphorylate several 
members of pre-RC and pre-IC, which leads to replication activation, but also inhibits 
re-licensing of replication origins.   
In metazoans, Cyclin A-Cdk2 phosphorylates Cdt1 and Orc1 (Depamphilis et al. 
2012). Phosphorylation of the Mcm2-7 chaperone Cdt1 in S-phase, leads to its 
ubiquitination, export to the cytoplasm, and subsequent degradation. This process 
ensures Cdt1 protein levels only being present in the nucleus in late mitosis/early G1. 
Additionally, Cdt1 activity is also repressed by Geminin, a specific Cdt1 inhibitor, 
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FIGURE 1.2: CELL CYCLE KINASE ACTIVITIES DETERMINE PRE-RC FORMATION AND ACTIVATION. Pre-
RC assembly happens in absence of kinase activities. With onset of CDKs (red, blue) and DDK. 
(green), replication is activated and re-licensing prevented. (Adapted from PINES 1999). The 
dashed grey line represents expression H4K20 monomethyltransferase PR-Set7 (introduced in 
chapter 1.2.2, p. 10.)  
exclusively existing in metazoans. Geminin is active from S-phase on and degraded 
with the onset of mitosis. Interestingly, Cdt1 recruits Geminin to DNA and their 
binding stabilizes Cdt1, probably securing the availability of Cdt1 for the next G1-
phase (Ballabeni et al. 2004).  
In metazoan cells, ORC subunits are phosphorylated to prevent re-licensing during 
and after S phase (DePamphilis 2005; DePamphilis et al. 2006). Orc1 phosphorylation 
reduces binding affinities to chromatin is followed by ubiquitination and degradation 
(Méndez et al. 2002). Orc2 phosphorylation also dissociates ORC subunits 2-5 from 
DNA (Lee et al. 2012). Orc1 re-associates to chromatin during mitosis to G1 
transition, followed by origin licensing (DePamphilis 2005).   
Replication forks encountering obstacles (such as DNA secondary structures or 
lesions), or reduced deoxyribonucleotide triphosphate (dNTP) pools within the cell 
can lead to replication stress and induce replication fork stalling (Yekezare, Gómez-
González, and Diffley 2013).  For the cell to complete DNA replication, it is crucial 
to activate another licensed origin, that has not been activated so far (dormant origin). 
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Consequently, activation of additional origins decreases inter-origin distances and S-
phase length remains constant (Blow, Ge, and Jackson 2011). Existence of dormant 
origins requires an excess of origin licensing during G1. Only a small proportion of 
licensed origins is actually activated during S-phase, while the vast majority remains 
dormant (Musiałek and Rybaczek 2015) and are evicted during passive replication 
(Kuipers et al. 2011). The choice of which origin to activate is thereby mainly 
stochastic.  
 
FIGURE 1.3: ORIGIN USAGE FREQUENCY DEFINES ORIGIN EFFICIENCY. Pre-RCs are assembled in G1. 
Only a subset is stochastically activated during S-phase, with each cell using a different cohort. 
The frequency of origin usage defines origin efficiency. Origin efficiency is represented 
schematically as result of SNS-seq (explained in chapter 1.4.2).  
1.1.5 METAZOAN ORIGIN LICENSING AND ACTIVATION IS MAINLY STOCHASTIC 
Only a subset of licensed origins is activated with the onset of S-phase and each cell 
uses a different cohort of replication origins. This observation led to the definition of 
origin efficiency as the frequency of a specific origin to be activated in a given cell 
during a given cell cycle (Méchali 2010) (Figure 1.3).   
There are many features identified so far that influence origin licensing and efficiency 
(Figure 1.4). While AT-richness defines ARS elements in yeasts, there is a clear 
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preference for CG-rich regions in mammals (Cayrou et al. 2015). Interestingly, not 
only CG-content, but also potentially resulting three-dimensional G-quadruplex 
structures (G4) impact on origin efficiency (Besnard et al. 2012; Valton et al. 2014; 
Langley et al. 2016). Thereby it remains controversial whether G4s actually positively 
or negatively influence DNA replication (Valton and Prioleau 2016). DNA 
accessibility, as well as specific histone modifications have been linked to active 
replication (introduced in detail in chapter 1.2, p. 8), as well as transcriptional activity 
and enhancer functions. Origins are often more concentrated and active in promoter 
regions, most probably due to open chromatin configurations, as direct interactions 
of transcription factors and replication factors have not been found so far (Fragkos et 
al. 2015). However, while all these different features contribute to origin licensing and 
activation on different levels, none of them is sufficient on its own and it is most likely 
a random combination of these different features that defines an origin (Méchali 
2010).  
 
FIGURE 1.4: DIFFERENT FEATURES INFLUENCE REPLICATION ORIGINS. From DNA sequence to 
structure over chromatin to functional organization, all features have been linked to regulation of 
replication, while none of these features alone define an origin. DNA: AT-rich sequences might 
facilitate replication activation due to lower melting temperatures. Replication and GC-richness 
seems to be mainly linked on the structural level, as G4-structures are enriched at active initiation 
sites. Whether G4-structures facilitate pre-RC binding or replication initiation remains unclear so 
far. Structure: Bent DNA or loop formation might also facilitate pre-RC loading; MAR: matrix 
attachment regions. Local chromatin: nucleosome positioning/ nucleosome-free regions promote 
pre-RC binding, specific histone modification might directly interact with pre-RC components, 
targeting factors (EBNA1, HMGA1a) interact with ORC and direct replication. Functional 
organization: Active transcription/transcriptional regulation through enhancers/promoters have 
been described to influence DNA replication. Direct interactions between replication origin 
factors and transcription factors have not been reported.  (Modified from Méchali 2010). 
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Recent work on the sequencing of Okazaki fragments led to the identification of broad 
(10-100 kb) initiation zones (Petryk et al. 2016, introduced in detail in chapter 1.4, p13). 
The authors claim that broad initiation zones represent replication units, within which 
replication preferentially initiates from multiple inefficient origins but only one single 
origin stochastically fires per cell. This observation also implies the necessity of 
broadly distributed licensed replication origins within such replication units.  
It has been demonstrated, that the number of chromatin-bound Mcm2-7 helicases 
exceeds the number of active origins of ORC by a factor of 10 to 50 (Donovan et al. 
1997; Powell et al .2015; Hyrien 2016). This can be achieved by either i) ORC loading 
several Mcm2-7 double-hexamers which spread from their binding site (Powell et al. 
2015, Drosophila) or ii) ORC loading only one Mcm2-7 double-hexamer at a time, 
associating and dissociating quickly from DNA (Sonneville et al. 2012, C. elegans). 
There is evidence for either mechanism and further investigations will be required to 
conclusively resolve this question.  
Finally, these recent findings evoked the model of the Mcm2-7 
double-hexamer excess influencing organization of replication timing (Das and Rhind 
2016; Hyrien 2016). Replication timing describes the time-point of origin activation 
during S-phase (early, middle, or late). Given that Mcm2-7 helicase activation can 
occur without the presence of ORC, higher densities of Mcm2-7 proteins could define 
early replicating regions, as the probability of early origin firing is simply higher than 
in late replicating domains containing less Mcm2-7 double-hexamers loaded on DNA. 
The organization of replication timing domains is described in chapter 1.3.  
 DNA REPLICATION REGULATION THROUGH CHROMATIN 
Chromatin is a combination of DNA and proteins and ensures DNA compaction in 
the cell. The core unit of chromatin is the nucleosome – 147 bp DNA wrapped 1.7 
times around a histone octamer consisting of two copies of H2A, H2B, H3 and H4.  
The most accessible chromatin level is the 10 nm fiber, often also referred to as “beads 
on a string” while higher order compacted structures constitute condensed chromatin 
(Soshnev, Josefowicz, and Allis 2016). Two main chromatin states exist: i) the compact 
and transcriptionally inactive state of chromatin is called heterochromatin, while ii) 
euchromatin represents accessible, transcriptionally active chromatin. Specific 
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modifications of histone tails regulate chromatin states. Activating histone marks 
often involve acetylation, methylation (e.g. H3K4me1/2/3), and ubiquitination 
(Kouzarides 2007). Main repressing histone modifications associated to gene silencing 
are H3K9me3 and H3K27me3. Histone modifications are recognized by specific 
chromatin readers which recruit other chromatin modifiers or remodelers, establishing 
chromatin as a very dynamic structure, being able to rapidly respond to environmental 
cues and requirements. However, not only histone modifications regulate chromatin 
structure, also nucleosome positioning impacts on chromatin and gene expression. 
Promoters and enhancers frequently exhibit accessible chromatin conformations, to 
allow binding of transcriptional regulators (Kouzarides 2007). Chromatin accessibility 
is not only a feature of transcriptional regulations, also pre-RC proteins preferentially 
bind accessible DNA regions (Méchali 2010; Miotto, Ji, and Struhl 2016), rendering 
chromatin conformation also important for regulation of DNA replication.  
1.2.1 HISTONE MODIFICATIONS REGULATING DNA REPLICATION 
Nucleosome depleted regions (NDRs) mark origins of replication in yeast (Field et al. 
2008), Drosophila (Ding and MacAlpine 2011), Epstein-Barr-Virus (Papior et al. 2012) 
and humans (Miotto, Ji, and Struhl 2016). Nucleosome depletion might also be the 
link between DNA replication and G4 structures, as G4s exclude nucleosomes, 
thereby eventually favoring pre-RC formation (Fenouil et al. 2012; Valton and Prioleau 
2016).   
Transcriptionally active chromatin is marked by active histone modifications, 
typically acetylations of lysine residues of histone H3 and H4 (H3ac, H4ac), and 
H3K4me1/2/3.  Genome-wide studies often correlate active chromatin modifications 
with DNA replication (Cadoret et al. 2008; Sequeira-Mendes et al. 2009; Valenzuela et 
al. 2011; Martin et al. 2011; Picard et al. 2014; Smith et al. 2016; Miotto, Ji, and Struhl 
2016). However, most of these correlations result from the general association of 
replication with accessible chromatin. The only evidence of direct interactions 
between pre-RC components and chromatin regulators is the histone acetyltransferase 
HBO1 (histone acetyltransferase binding to Orc1, (Iizuka et al. 2009; Miotto and Struhl 
2010). HBO1 interacts with Orc1 and Cdt1, and acetylates H4K5 and H4K12 in G1, 
which leads to chromatin decondensation and is necessary for Mcm2-7 loading.  
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In silent chromatin, origin licensing seems to be differently organized. 
Compacted chromatin has no accessible regions for pre-RCs to bind. Peptide-binding 
assays reported H3K9me3 and H3K27me3 peptides to interact with ORC 
components (Vermeulen et al. 2010). It has been shown very recently that pre-RC 
proteins directly interact with H3K9me3 demethylase Kdm4d, which presumably 
removes H3K9me3 to prepare favorable chromatin environment for origin firing (R. 
Wu et al. 2016). However, the question remains of how pre-RC assembly occurs in 
heterochromatin in the first place. One candidate is H4K20me3, which also localizes 
in silent chromatin and has been shown to directly interact with ORC (Vermeulen et 
al. 2010; Kuo et al. 2012; Beck et al. 2012). 
1.2.2 HISTONE 4 LYSINE 20 METHYLATION AFFECTS DNA REPLICATION  
Histone 4 lysine 20 methylation (H4K20me) is for several reasons the most promising 
histone methylation to be directly involved in regulation of DNA replication. First, 
the H4K20 monomethyltransferase PR-Set7 (also known as Set8, SetD8 or KMT5A) 
is cell cycle-dependently regulated, with low protein levels in G1 and complete absence 
in S-phase, while expression increases in G2 and peaks in mitosis (Figure 1.2, grey 
dashed line; S. Wu et al. 2010; S. Wu and Rice 2011). Second, both stabilization of PR-
Set7 expression and depletion of PR-Set7 have severe effects on DNA replication and 
S-phase progression.  Cell cycle regulation of PR-Set7 occurs mainly through the 
CRL4Cdt2 E3 ubiquitin ligase complex that uses PR-Set7 as direct substrate and targets 
it for proteasomal degradation during S-phase (Abbas et al. 2010; Centore et al. 2010; 
Oda et al. 2010). Expression of a non-degradable mutant (PR-Set7PIPmut) leads to DNA 
re-replication, suggesting repeated origin licensing and activation (Tardat et al. 2010; 
Beck et al. 2012). Additional mutation of the SET-domain of PR-Set7, responsible for 
methylation activity, rescues this re-replication phenotype. Complete absence of 
PR-Set7 impairs cell cycle progression and is embryonic lethal at early stages of mouse 
development (Oda et al. 2010; S. Wu and Rice 2011; Beck et al. 2012). PR-Set7 is the 
only enzyme known to catalyze H4K20me1, whereas Suv4-20h1 and –h2 further 
convert H4K20me1 to H4K20me2 and –me3 (Schotta et al. 2004; Schotta et al. 2008; 
Brustel et al. 2011). Interestingly, loss of Suv4-20h1/h2 and H4K20me2/3 results in a 
less severe phenotype than PR-Set7 knock-out (Schotta et al. 2008), strengthening the 
importance for H4K20 methylation states during cell cycle regulation.   
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Artificial targeting of PR-Set7 to an integrated targeting site in the genome 
leads to induction of H4K20me1, conversion to H4K20me2/3 by endogenous Suv4-
20h1/2 enzymes and to pre-RC assembly at the targeting site (Tardat et al. 2010). 
However, while Beck et al. claim necessity of conversion to H4K20me2/3 for efficient 
origin licensing (Beck et al. 2012), half of all detected active origins are found associated 
to H4K20me1 (Picard et al. 2014). Consequently, the exact role of PR-Set7/H4K20 
methylation in origin licensing and/or activation remains to be uncovered. 
 DNA REPLICATION DEPENDS ON NUCLEAR CHROMATIN 
ORGANIZATION  
DNA replication is organized on three different spatial levels. The first organizational 
level was described in detail in the chapter 1.1, consisting in pre-RC formation and 
single origin activation. The second level is composed in replication units (50-120 kb 
in size), which contain several origins from which only one is flexibly activated per 
cell. The third level consists of synchronously firing clusters of active replication units, 
the replication domains (400 kb – 1 Mb), which depend on nuclear 
compartmentalization (Fragkos et al. 2015).  
Replication domains are mainly characterized by their replication timing program. 
Replication timing is established at one precise point during G1 (timing decision 
point), which coincides with chromatin anchorage after mitosis (Pope and Gilbert 
2013). Concordantly, replication domains accord with topologically associating 
domains (TADs) (Pope et al. 2014). TADs were described by recent Hi-C (evolution 
of 3C: chromosome confirmation capture technique) experiments and are units of 
chromatin in spatial proximity, which are separated by distinct conserved boundaries. 
These boundaries are defined at the molecular level by CCCTC-binding factor (CTCF) 
and cohesins (Ciabrelli and Cavalli 2015). Interestingly, TADs are inherited to 
daughter cells after cell division. Furthermore, they are often conserved across cell 
types and species (Gonzalez-Sandoval and Gasser 2016) and are only reorganized 
during lineage specification in embryonic stem cells (Wilson et al. 2016). TADs 
contacting the nuclear lamina are also called LADs (lamin associated domains). LADs 
represent repressive chromatin with low transcriptional activities (Guelen et al. 2008). 
In general, LADs and also TADs with low gene densities and heterochromatin marks 
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are replicated late in S-phase, while early replicating TADs are gene-rich, 
transcriptionally active with active histone modifications (Fragkos et al. 2015) (Figure 
1.5). With the compartmentalization of the genome into replication domains, which 
are further subdivided into replication units, cells reduce the complexity of replication 
origin distribution. Also, replication fork stalling can be resolved at a local level and 
avoids involving the whole cellular organization (Rivera-Mulia and Gilbert 2016b). 
 
FIGURE 1.5: REPLICATION DOMAIN MODEL. Upper panel: Active chromatin TADs replicate early 
in S-phase and locate towards nuclear interior, while heterochromatin TADs replicate late during 
S-phase and locate towards the nuclear periphery (these lamin-associated TADs are also called 
LADs). Lower panel: Replication domains correspond to TADs. TADs are generally identified 
using Hi-C techniques and interactions between regions are plotted as Hi-C interaction heatmaps 
with dark-red regions strongly interacting and light-red regions only showing weak interaction 
(from Rivera-Mulia and Gilbert 2016a). 
In conclusion, replication timing is largely imposed by the nuclear 
compartmentalization of chromatin in TADs and their transcriptional activity. Thus, 
chromatin state within these TADs also defines origin activities. Boundaries of these 
domains are precisely defined by insulators (CTCF, cohesins) and are also 
hypersensitive to DNaseI, indicating a nucleosome- and protein-free chromatin 
environment.  
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 MAPPING OF DNA REPLICATION INITIATION EVENTS 
Several different approaches have been developed to detect active replication initiation 
events in metazoans. Strategies vary from detection of single, defined replication 
origins to revelation of whole replication units.  
1.4.1 SINGLE MOLECULE DNA COMBING 
Single molecule DNA combing consists in pulse-labeling replicating DNA with the 
thymidine analogues CldU and IdU and detecting progress of replication forks by 
fluorescent microscopy. This technique requires uniform spreading of DNA 
molecules on a cover-slip and allows obtaining precise information about replication 
fork speed, fork asymmetry and inter-origin distances within the same DNA molecule 
during the same S-phase. Combining this technique with fluorescence in situ 
hybridization (FISH) allows to map precise loci of interest (Urban et al. 2015). 
However, technical limitations permit only detecting a defined set of single origins and 
efforts are currently made to establish high-throughput origin detection by molecular 
combing (De Carli et al. 2016).    
1.4.2 BUBBLE-SEQUENCING AND SHORT NASCENT STRAND SEQUENCING 
Alternative methods taking advantage of high-throughput sequencing are bubble trap 
or the purification of short nascent strands (SNS) followed by sequencing. Bubble 
trap uses the circular nature of replication bubbles to trap restriction fragments 
containing replication forks in gelling agarose. Purification and subsequent sequencing 
revealed 35000 to 40000 bubble-containing fragments per experiment (Mesner et al. 
2013). However, although bubble trap was shown to contain few false positives 
(Mesner, Crawford, and Hamlin 2006), use of single restriction fragments does not 
allow to recover all possible genomic origins and resolution is limited (Urban et al. 
2015).  
For SNS-seq, short DNA fragments originating from leading strands of active 
replication forks are isolated and sequenced. Application of elevated sequencing depth 
revealed more than 200000 activated origins from bulk cells, representing different 
cohorts of potential origins being used per cell (Besnard et al. 2012). In short, this 
method relies on isolation of 500 - 2500 bp fragments by size fractionation on a 
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sucrose gradient. Exploiting the RNA-primer used to initiate DNA replication, λ-
exonuclease selectively digests all contaminating DNA fragments which are not 
protected by an RNA-primer from the 5’ end. The resulting DNA population 
represents nascent leading strands adjacent to replication origins (Figure 1.6). As λ-
exonuclease digest remains debated in the field for possible biases (favoring detection 
of GC-rich/G4 DNA), nascent DNA can be alternatively labeled with the thymidine 
analogue BrdU and precipitated by immunoprecipitation (Fu et al. 2014). However, 
both methods have been shown to be highly concordant (Smith et al. 2016) and the 
detection of G4-structures at origins has been recently confirmed by an independent 
approach (Langley et al. 2016). Isolation of SNS followed by sequencing has been 
performed on several different organisms, including mouse (Cayrou et al. 2015) and 
human (Besnard et al. 2012; Picard et al. 2014; Cayrou et al. 2015; Smith et al. 2016). 
Thereby, origin efficiency can be deduced from the accumulation of sequencing reads 
per origin (schematically represented in Figure 1.3).  
 
FIGURE 1.6: BIDERECTIONAL DNA REPLICATION REQUIRES LEADING AND LAGGING STRAND 
SYNTHESIS.  RNA primer allow DNA polymerase to start synthesis.  DNA polymerase only 
synthesizes in 5‘  3‘ direction, which leads to the continuously synthesized leading strand and 
the discontinuous Okazaki fragments. 
1.4.3 OKAZAKI-FRAGMENT SEQUENCING 
Isolation and sequencing of Okazaki fragments (OK-seq) not only represents an 
alternative method to detect replication origins, it also allows determining replication 
fork directionality (Petryk et al. 2016). Principal of OK-seq is pulse-labeling of 
Okazaki-fragments with the Thymidine analogue EdU and subsequent size 
fractionation of these fragments (< 200 bp). After biotinylation, adapter ligation, and 
precipitation, Okazaki fragments are sequenced and specific adapters allow to 
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distinguish between Watson (leftward moving fork) and Crick (rightward moving 
fork) Okazaki fragments. Calculation of replication fork directionality (RFD = 
(𝐶𝑟𝑖𝑐𝑘−𝑊𝑎𝑡𝑠𝑜𝑛)
(𝐶𝑟𝑖𝑐𝑘+𝑊𝑎𝑡𝑠𝑜𝑛)
 ) results in ascending (AS), descending (DS), and flat segments of 
different sizes and slopes (see also Figure 4.17 A). AS represent zones of preferential 
replication initiation, while DS are zones of preferential replication termination. The 
amplitude thereby reflects initiation efficiency. A broad initiation zone represents a 
zone of preferential replication initiation with multiple inefficient initiation sites but 
only one single origin firing per cell, corresponding to replication units (chapter 
1.1.5, p. 6). 
Interestingly, these different methods of replication origin detection show little 
concordance. SNS-seq studies already show poor overlap between each other, which 
might result from insufficient sequencing saturation (Urban et al. 2015). Also 
comparison of bubble-seq and SNS-seq only results in little agreement on the local 
level of single origins (Mesner et al. 2013). By contrast, initiation zones detected by 
OK-seq better align to bubbles than to SNS (Petryk et al. 2016). These little 
concordances between different approaches might originate from divergent 
replication events considered. SNS-seq focuses on narrow sites of defined active 
replication events, while bubble-seq and OK-seq both detect broader regions which 
might contain several origins, but only one origin firing per cell. Especially OK-seq 
reveals zones of preferential origin activation within initiation zones and preferential 
replication termination in termination zones. However, this does not limit origins to 
initiation zones, as inefficient origins might also be present (and detected by SNS-seq) 
in termination zones.  
Information about pre-RC sites would help in this context, to bridge the discrepancies 
of the different detection methods. To date, two attempts have been made to perform 
ChIP against ORC components in human cells and will be introduced in the following.      
1.4.4 CHIP-SEQUENCING OF PRE-RC COMPONENTS 
Little is known about genome-wide pre-RC positioning in humans. Major difficulty is 
thereby the low enrichment over background that hampers precise pre-RC detection 
(Schepers and Papior 2010). Due to the low sequence specificity and potentially high 
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on-and-off rates, chromatin association of metazoan ORC is dispersed, especially in 
comparison to other nuclear factors (such as transcription factors). To date, only two 
genome-wide studies are available that target either Orc1 (Dellino et al. 2013) or Orc2 
(Miotto, Ji, and Struhl 2016) in human cells. Dellino et al. overcame the high 
background problem by performing Orc1 ChIP from low-density chromatin. 
Thereby, they detected a prominent association of ORC to transcriptional start sites 
(TSS). However, chromatin selection prior to ChIP also introduced a bias towards 
Orc1 sites belonging to early replication origins (Dellino et al. 2013). Furthermore, 
44% of all Orc1 sites overlap with replication origins identified by SNS-seq (Picard et 
al. 2014) and Orc1 was rather found at borders of replication initiation zones 
determined by OK-seq (Petryk et al. 2016). Miotto et al. performed Orc2 ChIP-seq 
experiments in unfractionated chromatin. Orc2 peaks showed moderate concordance 
with replication origins detected from SNS-seq (13% of all SNS sites located within 
1 kb distance of Orc2 binding sites, 41% within 10 kb distance, Miotto, Ji, and Struhl 
2016). Comparing Orc2 positions with several chromatin features, the authors 
concluded that ORC positioning majorly depends on chromatin accessibility.   
Taken together, these results reveal that while ORC ChIP-seq already shows a certain 
level of concordance with active replication data, the overall picture remains 
incomplete. As ORC does not bind any consensus sequence in humans, but seems to 
solely depend on chromatin accessibility, ORC positions likely vary from cell to cell, 
resulting in a scattered ChIP-seq profile. This phenomenon might be even more 
pronounced for Mcm2-7, as there is evidence for multiple Mcm2-7 helicases at 
individual origins, which might even translocate from their original loading site (Das 
and Rhind 2016; Hyrien 2016). Consequently, Mcm2-7 ChIP-seq would result in a 
broad Mcm2-7 distribution, mostly lacking clear peaks. This is presumably the reason 
why human Mcm2-7 positions have not been assessed so far. However, as Mcm2-7 
helicases can activate replication without spatial proximity to ORC, Mcm2-7 positions 
might be the missing link to conclusively connect replication initiation SNS-seq and 
ORC ChIP-seq results.  
ORC and Mcm2-7 ChIP has been successfully performed in my laboratory focusing 
on latent EBV genome replication.  
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1.4.5 EPSTEIN-BARR VIRUS GENOME AS MODEL OF HUMAN DNA REPLICATION 
Until now, genome-wide pre-RC ChIP experiments in humans have been 
unsuccessful. My laboratory used Epstein-Barr virus (EBV) as model system to study 
the relation between pre-RC formation and origin activation. EBV infects human B-
cells and establishes a persistent latent infection. During latency, the EBV genome is 
maintained autonomously in proliferating cells and is thereby replicated in synchrony 
with the host cell genome by the cellular replication machinery (J. L. Yates and Guan 
1991). For autonomous maintenance of the EBV episome, the cis-acting element oriP 
is required. OriP consists of two distinct elements: the family of repeats (FR-element) 
and the dyad symmetry (DS) element. Both elements contain binding arrays for the 
viral transactivator EBNA1 (Epstein-Barr virus nuclear antigen 1). By binding of 
EBNA1 to the FR-element, the EBV genome is tethered to the host chromatin during 
chromosome segregation (Marechal et al. 1999; Sears et al. 2003; Sears et al. 2004). 
EBNA1 binding to DS targets ORC to oriP, designating oriP as exceptional origin, 
since origin licensing depends on direct interaction between DNA, a targeting factor 
and ORC (Schepers et al. 2001; Ritzi et al. 2003). Thus, oriP represents a very strong 
origin licensing site, however, this is not necessarily accompanied by efficient origin 
activation (Papior et al. 2012). My laboratory took advantage of full chromatinization 
of the EBV genome (166 kbp in size), and high EBV copy-numbers in the Burkitt’s 
lymphoma cell line Raji. Performing ChIP against the pre-RC components Orc2 and 
Mcm3, SNS isolation and micrococcal nuclease (MNase) digest in Raji cells, followed 
by hybridization against a designated microarray, allowed extensive analysis of the 
relation between origin licensing, activation and nucleosome positioning in a cell cycle 
resolved manner. They found 64 pre-RC sites, which also highly correlated with origin 
activation and S-phase-specific MNase sensitivities. Origin activation efficiencies were 
moderately influenced by AT-richness, however pre-RC sites themselves were 
independent of any specific primary motifs (Papior et al. 2012).  
EBV employs cellular replication machinery to duplicate its genome and correlation 
of pre-RC and replication initiation sites provided insights in our understanding of 
replication origin organization in mammalian cells. It also showed that ChIP of human 
pre-RC components is technically feasible and sensibilized for need of careful 
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controls. The next step will be to perform similar analysis on the human genome to 
answer the question of similar pre-RC organization genome-wide.        
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2. AIM OF THE THESIS 
While the regulation of replication initiation in humans is already extensively studied 
and led to the identification of several contributing features, full understanding of the 
regulation of DNA replication can only be provided by combining replication 
initiation with the regulation of pre-RC positioning. Especially Mcm2-7 positioning – 
which has not been assessed so far – is expected to bridge the discrepancies between 
current ORC ChIP-seq and replication initiation data. In my laboratory, human 
pre-RC ChIP has been technically established using the EBV genome as model 
system. Intent of my thesis was to adopt this pre-RC ChIP technique for genome-
wide ChIP-seq in Raji cells, by targeting the two major pre-RC subunits ORC and 
Mcm2-7. Containing the EBV genome as internal reference, Raji cells present the 
perfect control for ChIP-seq result quality. Once established, ChIP-seq will be also 
performed on embryonic stem (hES) cells, in collaboration with my co-supervisor Dr. 
Jean-Marc Lemaitre (Genome and Stem Cell Plasticity in Development and Ageing, 
IRMB, Montpellier, France). When compared to replication initiation, information 
about pre-RC positions and features that drive this positioning will contribute to the 
fundamental understanding of the relation between origin licensing and activation. 
Furthermore, pre-RC positions will be attributed to chromatin features, such as 
histone modifications. There is functional evidence for H4K20 methylation to be 
involved in DNA replication, however, we lack molecular understanding. Thus, ChIP-
seq will also be performed for H4K20me1 and –me3, in order to directly conclude for 
possible implications between either H4K20 methylation and origin licensing. Possible 
candidates will be validated using an EBV-based plasmid system established in our 
2. AIM OF THE THESIS 
20 | 
 
laboratory, to functionally confirm the relation between H4K20 methylation and 
replication.  
Consequently, I aim to combine genome-wide pre-RC positioning with the regulation 
of replication initiation. Simultaneously, I will evaluate the implication of H4K20 
methylation as a promising histone modification candidate for regulation of DNA 
replication licensing and activation both by genome-wide correlation studies and by 
functional approaches.      
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3. MATERIAL AND METHODS 
 MEDIA, MATERIAL, DEVICES, CHEMICALS AND AGENTS 
In the following, cell culture media and supplements (Table 3.1), chemicals and agents 
(Table 3.2), Enzymes (Table 3.3), Kits (Table 3.4), Material (Table 3.5), and devices 
(Table 3.6) used in this work are listed.   
Table 3.1 lists all media, supplements, antibiotics, and other substances that were used 
for cell culture.  
TABLE 3.1: CELL CULTURE MEDIA, SUPPLEMENTS, ANTIBIOTICS AND AGENTS. 
Cell culture media and supplements Distributor 
BD Matrigel BD Biosciences 
CryoStor CS10  STEMCELL, Canada 
Dimethylsulfoxide (DMSO) Carl Roth GmbH, Germany 
DMEM, high glucose, L-Glutamine Gibco, Thermo Fisher, USA 
Essential 8 Basal Medium + supplement Gibco, Thermo Fisher, USA 
Fetal calf serum (FCS) Lot BS225160.5, Bio&SELL, Germany 
G418 Carl Roth GmbH, Germany 
L-Glutamin Gibco, Thermo Fisher, USA 
Lipofectamine 2000 Invitrogen, Germany 
MEM non-essential amino acids Gibco, Thermo Fisher, USA 
PBS Dulbecco, pH 7.2 Biochrom AG, Berlin 
Penicillin Streptomycin Gibco, Thermo Fisher, USA 
RPMI 1640 Gibco, Thermo Fisher, USA 
Sodium pyruvate Gibco, Thermo Fisher, USA 
TripLE Select  Life technologies, USA 
Trypsin-EDTA Gibco, Thermo Fisher, USA 
Versene solution Gibco, Thermo Fisher, USA 
Zeocine Invitrogen, Germany 
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In the following Table 3.2, all chemicals and agents used during this work are specified.  
TABLE 3.2: CHEMICALS AND AGENTS. 
Chemicals and agents Distributor 
Ampicillin sodium salt Carl Roth GmbH, Germany 
ATX Ponceau S red staining solution Fluka Analytical, Germany 
Bovine serum albumin Sigma-Aldrich, Germany 
Bradford reagent, Bio-Rad protein assay Bio-Rad, Germany 
Chloroform Merck-Eurolab GmbH, Germany 
Deoxycholic acid (DOC) Sigma-Aldrich, Germany 
Dithiothreitol (DTT) Sigma-Aldrich, Germany 
EGTA, Titriplex® Merck Millipore, Germany 
Ethanol Merck-Eurolab GmbH, Germany 
Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH, Germany 
Formaldehyde, MeOH-free Thermo Scientific, USA 
Glycerol AppliChem GmbH, Germany 
Glycine Carl Roth GmbH, Germany 
HEPES Sigma-Aldrich, Germany 
Isoamyl alcohol Merck-Eurolab GmbH, Germany 
Methanol Merck-Eurolab GmbH, Germany 
NP-40 (Igepal CA-630) Sigma-Aldrich, Germany 
Phenol Carl Roth GmbH, Germany 
Polyacrylamide Carl Roth GmbH, Germany 
Propidium iodide Sigma-Aldrich, Germany 
Salmon sperm  Invitrogen, Germany 
Sodium chloride Merck-Eurolab GmbH, Germany 
Sodium dodecylsulfate (SDS) Serva Electrophoresis GmbH, Germany 
Sodium lauroyl sarcosinate (Sarkosyl) Sigma-Aldrich, Germany 
Tris AppliChem GmbH, Germany 
Triton-X-100 Sigma-Aldrich, Germany 
Tween-20 AppliChem GmbH, Germany 
 
Table 3.3 shows all enzymes employed during the study. 
TABLE 3.3: ENZYMES.  
Enzymes Distributor 
Benzonase Sigma-Aldrich, Germany 
DNase Roche, Germany 
DpnI New England Biolabs, USA  
Protease inhibitor complete Roche, Germany 
Proteinase K Roche, Germany 
RNase, DNase-free Roche, Germany 
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Kits used during this work are listed in Table 3.4.  
TABLE 3.4: KITS. 
Kits Distributor 
BD StemflowTM Human and Mouse 
Pluripotent Stem Cell Analysis Kit 
BD Biosciences, Germany 
NTB buffer Macherey-Nagel, Germany 
NucleoSpin Extract II Kit Macherey-Nagel, Germany 
Qubit HS dsDNA Invitrogen, Germany 
SYBR Green I Master Roche, Germany 
 
In Table 3.5, all material needed for the experiments are specified.  
TABLE 3.5: MATERIAL. 
Material Distributor 
AFA Fiber & Cap tubes (12x12 mm) Covaris Inc., UK 
Amersham Hybond ECL GE Healthcare, Germany 
CEA Blue Sensitive X-ray films Agfa Healthcare, Germany 
Cell culture dishes and 6-well plates Nunc GmbH, Germany 
Cell strainer, 40 µm, 100 µm Corning Inc., USA 
CoolCell LX Freezing Container Sigma-Aldrich, Germany 
Cryotubes Nunc GmbH, Germany 
Nalgen Nunc Cryo 1°C freezing container Nunc GmbH, Germany 
 
Table 3.6 names the devices used during this work.  
TABLE 3.6: DEVICES. 
Devices Distributor 
Beckman JE-5.0 rotor with a large separation 
chamber 
Beckman-Coulter, Germany 
Cole-Parmer Masterflex pump Cole-Parmer, USA 
FACSCaliburTM BD Biosciences, Germany 
semiDry blotting system Hoefer Scientific Instruments, USA 
Covaris S220 Covaris Inc., Germany 
NanoDrop ND-1000 Spectrometer ThermoScientific, USA 
Qubit fluorometer Invitrogen, Germany 
Roche LightCycler 480 System Roche, Germany 
Optimax X-ray film processor Rotec GmbH, Germany 
Electroporation system Gene-Pulser II Bio-Rad Laboratories, USA 
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 BIOLOGICAL METHODS 
3.2.1 CELL CULTURE 
Cells with corresponding AGV-internal identification number, a short description and 
the respective media are listed in Table 3.7. More detailed cultivation information is 
given in the following. 
RAJI CELLS 
Raji cells (ATCC) were cultivated at 37°C and 5% CO2 in RPMI 1640 (Gibco, Thermo 
Fisher, USA) supplemented with 8% FCS (Lot BS225160.5, Bio&SELL, Germany), 
100 Units/ml Penicillin/ 100 µg/ml Streptomycin (Gibco, Thermo Fisher, USA), 1x 
MEM non-essential amino acids (Gibco, Thermo Fisher, USA), 2 mM L-Glutamin 
(Gibco, Thermo Fisher, USA), and 1 mM Sodium pyruvate (Gibco, Thermo Fisher, 
USA). Cells were routinely diluted to 2x105 cells/ml and maximally grown to a density 
of 5x105.  
ADHERENT HEK293 CELLS 
HEK293 EBNA1+ cells were cultivated at 37°C and 5% CO2 in DMEM (Gibco, 
Thermo Fisher, USA) supplemented with 8% FCS (Lot BS225160.5, Bio&SELL, 
Germany), 100 Units/ml Penicillin/ 100 µg/ml Streptomycin (Gibco, Thermo Fisher, 
USA), and 220 µg/ml G418 (Carl Roth GmbH, Germany). Cells were grown to 80% 
confluence and routinely split 1:4. Therefore, cells were washed with PBS, treated with 
0.25% Trypsin-EDTA (Thermo Fisher, USA) for 2 min at 37°C, carefully resuspended 
in new medium and seeded on a new culture dish.   
GENERATING STABLE HEK293 CELL LINES 
Cells were seeded in a 6-well (Nunc GmbH, Germany) to a density of 2x105 and 
transfected with 3 µg linearized expression plasmid (see also Table 3.7) using 
Lipofectamine2000 according manufacturer’s instructions (Invitrogen, Germany). 
Transfected cells from one 6-well were plated in medium with 20 µg/ml Zeocine 
(Invitrogen, Germany) on three 150 mm culture dishes (Nunc GmbH, Germany) the 
next day. After two to three weeks, single colonies were selected and expanded in 
6-well plates. Expression of the protein of interest was verified by immunoblot. 
Positive clones were expanded and frozen.       
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HES CELLS H9 
HES cells were cultivated in standard conditions (Ludwig et al. 2006) at 37°C, 5% CO2. 
The hES cell line H9 was cultivated on BD Matrigel (Basement membrane matrix, BD 
Biosciences) covered dishes. From BD Matrigel stocks, 72 µl aliquots were routinely 
prepared in chilled 2 ml Eppendorf tubes and stored at -20°C. For BD Matrigel 
preparation, one aliquot was thawed, resuspended in 1.5 ml Essential 8 Basal Medium 
(Gibco, Thermo Fisher, USA) and mixed with 4.5 ml medium (6 ml total). Of this 
mixture, 1 ml was distributed per 35 mm dish and incubated for at least 30 min at 
37°C. For larger plates, surfaces and volumes were upscaled accordingly.   
For passaging, cells were washed twice with PBS, 1 ml of Versene solution (Gibco, 
Thermo Fisher, USA) was added per 35 mm dish. Before cells detached, Versene 
solution was removed, new medium added and cells were gently detached from the 
dish. Cells were routinely diluted 1:6 once per week. Medium was changed every day.         
CRYOPRESERVATION 
HEK293 and Raji cells were concentrated by centrifugation (200g, 7 min, room 
temperature) and the cell pellet was resuspended in FCS 10% DMSO to a 
concentration of ~ 5x107 cells/ml (HEK293) and 5x106 cells/ml (Raji cells). 1 ml cell 
suspension was aliquoted in 2 ml cryotubes (Nunc GmbH, Germany) and slowly 
cooled at a rate of -1°C/ min in a Nalgen Nunc Cryo 1°C freezing container (Nunc 
GmbH, Germany) at -80°C. After few days, cells were transferred in liquid nitrogen 
for long term storage. For thawing, cells were incubated at 37°C in water bath, washed 
with 30 ml fresh pre-warmed medium and plated accordingly. 
HES cells were detached as previously described and concentrated by centrifugation 
(300g, 5 min, room temperature). 106 cells were resuspended in 1 ml CryoStor CS10 
(STEMCELL, Canada), transferred to 2 ml cryotubes, placed in CoolCell LX Freezing 
Container (Sigma, Germany) at -80°C. After few days, cells were transferred in liquid 
nitrogen. 
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TABLE 3.7: ESSENTIAL CELL LINE INFORMATION. 
Cell lines (AGV 
identification) 
Description Medium 
Raji (#1577) EBV-containing Burkitt’s 
lymphoma cell line 
RPMI 1640, 8% FCS, 1% 
Penicillin/ Streptomycin, 
2 mM Glutamin, 1% 
MEM Non-essential 
amino acids, 1 mM 
Sodium Pyruvate   
HEK293 
EBNA1+(#1803) 
Human embryonic kidney 
cells, stably expressing 
EBNA1 
DMEM, 8% FCS, 1% 
Penicillin/ Streptomycin, 
220 µg/ml G418 
HEK293 EBNA1+ Gal4 
(#2116) 
Generated from cell line 
#1803 by integrating 
expression plasmid p5237 
DMEM, 8% FCS, 1% 
Penicillin/ Streptomycin, 
220 µg/ml G418, 20 
µg/ml Zeocine 
HEK293 EBNA1+ Gal4-
Suv4-20h1 (#2680) 
Generated from cell line 
#1803 by integrating 
expression plasmid p5572 
DMEM, 8% FCS, 1% 
Penicillin/ Streptomycin, 
220 µg/ml G418, 20 
µg/ml Zeocine 
HEK293 EBNA1+ Gal4-
PR-Set7 (#2113) 
Generated from cell line 
#1803 by integrating 
expression plasmid p5235 
DMEM, 8% FCS, 1% 
Penicillin/ Streptomycin, 
220 µg/ml G418, 20 
µg/ml Zeocine 
HEK293 EBNA1+ Gal4-
PR-Set7SETmut (#2188) 
Generated from cell line 
#1803 by integrating 
expression plasmid p5236 
DMEM, 8% FCS, 1% 
Penicillin/ Streptomycin, 
220 µg/ml G418, 20 
µg/ml Zeocine 
hES cells H9 (cultivated at 
the IRMB, Montpellier) 
Human embryonic stem 
cell line, cultivated from 
passage 15 to 24 
Essential 8 Basal Medium 
+ Essential 8 Supplement 
3.2.2 CELL CYCLE FRACTIONATION BY CENTRIFUGAL ELUTRIATION 
For centrifugal elutriation, 5x109 exponentially growing Raji cells were harvested, 
washed with PBS and resuspended in 50 ml RPMI 1640/ 8% FCS/ 1mM EDTA/ 
0.25 U/ml DNaseI (Roche, Germany). Concentrated cell suspension was passed 
through 40 µm cell strainer and injected in a Beckman JE-5.0 rotor with a large 
separation chamber turning at 1500 rpm and a flow rate of 30 ml/min controlled by 
a Cole-Parmer Masterflex pump. While rotor speed was kept constant, 400 ml 
fractions were collected at increasing flow rates (40, 45, 50, 60, 80, 100ml/min). 
Individual fractions were quantified, 5x106 cells taken for propidium iodide stain and 
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subsequent FACS analysis, while the remaining cells were subjected to cross-link 
(chapter 3.2.6, p. 30).   
3.2.3 FLUORESCENCE ACTIVATED CELL SORTING (FACS) 
CELL CYCLE DETERMINATION BY FACS 
Cells from elutriation fractions (5x106 cells) were washed with PBS, resuspended in 3 
ml PBS (4°C) and fixed by addition of 7 ml ice-cold 100% EtOH for at least 30 min 
at -20°C. After centrifugation at 400g for 5 min at 4°C, the pellet was washed with 
PBS 4°C and resuspended in 500 µl PBS 4°C. After 5 min of RNase (200 µg/ml final) 
treatment, propidium iodide (0.5 mg/ml in PBS) was added to a final concentration 
of 50 µg/ml and cells were subjected to FACSCaliburTM (BD Biosciences, Germany) 
detection by the FL2 channel. 
DETECTION OF PLURIPOTENCY MARKERS BY FACS 
hES cells were stained and assessed for pluripotency markers with the BD StemflowTM 
Human and Mouse Pluripotent Stem Cell Analysis Kit (BD Biosciences) according to 
manufacturers’ instructions. 
3.2.4 IMMUNOBLOT 
VERIFICATION OF STABLE CELL LINES  
Cell extracts were prepared using NP-40 lysation. Cells were washed with ice-cold PBS 
and 400µl NP-40 extract buffer (4°C) were added to 15 cm culture dish. Cells were 
scraped off the plate and transferred to 1.5 ml Eppendorf tube. After 30 s vortex and 
15 min on ice, cell lysate was centrifuged (16.100 g, 10 min, 4°C) and supernatant was 
kept for experiments or long term storage at -20°C. 
Protein concentration was determined using Bradford reagent (BioRad, USA) and 
50 µg protein extract with 1X Laemmli was loaded on the gel.   
Proteins were separated on a 10% SDS-polyacrylamide gel and blotted on Amersham 
Hybond ECL (GE Healthcare, Germany) membrane using semiDry blotting system 
(Hoefer Scientific Innstruments, USA). Successful protein separation was verified by 
ponceau stain (ATX Ponceau S red staining solution; Fluka Analytical, Germany) and 
the membrane was blocked for at least 30 min in PBS, 1% Tween-20 (AppliChem 
GmbH, Germany), 5% milk. Incubation with primary anti-Gal4 (DBD) (sc-577, Santa 
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Cruz Biotechnology) antibody (1:400 in PBS 1% Tween-20) was performed for 16h 
at 4°C, membrane was washed 3x 10 min with PBS 1% Tween-20 and incubated with 
anti-rabbit-HRP (Jackson ImmunoResearch Inc., USA) 1:10000 secondary antibody 
in PBS 1% Tween-20, 2.5% milk for 1 h at room temperature. After repeated washing 
steps, revelation was done using ECL on CEA Blue Sensitive X-ray films (Agfa 
Healthcare, Germany).  
NP-40 extract buffer: 150 mM NaCl, 50 mM HEPES, 5 mM EDTA, 0.1% (v/v)  
  NP-40, freshly add 1x protease inhibitor complete (EDTA-free, Roche, 
Germany) 
5X Laemmli buffer: 250 mM Tris pH 6.8 (2M), 10% SDS, 500 mM DTT, 25% 
Glycerol, 0.5% Bromphenolblue 
10% polyacrylamide running gel: 10% polyacrylamide (Carl Roth GmbH, 
Germany), 3.4 mM SDS, 375 mM Tris pH 8.8 
Stacking gel: 4% polyacrylamide (Carl Roth GmbH, Germany), 3.4 mM SDS, 125 
mM Tris pH 6.8  
1X running buffer: 192 mM Glycine, 24 mM Tris pH 7.4, 3.4 mM SDS 
Blotting buffer: 1X running buffer, 20% MeOH 
ECL solution: 1 ml solution A, 3 µl solution B 
 Solution A: 100mM Tris pH 8.8, 200 mM p-cumaric acid, 1.25 mM Luminol 
 Solution B: 3% (v/v) H2O2 
HISTONE IMMUNOBLOT 
RIPA protein extraction was performed by trypsinizing HEK293 cells, washing with 
ice-cold PBS, adding two pellet volumes RIPA extract buffer (+ 1X complete protease 
inhibitor, Roche) and incubation for 20 minutes on ice. After 30 seconds vortex, 50 
U Benzonase (Sigma, Germany) were added for 15 minutes at room temperature. 
Extract was centrifuged (16100 g, 15 min, 4°C), supernatant transferred to a new tube 
and subjected to immunoblot or stored at 20°C for long term storage.  
Extract (50 µg) was loaded on a 15% layered with 12.5% polyacrylamide gel and 
treated as described above. Antibody dilutions were applied as listed in Table 3.8. 
RIPA extract buffer: 50 mM Tris-HCl pH 7.9, 150 mM NaCl, 1% NP-40, 0.5% 
DOC, 0.1% SDS 
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15% polyacrylamide gel: 15% polyacrylamide (Carl Roth GmbH, Germany), 3.4 
mM SDS, 375 mM Tris pH 8.8 
12.5% polyacrylamide gel: 12.5% polyacrylamide (Carl Roth GmbH, Germany), 
3.4 mM SDS, 375 mM Tris pH 8.8 
TABLE 3.8: HISTONE ANTIBODIES AND RESPECTIVE DILUTIONS FOR IMMUNOBLOT. 
Target protein Antibody Dilution in PBS 1% 
Tween 
H4K20me1 Cell Signaling 9724S 1:1000 
H4K20me2 Cell Signaling 9759S 1:1000 
H4K20me3 Cell signaling 5737S 1:1000 
H3K4me3 Abcam 8580 1:1000 
H3K9me3 Active Motif 39161 1:1000 
H3K27me2/3 Active Motif 39536 (use 
anti-mouse-HRP 
secondary antibody) 
1:1000 
H4 Abcam 31830 (use anti-
mouse-HRP secondary 
antibody) 
1:1000 
3.2.5 PLASMID ABUNDANCE ASSAY 
GFP-positive reporter plasmids (1µg, Table 3.9) were transfected into HEK293 
EBNA1+ cell line stably expressing the respective GAL4-fusion protein using 
Lipofectamine2000 (Invitrogen, Germany) according to manufacturer’s instructions. 
Transfections with comparable efficiencies were verified by visualizing GFP-positive 
cells. Six days post-transfection, cells were harvested according to the HIRT protocol 
(Hirt 1966). After washing with PBS, cells were equilibrated in 5ml TEN buffer. TEN 
was removed and cells were collected in 1,5 ml TEN buffer and an equal volume of 
2X HIRT buffer. The lysate was then incubated at 4°C for 16h, in the presence of 
1.25 M NaCl. After centrifugation at maximal speed, 4°C for 1h, DNA was purified 
by phenol-chloroform extraction (with Phenol/ Phenol-Chloroform/ Chloroform-
Isoamyl alcohol steps). After precipitation, DNA was digested with 40 U DpnI (NEB, 
USA) in presence of 200µg/ml RNase (Roche, Germany). Digested DNA (300 ng) 
was electroporated into Electromax DH10B competent cells (Invitrogen, Germany) 
and ampicillin-resistant colonies, representing the number of recovered plasmids, 
were counted. The FR-DS plasmid was always transfected in parallel and the number 
of resulting colonies was used for normalization. 
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The Suv4-20h1/2 inhibitor A-196 (kind gift of Structural Genomics Consortium 
(SGC)) was added to a final concentration of 5 µM immediately after transfection to 
the cell culture medium and the cells were kept under 5% O2 during A-196 treatment. 
Medium was exchanged every second day. 
TEN buffer: 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl 
2x HIRT buffer: 1.2% SDS, 20 mM Tris-HCl pH 7.5, 20 mM EDTA 
TABLE 3.9: REPORTER PLASMIDS USED FOR PLASMID ABUNDANCE ASSAYS AND PLASMID CHIPS. 
Plasmid (AGV identification) Plasmid name 
p3230 FR-DS 
p5233 FR-UAS-DS 
p5234 FR-UAS 
p3244.2 FR-oriRDH 
p5588 FR-UAS-oriRDH 
3.2.6 CROSS-LINK  
RAJI CELLS (STANDARD PROTOCOL)  
Cells were washed twice with PBS, resuspend in PBS to a concentration of 2x107 
cells/ml and passed through 100 µm cell strainer (Corning Inc., USA). An equal 
volume of PBS 2% methanol-free formaldehyde (Thermo Scientific, USA) was added 
and cells were fixed for 5 minutes on a roller at room temperature. The cross-linking 
reaction was then quenched with glycine (125 mM final concentration) and incubated 
for another minute on the roller. After washing once with PBS and once with PBS 
0.5% NP-40, cells were resuspended in PBS containing 10% glycerol, pelleted and 
snap frozen in liquid nitrogen. 
HES CELLS 
HES cells are more fragile and need to be resuspended with care. Cells were covered 
with 10 ml TripLE Select (Life technologies, USA) on a 15 cm dish and incubated 
until cells detach. Cells were dissociated by carefully resuspending once, transferred to 
centrifugation tube and washed once with PBS. Cell concentration was adjusted to 
2x107 cells/ml in PBS, passed through 100 µm cell strainer and cross-link was 
performed according to the standard protocol.   
 
  3. MATERIAL AND METHODS 
31 | 
 
HEK293 
Transfected HEK293 EBNA1+ cell lines were trypsinized, washed twice in PBS and 
standard cross-link protocol was performed.   
3.2.7 CHROMATIN IMMUNOPRECIPITATION (CHIP) 
SONICATION 
Cross-linked cell pellets were thawed on ice for 15 min and resuspended for lysis in 
LB3+ buffer to a final concentration of 2x107 cells/ml. Sonication was performed in 
AFA Fiber & Cap tubes (12x12 mm, Covaris, Great Britain) at an average temperature 
of 5°C according the settings established for each cell line (Table 3.10) using the 
Covaris S220 (Covaris Inc., Great Britain) .  
TABLE 3.10: SONICATION SETTINGS ESTABLISHED FOR EACH CELL LINE. 
Cell line Sonication settings 
Raji 100W, 150 cycles/burst, 10% duty cycle, 
20 min (S-phase: 17 min) 
hES 100W, 150 cycles/burst, 10% duty cycle, 
14 min 
HEK293 EBNA1+ Gal4-fusion 150W, 200 cycles/burst, 20% duty cycle, 
20 min 
 
IMMUNOPRECIPITATION 
After sonication, sheared chromatin was pre-cleared with 50 µl protein A beads 
(protein A Sepharose 4 Fast Flow, GE Healthcare, Germany; washed 3x in PBS, 50% 
bead slurry prepared) per 500 µg chromatin for 2h. Chromatin concentration was 
measured by NanoDrop ND-1000 Spectrometer (ThermoScientific, USA). An 
appropriate amount of chromatin was incubated with the respective antibody (for 
plasmid ChIPs see Table 3.11, for ChIP-seq see Table 3.12) for 16h at 4°C. BSA-
blocked protein A beads (incubated for 2h on roller in blocking solution at 4°C; 
protein G beads (protein G Sepharose 4 Fast Flow, GE Healthcare, Germany) were 
used for antibodies raised in mouse) were then added (50 µl/ 500 µg chromatin) and 
incubated for at least 4h on orbital shaker at 4°C. Sequential washing steps with RIPA-
150 mM NaCl, RIPA-300 mM NaCl, LiCl buffer and finally twice in TE (pH 8.0) 
buffer were performed. Immunoprecipitated chromatin fragments were eluted from 
the beads by shaking twice at 1200 rpm for 10 min at 65°C with 100µl of TE and 1% 
SDS. The elution was treated with 80 µg RNAse A (Roche, Germany) for 2h at 37°C 
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and with 8 µg proteinase K (Roche, Germany) at 65°C for 16h. DNA was purified 
using the NucleoSpin Extract II Kit (and NTB binding buffer for SDS containing 
samples) according to manufacturer’s instructions. Quantitative PCR analysis was 
performed as described in 3.2.8, p. 33 and quantitative PCR values were represented 
as fold enrichment relative to isotype IgG control. Chromatin sizes were verified by 
loading 1-2 µg chromatin on an 1.5% agarose gel. Samples intended for ChIP-seq were 
quantified using Qubit HS dsDNA (Invitrogen, Germany).  
LB3+ buffer: 25 mM HEPES (pH 7.5), 140 mM NaCl, 1 mM EDTA, 0.5 mM  
  EGTA, 0.5% Sarcosyl, 0.1% DOC, 0.5% Triton-X-100, 1X protease inhibitor  
  complete (Roche, Germany) 
Blocking solution: 0.5 mg/ml BSA, 30 µg/ml salmon sperm (Invitrogen, 
Germany), 1X protease inhibitor complete, 0.1% Triton-X-100 in LB3(-) buffer 
(without detergents) 
RIPA-150 mM NaCl: 150 mM NaCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 50 mM  
  Tris (pH 8.0), 1 mM EDTA 
RIPA-300 mM NaCl: 300 mM NaCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 50 mM  
  Tris (pH 8.0), 1 mM EDTA 
LiCl: 250 mM LiCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 50 mM Tris (pH 8.0), 1 mM  
  EDTA 
1X TE: Tris-EDTA pH 8.0 (Carl Roth GmbH, Germany) 
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TABLE 3.11: ANTIBODIES FOR PLASMID CHIPS IN HEK293 EBNA1+ GAL4-FUSION CELL LINES.  
ChIP target Antibody Amount Chromatin 
Gal4 anti-Gal4 (Santa 
Cruz 
Biotechnologies, 
sc-577) 
2.5 µg 
250 µg 
H4K20me1 anti-H4K20me1 
(Diagenode, MAb-
147-100) 
2.5 µg 
H4K20me3 anti-H4K20me3 
(Diagenode, pAB-
057-050) 
2.5 µg 
Mcm3 anti-Mcm3 
SA8413 
15 µl 
IgG Rabbit IgG 
(Sigma, R2004) 
2.5 µg 
 
TABLE 3.12: ANTIBODIES FOR CHIP-SEQUENCING. 
ChIP target Antibody Amount Chromatin 
Orc2 anti-Orc2 SA93 15 µl 500 µg 
Orc3 anti-Orc3 SA7976 15 µl 500 µg 
Mcm3 anti-Mcm3 
SA8413 
15 µl 500 µg 
Mcm7 anti-Mcm7 
SA8496 
15 µl 500 µg 
H4K20me1 anti-H4K20me1 
(Diagenode, MAb-
147-100) 
2.5 µg 250 µg 
H4K20me3 anti-H4K20me3 
(Diagenode, pAB-
057-050) 
2.5 µg 250 µg 
H4 anti-H4 (Millipore, 
05-838, clone 62-
141-13 
5 µl 250 µg 
IgG Rabbit IgG 
(Sigma, R2004) 
10 µg/ 2.5 µg 500 µg/ 250 µg 
3.2.8 QUANTITATIVE PCR (QPCR) 
Quantitative PCR was performed Roche LightCycler 480 System and the SYBR Green 
I Master (Roche). 2 µl of ChIP elution were mixed with [5 µl 2xSYBR, 2.5 µl H2O, 
0.5 µl 5 µM primer mix]. Amplification was performed using the Roche SYBR 
standard program Table 3.13. QPCR primers are listed in Table 3.14. 
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TABLE 3.13: ROCHE SYBR QPCR STANDARD PROGRAM.  
 Temperature 
[°C] 
Duration [s] Cycles Detection 
Pre-
incubation 
95 300 1  
Amplification 
95 1 
45 
 
60 10  
72 10  
75 3 single 
Melting 
curve 
97 1 
1 
 
67 10, then 
heat to 97°C 
 
97 continuous 
Cooling 37 15   
 
TABLE 3.14: QPCR PRIMERS. 
Primer (Schepers group internal 
numeration) 
Sequence [5’  3’]  
DS_for (575) AGTTCACTGCCCGCTCCT 
DS_rev (576) CAGGATTCCACGAGGGTAGT 
FR_for (276) CGTGCTCTCAGCGACCTCG 
FR_rev (277) TCAAACCACTTGCCCACAAAAC 
UAS_for (270) TTACAGTCCAAAACCGCAGGG 
UAS_rev (271) TTGTCGCTCCGTAGACGAAGC 
oriRDH_for (414) CTGTCTTGGTCCCTGCC 
oriRDH_rev (415) TGCCTTCTCCTTCTCATCC 
Mcm4+_for (776) CTGAAAGAAGCGGCACTGTC 
Mcm4+_rev (777) CTCACCAATCACAGCGGC 
Mcm4-_for (778) CCACCCAGGCATTGCTAAAG 
Mcm4-_rev (779) CCCCTCTATTTGCCGTTCCT 
BANF1+_for (772) CCTCCCTTGTCCGTCTTCTA 
BANF1+_rev (773) GACCCGGAACTCAAGGACTTA 
H4K20me1+_GAPDH_for (629) ATGCCTTCTTGCCTCTTGTC 
H4K20me1+_GAPDH_rev (630) AGTTAAAAGCAGCCCTGGTG 
H4K20me3+_ZNF180_for (621) TCTGAGCAGGGTTGCAAGTAC 
H4K20me3+_ZNF180_rev (622) AAGGAAATGATGCCCAGCTG 
3.2.9 SEQUENCING 
The Genomics unit of LAFUGA (headed by Helmut Blum, LMU Munich) performed 
ChIP sample library preparations from > 4 ng of ChIP-DNA using Accel-NGS® 1S 
Plus DNA Library Kit for Illumina (Swift Biosciences). 50 bp single-end sequencing 
was done with the Illumina HiSEQ 1500 sequencer to a sequencing depth of ~ 70 
million reads (for pre-RC) and 35 million reads (for histone modifications).  
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 BIOINFORMATICS 
Programs used for bioinformatics analyses are listed in Table 3.15. 
TABLE 3.15: PROGRAMS USED DURING BIOINFORMATIC ANALYSIS. Program sources are indicated. 
[Typo] marks terminal commands.  
Program Source 
Bowtie1 (1.1.1) https://sourceforge.net/projects/bowtie-
bio/files/bowtie/1.1.1/ 
R (3.2.3) https://cran.rstudio.com/ 
R package GenomicRanges 
(1.22.4) 
In R: install.packages(“package”) 
library(package) 
R package IRanges (2.4.8) 
R package S4Vectors (0.8.11) 
R package BiocGenerics 
(0.16.1) 
R package RColorBrewer 
(1.1-2) 
R package gplots (3.0.1) 
MACS2 (8.1.2) pip install macs2 
HOMER (v4.8) http://homer.salk.edu/homer/ 
T-PIC Download scripts from 
http://www.math.miami.edu/~vhower/tpic.html 
Bedtools (2.25.0) https://github.com/arq5x/bedtools2/releases 
CEAS (1.0.2) http://liulab.dfci.harvard.edu/CEAS/download.html 
Venn Diagram Plotter https://omics.pnl.gov/software/venn-diagram-
plotter 
3.3.1 BOWTIE MAPPING OF SEQUENCING READS AGAINST THE GENOME 
Fastq-files from sequencing were mapped against the human genome (hg19, GRCh37, 
version 2009), extended for the EBV genome (NC007605) using the bowtie 
command:  
bowtie -m 1 index file.fastq 
3.3.2 GENERATION OF PILEUP PROFILES 
Pileup profiles were generated in R by extending 50 bp reads by 150 bp and calculating 
the number of reads per base. The coverage was either saved as .wig files for 
visualization in IGB or as .rda for coverage analyses.  
 
3. MATERIAL AND METHODS 
36 | 
 
3.3.3 MACS2, HOMER, AND T-PIC PEAK-CALLING 
PEAK-CALLING ON THE EBV GENOME 
Peak-calling on the EBV genome was performed using the following commands. 
Commands in italics are variable and adapted for each file. 
 MACS2:  
macs2 callpeak -t ChIP.bam -c input.bam -f BAM -g 1.75e5 
-n output_name -B -q 0.01 –nomodel 
 HOMER:  
1. create tag directory: 
makeTagDirectory tags_name1 input.bam –single 
makeTagDirectory tags_name2 ChIP.bam –single 
2. perform peak calling: 
findPeaks tags_name2 -i tags_name1 -style factor -size 
200 -fragLength 200 -inputFragLength 200 -C 0 > 
output_name.txt 
3. convert .txt to .bed 
pos2bed.pl output_name.txt > output_name.bed 
 T-PIC:  
T-PIC uses scripts running in perl and R (download scripts from 
http://www.math.miami.edu/~vhower/tpic.html). The scripts need to be placed the 
same folder as ChIP and input .bed files. Scripts have to be adapted for each filename 
and each genome (create_coverage.pl: my $bed_filename = "ChIP.bed"; 
zeta.pl: my $bed_filename = "ChIP.bed", my $input_filename = 
"input.bed"). For T-PIC peak-calling on the EBV genome, both scripts also need 
to be adapted for detecting the EBV “chromosome” (my @index_set = 
("EBV")).  
PEAK-CALLING ON THE HUMAN GENOME 
The HOMER peak-calling command for the human genome does not differ from 
EBV. For histone ChIPs, the – style parameter was changed to “histone”.  
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For T-PIC peak calling, the scripts run with the human and filenames have to be 
modified as described previously. 
MACS2 peak-calling for hES cells samples was performed with the following 
command:  
macs2 callpeak -t ChIP.bed -c input.bed -g hs --broad -B 
-f BEDPE -n output_name 
3.3.4 DEFINITION OF ORC, MCM2-7, AND PRE-RC 
Complexes were calculated by first merging overlapping peaks, counting the number 
of overlapping events and retaining only the positions display sufficient overlaps:   
3.3.5 PEAK COMPARISONS: JACCARD INDEX AND OVERLAPS 
JACCARD INDEX 
Jaccard index was calculated using the “bedtools jaccard” function applied for 
every possible ChIP combination. Heatmap representation was calculated in R.   
OVERLAPS 
Overlaps of peak/ complex positions were calculated using the “bedtools 
intersect” function. Thereby, overlaps of the query files were calculated in both 
directions, merged, and the unique positions of every file were also retained. The 
results were used for Venn Diagram generation using VennDiagramPlotter.  
3.3.6 CALCULATING GENOMIC DISTRIBUTIONS WITH CEAS 
The genomic distribution of peaks or complexes were calculated using the command  
ceas --name=output_name -g hg19.refGene -b 
ChIP/COMPLEX.bed 
Thereby, hg19.refGene was downloaded from http://liulab.dfci.harvard.edu/CEAS/ 
download.html. The results of interest were extracted and used for differential 
representation in R.  
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4. RESULTS AND DISCUSSION 
To date, little is known about the mechanisms that define pre-RC formation and 
activation in mammals. Because PR-Set7 and consequently H4K20 methylation clearly 
impact on DNA replication, I decided to receive a first impression of the relationship 
between replication licensing and H4K20 methylation by ChIP-seq in human cells. I 
targeted both H4K20me1 and H4K20me3, as well as four different members of the 
pre-RC complex, targeting the two major subunits ORC and Mcm2-7: Orc2, Orc3, 
Mcm3, and Mcm7. In the following chapters, I will refer to the setup of ChIP 
experiments in both human lymphoblastoid Raji cells and hES cells H9. Further, I will 
detail the analysis of sequencing results and resulting conclusions in Raji cells, and a 
functional approach to functionally validate the relation between H4K20 methylation 
and DNA replication.  
 SETTING UP CHIP-SEQ EXPERIMENTS IN HUMAN CELLS 
ChIP is a sensitive technique to study protein-DNA interactions. To fix the current 
chromatin state of the cells, DNA and proteins within a distance of ~2-3 Å are 
covalently linked by formaldehyde. After chromatin fragmentation, specific antibodies 
are used to precipitate the target proteins together with the associated DNA 
fragments. These DNA fragments are then isolated and quantified either by qPCR at 
defined loci or by sequencing to detect all possible protein binding sites. 
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4.1.1 CONSIDERATIONS TO OPTIMIZE PRE-RC CHIP-SEQ EXPERIMENTS 
To date, there are only two ChIP-seq studies of pre-RC proteins in mammalian cells, 
both targeting the pre-RC subcomponent ORC (Dellino et al. 2013; Miotto, Ji, and 
Struhl 2016). Despite much effort, members of the Mcm2-7 complex have not been 
successfully targeted so far. One of the major difficulties is the low enrichment over 
background, challenging identification of clear pre-RC binding sites. In contrast to 
transcription factor and histone ChIPs, which are rather easy to perform and very 
robust to methodological differences, I considered several optimization steps for 
pre-RC ChIPs (Figure 4.1): 
a) Performing ChIPs on a G1 cell population 
b) Optimizing cross-linking time and mild sonication to preserve complexes 
c) Usage of several antibody targets within the same complex 
d) Increasing antibody specificity (buffer and washing conditions) 
 
FIGURE 4.1: SCHEMATIC REPRESENTATION OF CRUCIAL CHIP STEPS. A) CELL CYCLE FRACTIONATION 
BY CENTRIFUGAL ELUTRIATION. B) CROSS-LINK AND SONICATION. C) ANTIBODY INCUBATIONS. 
D) IMMUNOPRECIPITATION AND WASHING CONDITIONS. After ChIP, DNA fragments were 
eluted from the beads, the DNA was isolated and quality control was performed by qPCR prior 
to sequencing. 
  RESULTS AND DISCUSSION  
41 | 
 
Performing ChIP exclusively in G1 cell cycle stage - the moment where pre-RC is 
present on chromatin - is one possibility to increase sensitivity. Centrifugal elutriation 
is a convenient method to do so, as an asynchronous cell population is fractionized 
into the different cell cycle stages by simple size selection. This is easily feasible in Raji 
cells, however impossible in hES cells. I decided against chemical synchronization of 
hES cells and performed ChIPs on asynchronous cell populations instead.  
ChIP procedure was optimized experimentally for increased stringency and sensitivity. 
First, cross-linking needs to be strong enough to efficiently conserve protein-DNA 
interactions, but should not impair proper sonication or mask any epitopes for 
antibody recognition. For this reason, I chose a very mild cross-link of 5 min with 1% 
FA at room temperature. Second, sonication itself needs to be as mild as possible, to 
not destroy any protein-DNA interactions, but should result in chromatin fragments 
small enough for high-throughput sequencing (200-400bp). The focused-
ultrasonicator S220 from Covaris was used, as energy focusing directly on the sample 
allows to considerably reduce the applied power. This ensures maximum conservation 
of protein-DNA interactions. Indeed, usage of Covaris S220 in comparison to 
standard sonication methods (Bioruptor or tip sonifier) clearly increased protein 
enrichments compared to mock ChIPs at known positive loci (data not shown).  Prior 
to the actual immunoprecipitation, chromatin was treated first with mock IgG 
antibody, then with protein A sepharose beads. This step removes background 
binding of chromatin fragments that stick to IgG and/or protein A sepharose beads.  
To ensure unbiased detection of pre-RC sites, I simultaneously targeted four different 
pre-RC components: Orc2, Orc3 as members of ORC and Mcm3, Mcm7 as members 
of the Mcm2-7 complex. Targeting two different subunits decreases possible antibody 
biases and increases the significance of the results. The ChIP-grade of rabbit pre-
immune serum antibodies targeting Orc2, Orc3, Mcm3, and Mcm7 have been already 
validated in repeatedly (Papior et al. 2012; Ghosh et al. 2006; Ritzi et al. 2003; Schepers 
et al. 2001). Furthermore, ChIPs were performed in three independent experiments to 
account for experimental and biological variation. During data analysis, usage of 
rigorous parameters for pre-RC definition from all these replicates increased 
confidence in the results. 
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Sonication and immunoprecipitation were performed in detergent containing buffer. 
I decided for a combination of Deoxycholate, Sarkosyl, Triton-X-100, and NP-40. 
After the precipitation, I performed sequential stringent washing steps with RIPA 
buffer containing SDS, NP-40, DOC, while increasing salt concentrations decrease 
low affinity interactions. 
After protein-DNA complex elution from beads, samples were treated with RNase, 
covalent cross-link was reversed by heating to 65°C and proteins were digested using 
Proteinase K. The resulting DNA fragments were purified and inserted in control 
qPCR reactions.   
4.1.2 PERFORMING CHIP-SEQ EXPERIMENTS IN RAJI CELLS 
After careful setup of the ChIP conditions, I performed the ChIPs intended for 
sequencing. To start with, I fractionized asynchronous cell populations to obtain G1- 
and S/G2-phase enriched cells. The S/G2 population thereby served as control for 
pre-RC ChIP-seq, as activated and passively replicated pre-RCs disassemble after 
replication.  
EXPERIMENTAL SETUP: CELL CYCLE FRACTIONATION 
Counterflow centrifugal elutriation is a convenient method for separation of mixed 
cell populations according to size and mass and regularly used in my laboratory (Ritzi 
et al. 2003). Elutriation has the advantage to not disturb the cellular metabolism. The 
principle is based on centrifugation of a logarithmically growing asynchronous cell 
population, with largest cells (late cell cycle stages) being sedimented, while a 
counterflow of medium extracts smaller cells (early cell cycle stages) from this 
population. Regulation of the speed of this counterflow thus determines sizes of 
isolated cells. I routinely used counterflow rates 40, 45, 50, 60, 80, 100ml/min to 
isolate all different cell stages. The respective cell cycle stages were validated by 
propidium iodide (PI) staining of the DNA content and subsequent FACS analysis 
(Figure 4.2). I performed three independent elutriation experiments as basis for three 
ChIP replicates. I chose fractions G1 (counterflow rate 40 ml/min) - pre-RC 
formation is supposedly completed - and S/G2 cells (80 ml/min), directly after 
replication. The sonication time had to be slightly reduced for S/G2-phase cells, as 
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the chromatin of S/G2 cells is fragmented more easily. An example for efficient 
sonication is depicted in Figure 4.3 A. 
 
FIGURE 4.2: EXAMPLE FACS PROFILE OF RAJI CELLS FRACTIONNATED BY CENTRIFUGIAL ELUTRIATION 
REVEALED DISTINCT CELL CYCLE STAGES. Propidium iodide (PI) is an intercalating agent and was 
used to determine DNA content in the cells. The first peak represents the G1 cell population with 
2n content, the second peak represents G2 population with 4n. The different counterflow rates 
led to a separation into cell populations of different cell cycle stages (indicated on top of each 
profile). The cell populations marked in green were taken for ChIP-seq experiments.  
EXPERIMENTAL SETUP: CHIP VALIDATION 
Like almost all EBV-infected cell lines, the Raji cell line maintains the EBV genome 
as an independent genetic entity, which is autonomously replicated during latency by 
the host cellular replication machinery (John L. Yates 1996). The latent Epstein-Barr 
virus origin oriP can serve as a positive control for pre-RC ChIP efficiencies. The viral 
latent protein EBNA1 specifically targets ORC to the dyad symmetry (DS) element of 
oriP, independent of the cell cycle stage. Consequently, ChIPs showed an enrichment 
of Orc2 and Orc3 at DS in both G1 and S/G2, while Mcm3 and Mcm7 binding is cell 
cycle dependent (Ritzi et al. 2003) and was decreased in S/G2 (Figure 4.3 B).     
H4K20 methylation ChIPs were validated at previously identified genomic positive 
loci for either H4K20me1 or –me3 (primer sequences obtained from Stanimir Dulev, 
OICR, Canada). ChIP against canonical histone H4 was also included. There were no 
considerable cell cycle dependent differences observed (Figure 4.4). After qPCR 
validation, the samples were sequenced. As a measure for sonication and sequencing 
biases, “input DNA” (cross-linked DNA fragmented under same conditions as the 
ChIPs) was used as appropriate control. 
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FIGURE 4.3: PRE-RC CHIP VALIDATION IN RAJI CELLS. A) REPRESENTATIVE EXAMPLE OF SONICATED 
CHROMATIN IN G1 AND S/G2. 1.5% agarose gel, stained with EtBr. B) PRE-RC CHIP VALIDATION 
BY QPCR AT THE DS LOCUS OF ORIP. Cell cycle stages as indicated. Rabbit IgG mock IP served as 
negative control. Mean ± SEM (n=3).  
 
 
 
FIGURE 4.4: H4K20 METHYLATION CHIP VALIDATION BY QPCR AT GAPDH H4K20ME1 POSITIVE AND 
ZNF180 H4K20ME3 POSITIVE LOCI. Cell cycle stages as indicated. Rabbit IgG mock IP served as 
negative control. Mean ± SEM (n=3).  
TREATING SEQUENCING DATA 
A) B) 
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The Genomics unit of LAFUGA (headed by Helmut Blum, LMU Munich) performed 
ChIP sample library preparations, as well as final 50bp single-end sequencing with the 
Illumina HiSEQ 1500 sequencer. Due to the expected variability of pre-RC ChIPs, I 
chose an elevated sequencing depth of around 70 million reads for pre-RC ChIPs and 
35 million reads for histone modifications.  
Quality of the ChIP-seq reads (or tags) was controlled using FastQC, and mapped 
against the human genome hg19 (GRCh37, version 2009), extended for the EBV 
genome (NC007605) using bowtie1. Choice of mapping parameters has an effect on 
sensitivity and specificity. Usage of only uniquely mapping reads excludes some true 
binding sites, simply because they locate in duplicated or repeated regions. However, 
allowing multiple read alignments leads to the detection of false positives. For the 
following analyses, false positives and possible amplification artefacts were excluded 
by blocking the repeated alignment of the identical sequence read.   
An example of either input (input (G1) repl1) or Orc2-ChIP (Orc2 (G1) repl1) read 
sequences aligned on hg19 at the published origin Mcm4/PRKDC (Schaarschmidt et 
al. 2002) is shown in Appendix Figure 1 A. Visualization was performed with the 
Integrated Genome Browser (IGB). In principle, protein binding at a specific position 
leads to an accumulation of reads aligning at this locus. A direct comparison of 
sequencing alignments showing single reads and pileup profiles is depicted in 
Appendix Figure 1 B.  
In general, raw ChIP-seq pileup profiles (without input normalization or any filters) 
turned out to be rather broad with much background, but I also observed regions with 
clear peaks (examples are visualized in Figure 4.14 (Mcm4/PRKDC locus, broad 
profile) and Figure 4.15 (chr6: 26516717-26543982, sharp peaks). Browser 
visualization is very useful to get an impression of the data, but is not quantitative for 
further analyses. For quantitative analysis, significant peaks need to be determined. 
Peak-calling programs compare read distribution of input to the specific ChIP and 
detect significant enrichments by applying dedicated algorithms.  
My Laboratory previously determined positions of active replication and pre-RC on 
the EBV genome by SNS- or ChIP-on-chip experiments (Papior et al. 2012). Thereby, 
independent ChIP and SNS data sets displayed high concordance. To decide for the 
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most appropriate peak-calling program, I applied different peak-calling algorithms on 
EBV ChIP-seq data and selected the program whose results matched best to the 
previously identified pre-RC and SNS positions on the EBV genome.    
VALIDATION OF PEAK-CALLING ON THE EBV GENOME 
Any peak-calling program’s key task is to reproducibly identify correct protein binding 
positions while avoiding false positives. There are over fifty different peak calling 
programs available and I chose to compare three of them: i) the most popular one: 
MACS2 (Model-based analysis of ChIP-seq; Zhang et al. 2008); ii) a similar stringent 
peak calling program with many downstream applications: HOMER (Hypergeometric 
optimization of motif enrichment; Heinz et al. 2010); and iii) a program that has been 
shown to detect an increased number of biological relevant peaks: T-PIC (Tree-shape 
peak identification for ChIP-seq; Hower, Evans, and Pachter 2011).   
A ChIP-seq profile representation of single replicates and the respective peak calling 
result from EBV is depicted in Figure 4.5 for Orc2 and Orc3 and in Figure 4.6 for 
Mcm3 and Mcm7. While both MACS2 and HOMER peak calling programs did not 
detect any major peaks except for oriP, the T-PIC peak calling program also identified 
significant protein binding outside of oriP (Figure 4.5, Figure 4.6). This is consistent 
with published results, as Papior et al. found considerable pre-RC binding as well as 
active replication initiation events all over the EBV genome (dark brown (pre-RC) and 
light brown (SNS) bars in Figure 4.5, Figure 4.6; Papior et al. 2012).   
These very divergent results of different peak-calling programs originate from the 
different underlying algorithms. Despite a lot of work invested, it remains difficult to 
accurately define a peak within the data. MACS2 is designated for transcription factor 
binding detection and histone modifications (Feng, Liu, and Zhang 2011). The 
principle of MACS2 peak-calling relies on a peak showing a bimodal enrichment 
pattern, as the sequencing reads represent each the end of a ChIP fragment (Figure 
4.7). Based on the read distribution, MACS2 shifts the reads towards the 3’ends to 
optimize protein binding site location. Thereby, the shift size (d) is often unknown. 
MACS2 either relies on the sonication size (bandwidth parameter determined by the 
user) or calculates shift sizes based on high-quality peaks. 
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FIGURE 4.7: STRAND-DEPENDENT BIMODALITY IN SEQUENCING READS DISTRIBUTION. The protein 
of interest (blue oval) binds DNA. Wavy lines represent sense (blue) and antisense (red) DNA 
fragments from ChIP enrichments. Sequenced reads are indicated as thicker portion. Alignment 
to the reference genome produces bimodal distribution of a peak that is corrected by peak-calling 
programs. Distance between sense and antisense reads (d) represents optimal shift size. From 
Wilbanks and Facciotti 2010.   
Careful determination of the shift size is thus crucial for proper peak detection. 
MACS2 performs peak detection by using a dynamic parameter defined for each read 
enriched region (λlocal) and compares this enrichment to the peak region and 
neighboring regions (1 kb, 5 kb, 10 kb from the peak) in ChIP and control input 
sample. Thereby, variations in sequencing depth between ChIP and input samples are 
adjusted by diminishing the elevated depth. A p-value is calculated for each enriched 
region and those regions with a p-value smaller that the threshold (default p=10-5) are 
considered significant (Zhang et al. 2008). MACS2 provides two general peak-calling 
functions: “standard” for punctuate enrichments as e.g. transcription factors and 
“broad” to detect enrichments from e.g. histone modification patterns that cover 
broader regions.   
Also the HOMER “findPeaks” function allows choosing two different approaches. 
Either the setting “factor” for defined peaks, and “histone” for broader enriched 
regions can be chosen. To start with, HOMER requires to build a “tag directory” from 
the reads and performs a first quality control on data while estimating required 
parameters for downstream analysis (e.g. fragment length). Similar to MACS2, the 
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program also shifts the enriched reads in the 3’ direction to center the actual peak 
depending on the fragment size. It scans the genome for clusters of high-density tags 
and excludes the regions directly adjacent to these clusters. Assuming that the local 
tag densities follow a Poisson distribution, the program estimates the expected peak 
numbers and simultaneously calculates the expected number of false positive peaks 
for each tag threshold. It then uses the threshold that meets the specified false 
discovery rate (default: fdr=0.001). Peaks are filtered against the input control 
experiment using the sequencing-depth independent fold-change parameter. This 
means that a potential peak in the target experiment needs 4-fold (default) more 
normalized tags than the control. Similar to MACS2, HOMER also filters peaks based 
on the local tag count. Peak tag densities have to be 4-fold above the surrounding 10 
kb region (homer.salk.edu/homer/ngs/peaks.html). 
In contrast to MACS2 or HOMER, T-PIC identifies significant peaks from read 
coverage and applies tree-based statistics on the data. The program starts by 
calculating the coverage from the reads of input and target sample extended by defined 
fragment length (set to 200 bp final). Already during this calculation, “anomalous” 
coverage is flagged for being subsequently analyzed as putative peaks. In order to 
detect statistically significant peaks, the program first calculates a “null hypothesis” to 
model regions without peak for a given coverage. The actual peak detection is then 
based on the shape of the peak (instead of it’s simple height, also the information from 
the neighborhood is taken into account and used to differentiate from random 
fragment distributions). Potential peaks identified during coverage calculation are then 
reprocessed and the coverage change within the shape is represented as a “tree” 
(Figure 4.8). Sharp peaks consequently correspond to large trees without many 
branches, while broad peaks lead to low, rather bushy trees. A value is attributed to 
the tree which reflecting its shape. The “null hypothesis model” is equally scanned for 
peaks and corresponding trees are calculated to be able to correct for randomly 
occurring read accumulations. By comparing the detected peaks to the random peaks 
from the “null hypothesis model”, significant peaks are identified and displayed 
(Hower, Evans, and Pachter 2011).     
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FIGURE 4.8: SCHEMATIC REPRESENTATION OF TRANSFORMATION OF A PEAK SHAPE INTO A TREE. 
The peak starts at a coverage height h and its end is considered at the same height. Every time the 
coverage changes by adding a read, the tree gains in vertices (blue stars, connected by red dotted 
line). The branches originate from “deviations” of the main shape (smaller dotted red lines). 
Adapted from Hower, Evans, and Pachter 2011.  
This diverging mathematical models for peak-calling explain the differences of T-PIC 
to the other two peak-calling algorithms MACS2 and HOMER. Furthermore, the 
authors of the T-PIC algorithm validated their approach by re-analyzing already 
published data of factors with specific binding motifs. Indeed, T-PIC identified peaks 
that specifically contain the corresponding motifs, while other peak-calling programs 
(like MACS) missed some of these peaks (Hower, Evans, and Pachter 2011). In 
conclusion, T-PIC is a more sensitive program to detect peaks of biological relevance. 
Based on the comparative analysis of the different peak-calling algorithms on the EBV 
pre-RC ChIP-seq results and the published EBV replication profile, T-PIC seems to 
be the most appropriate peak-calling program. I investigated the similarities of 
identified peaks between replicates and the different pre-RC proteins by calculating 
the Jaccard index. This index was calculated as explained in Figure 4.9 A. Jaccard index 
is a direct measure of replicate similarities with 1 being exactly redundant and 0 being 
completely different. Jaccard indices can be represented by a heatmap, which allows 
direct visual estimation of ChIP reproducibility. As observed in Figure 4.9 B, ChIP 
peaks clustered principally by experiment. Replicate 1, 2, and 3 cluster among 
themselves, but there was also a clustering visible depending on the ORC or Mcm2-7 
complex. ChIPs from the third experiment (repl3) were least similar. 
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FIGURE 4.9: CHIP SIMILARITIES REPRESENTED BY JACCARD INDICES. A) SCHEMATIC EXPLANATION 
OF CALCULATING THE JACCARD INDEX. The peak properties of two ChIPs are directly compared 
by calculating the overlap of both peaks and dividing by the sum of the totality and the overlap. 
The resulting index is a direct measure of similarity and ranges between 0 (no similarity) and 1 
(identical). B) HEATMAP REPRESENTATION OF JACCARD INDICES OF THE INDIVIDUAL CHIP T-PIC 
PEAKS ON THE EBV GENOME. Dark red represents great similarities while lighter red indicates less 
redundancies.  
 
A) 
B) 
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These observed differences resulted principally from the biological and experimental 
difference of the samples. Working with three independent elutriation fractions, that 
were cross-linked at different time-points might account for experimental differences. 
Also, Mcm2-7 complexes are not necessarily positioned at defined sites but slide away 
from their ORC-dependent loading sites (discussed in more detail in chapter 4.3). This 
might explain the increased variance in Mcm2-7 protein ChIPs.   
DEFINING THE PRE-REPLICATION COMPLEX 
The high experimental and biological variances strengthen even more the necessity 
for stringent pre-RC definition. The availability of several replicates (two for each Orc-
ChIP and three for each Mcm2-7 ChIP) and two target proteins within each pre-RC 
sub-complex, makes robust complex definitions possible. Because ORC can also exist 
without Mcm2-7 helicases and the Mcm2-7 helicases might define initiation sites on 
their own, I defined and examined three different complexes: ORC, Mcm2-7, and pre-
RC. A complex is per definition composed of at least 50% overlapping peaks within 
respective target ChIPs and replicates (Figure 4.10 A). Consequently, ORC consisted 
of at least two peaks overlapping from Orc2_repl1, Orc2_repl3, Orc3_repl1, 
Orc3_repl3, Mcm2-7 demanded at least three overlapping peaks in Mcm3_repl1, 
Mcm3_repl2, Mcm3_repl3, Mcm7_repl1, Mcm7_repl2, and Mcm7_repl3. Pre-RC 
was built of at least five overlaps of all ChIPs. 
A visualization of the determined T-PIC-defined complex distributions together with 
pre-RC and SNS determined by Papior et al. 2012 is shown in Figure 4.10 C. W-repeats 
and terminal-repeats were excluded from the analysis. When calculating overlaps of 
T-PIC-defined pre-RCs with pre-RC determined by Papior et al., 66% of all T-PIC-
pre-RCs overlapped. The same was true regarding the overlap of T-PIC-pre-RCs with 
SNS (Figure 4.10 B). Interestingly, one particular region from 102000 to 137600 was 
heavily enriched for pre-RCs detected by Papior et al., while T-PIC did not detect any 
enrichments of ORC, Mcm2-7 or pre-RC. Either this region is constantly covered by 
pre-RC components, which impairs T-PIC from detecting significant enrichments, or 
this observation results from differences in technique and bioinformatics analysis. 
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Jaccard indices of all determined complexes were also calculated and are represented 
in Appendix Figure 2. T-PIC-defined complexes clustered together with high 
similarities and were slightly more similar to SNS positions determined by Papior et al. 
(Jaccard index = 0.32) than to their pre-RC positions (Jaccard index = 0.18).   
In conclusion, the T-PIC peak-calling algorithm is most suitable to detect relevant 
peaks from pre-RC ChIPs. The observed differences of T-PIC-defined peaks to pre-
RC and SNS positions defined by Papior et al. might account for completely different 
technical and bioinformatical approaches. Even more, the fact that I also observed 
considerable similarities (66% overlaps) argues for my chosen analysis procedure.   
4.1.3 PERFORMING CHIP-SEQ EXPERIMENTS IN HUMAN EMBRYONIC STEM (HES) 
CELLS  
Setting up pre-RC ChIP-seq experiments in Raji cells had the advantage that an 
internal ChIP quality control was available with oriP on the EBV genome. The 
resulting sequencing data now allowed determination of genomic pre-RC positive loci 
to enable qPCR validation of pre-RC ChIPs in other human cells. Together with my 
partner laboratory of Dr. Jean-Marc Lemaitre at the IRMB in Montpellier, we decided 
to apply pre-RC ChIP-seq on the human embryonic stem cell line H9 (hES cells). In 
these cells, SNS-sequencing data is also available, which allows direct comparison of 
pre-RC positions with specific sites of active replication (Besnard et al. 2012). 
However, easy G1 synchronization of hES cells is impossible and I decided against 
chemical synchronization to avoid treatment biases, performing the ChIPs on 
asynchronous cell populations.  
 
FIGURE 4.10: ORC, MCM2-7, AND PRE-RC DIFINITION ON EBV GENOME. A) PRINCIPLE OF COMPLEX 
DEFINITION. At least 50% overlapping peaks are needed to determine a complex. During merging, 
leftmost start position and rightmost end position are conserved. B) DIRECT COMPARISON OF 
T-PIC DEFINED PRE-RC POSITIONS WITH PRE-RC AND SNS POSITIONS FROM PAPIOR ET AL. Pre-RC 
(Papior et al. 2012) are represented in brown, SNS (Papior et al. 2012) in light brown and T-PIC-
defined pre-RCs in green. C) IGB VISUALIZATION OF T-PIC-DEFINED ORC, MCM2-7 AND PRE-RC, 
TOGETHER WITH PRE-RC AND SNS DETERMINED BY PAPIOR ET AL. 2012 ON THE EBV GENOME. 
T-PIC ORC:  orange, T-PIC Mcm2-7: blue, T-PIC pre-RC: green, pre-RC (Papior et al. 2012): 
brown, SNS (Papior et al. 2012): lightbrown; [chrEBV: 0-171823]. 
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EXPERIMENTAL SETUP: CHIP VALIDATION 
ES cells were cultivated to high quantities (up to 2x108 cells). This made careful 
pluripotency controls necessary, as hES cells easily differentiate. Besides 
morphological criteria (Appendix Figure 3 A), I also performed FACS staining of 
known pluripotency markers SSEA4 and Oct4 (Appendix Figure 3 B). FACS stain 
revealed a pluripotent population of about 98% of all cells. During cross-link using 
my established protocol, I omitted the second washing step prior to cross-linking 
because cells were more fragile and lysed more easily. Sonication time was also reduced 
and ChIPs were performed as described in chapter 3.2.7, p. 31. 
From Raji sequencing data, I chose two positive loci for ChIP validation in hES cells 
by qPCR. The Mcm4/PRKDC locus represents a known origin of replication 
(Schaarschmidt et al. 2002) and primer positions together with example ChIP-seq 
profiles in Raji cells are shown in Appendix Figure 4. When screening Raji ChIP-seq 
data for strong enrichment peaks, I defined the BANF1 locus as additional positive 
control (sequencing profile and primer positions are shown in Appendix Figure 5). 
After validation of positive and negative control primers in Raji cells (not shown), I 
performed pre-RC ChIPs according to the established protocol and validated ChIP 
quality by qPCR (Figure 4.11).  
FIGURE 4.11: PRE-RC CHIP QPCR VALIDATION AT SELECTED BANF1 (BANF1+) AND MCM4/PRKDC 
POSITIVE (MCM4+) AND MCM4/PRKDC NEGATIVE (MCM4-) LOCI. IgG was used as negative control. 
Mean ± SEM (n=3). 
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Pre-RC ChIP validation on the human genome resulted in low % input values, which 
possibly emerge from the variable binding of pre-RC proteins. However, ChIPs 
remained enriched at positive loci in comparison to the Mcm4/PRKDC negative 
locus and were sequenced at the platform MGX-Montpellier GenomiX. 
Two complete replicates of Orc2, Orc3, Mcm3, and Mcm7 were sequenced by paired-
end sequencing of 100 nucleotides from both ends of the ChIP fragments. This 
method improves data set quality because alignment to the reference genome is 
facilitated and also repetitive sequence elements can be covered.  
TREATING SEQUENCING DATA 
Anissa Zouaoui, bioinformatician in the laboratory of Dr. Jean-Marc Lemaitre, 
mapped the sequencing data against the human genome hg19 (GRCh37, version 2009) 
and performed standard MACS2 broad peak calling, as pre-RC binding turned out to 
be more spread over the genome, rather than representing distinct peaks. Currently, 
we are also adapting the T-PIC peak calling algorithm for paired-end sequencing data, 
as T-PIC is originally designed for single-end sequencing results. Nevertheless, to get 
a first impression of the data, I defined ORC, Mcm2-7 and pre-RC as previously 
described and compared their positions to sites of active replication (SNS, Besnard et 
al. 2012). 
First of all, I looked at the total number of defined complexes from replicates (Figure 
4.12 A). It is evident that many more Mcm2-7 complexes (43846) were detected than 
ORC (12848) or pre-RCs (8651). By extensive deep sequencing, Besnard et al. 2012 
detected more than 200000 sites of active replication. Although this elevated number 
of origins has been recently questioned by Cayrou et al. 2015 and highly depends on 
definition and detection algorithm, it remained very robust when changing algorithm 
parameters (data not shown). Evidently, the number of defined ORC, Mcm2-7 and 
pre-RCs was smaller and cannot be directly compared to the number of active origins. 
Nevertheless, I analyzed the overlaps of the defined complexes with SNS (Figure 4.12 
B). While ORC and pre-RC overlapped to nearly 80% with SNS sites, only 30% of all 
Mcm2-7 complexes were found at SNS sites.  
Given that mainly ORC and pre-RC complexes overlapped with SNS, I wondered for 
the distance of all the complexes towards SNS center. I calculated and plotted the 
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distance of the defined complexes towards the next SNS center in log10 scale in a bar 
chart (Figure 4.12 C). Distribution of close and more farther located complex 
populations gives visual impression of the behavior towards SNS. 
It becomes evident that majority of ORC (80.5%) and pre-RC (80.3%) located within 
~1600 bp (log10 = 3.2, marked by red dashed line in Figure 4.12 C) of SNS center, 
while only 40.4% of Mcm2-7 located that close. This also corresponded to the directly 
calculated overlaps and shows again, that while ORC was located in closer proximity 
to SNS (mean=4561 bp), Mcm2-7 complexes were detected further away (22052 bp, 
p < 2.2x10-16).   
The observed 3.4-fold excess of the total Mcm2-7 numbers of compared to ORC is 
consistent with already reported Mcm2-7 helicase surplus in Drosophila, although not 
to the same extend (Powell et al. 2015 reported 10 to 50-fold Mcm2-7 helicase excess). 
The number of detected ORC (12848) corresponds to the number of Orc1 sites 
detected by Dellino et al. 2013 (~13000) in HeLa cells, but not to ~52000 Orc2 peaks 
in K562 cells (Miotto, Ji, and Struhl 2016) neither to the expected number of total 
origins (30000-50000). Although the numbers and positions of ORC and Mcm2-7 
differ considerably, 67% of all defined ORC coincide with Mcm2-7, which resulted in 
8651 detected pre-RC positions. Apart from apparent technical fluctuations in 
antibody specificities, this might reflect ORC-dependent Mcm2-7 loading 
(overlapping ORC/Mcm2-7) and subsequent Mcm2-7 sliding from the loading site 
(Mcm2-7 without corresponding ORC), as suggested previously (Das and Rhind 2016; 
Hyrien 2016).  
The strong overlap of ORC, but not Mcm2-7 with SNS contradicts the idea that 
Mcm2-7 complexes are solely responsible for replication initiation. In that case, mostly 
Mcm2-7 should overlap with replication initiation sites. These results rather indicate, 
that ORC is indeed important defining active origins, and it would be interesting to 
test, which cohort of origins overlaps with ORC (in terms of origin efficiency, links to 
transcription or histone modifications, etc.). However, it would also be interesting to 
further define the Mcm2-7 population not correlating with SNS, to find possible 
explanations.  
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C) 
FIGURE 4.12: SNS CORRELATE MORE WITH ORC THAN WITH MCM2-7. A) TOTAL NUMBERS OF 
DEFINED COMPLEXES. B) OVERLAP OF DEFINED COMPLEXES WITH SNS. Percentages in brackets 
represent the % overlap of the complex with SNS. C) SNS SIZE DISTRIBUTION AND DISTANCE TO 
SNS CENTER ANALYSIS OF EACH DEFINED COMPLEX. The frequency of the distance of each 
complex was calculated in respect to the center of the next SNS position and plotted as log10. 
The red dashed line marks log10(3.2) = 1585bp from center. ORC: orange, Mcm2-7: blue, pre-RC: 
green, SNS: lightbrown. 
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In conclusion, although the data seems promising, it still needs extensive further 
analysis in collaboration with Anissa Zouaoui. First effort will be to apply the earlier 
validated T-PIC peak calling algorithm on the data to gain confidence in the peak 
number and positions detected. This will also improve the comparative analysis with 
SNS positions. Further steps will include the correlation of SNS and pre-RC positions 
with other chromatin features, like histone modifications, MNase sensitivity, CG-
content, etc. This will allow to define features predicting pre-RC correlation with SNS.  
 PRE-RC COMPONENTS ARE ENRICHED WITHIN REPLICATION 
UNITS 
Pre-RC ChIP-seq analysis in hES cells still needs further effort concerning data 
treatment and evaluation. Besides comparison to active replication, there is a lot of 
histone modification ChIP-seq data available in hES cells and comparative 
correlations promise insights into regulation of origin licensing and activation.  
For Raji pre-RC ChIP-seq comparisons however, there is less data published, and I 
initiated collaborations with Dr. Olivier Hyrien (IBENS, Paris) for active replication 
data, Prof. Dr. Wolfgang Hammerschmidt (HelmholtzZentrum München) for RNA-
seq data, and Dr. Jean-Christophe Andrau (IGMM, Montpellier) for histone 
modification data.  
To start data analysis on the human genome, I performed T-PIC and HOMER peak-
calling on pre-RC ChIP-seq data sets. T-PIC is the peak calling algorithm of choice, 
as validated on the EBV genome. However, I decided to also separately focus 
exclusively on the strongest pre-RC peaks and to in parallel use the HOMER 
algorithm.  
4.2.1 COMPARING T-PIC VS. HOMER PEAK-CALLING ALGORITHMS AND DEFINING 
ORC, MCM2-7, AND PRE-RC ON THE HUMAN GENOME 
As already observed on the EBV genome, T-PIC peak-calling is much more sensitive 
than the HOMER algorithm. This was also true for peak-calling on the human 
genome. As a consequence, peak-calling with T-PIC detected around 20-times more 
peaks than HOMER (Table 4.1). Most HOMER peaks resided within the top 10% of 
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T-PIC peaks (representative example for one replicate of Orc2 and Mcm3 depicted in 
Figure 4.13, see Appendix Figure 6 for Orc3 and Mcm7), confirming that HOMER 
mostly calls the strongest peaks. 
TABLE 4.1: COMPARISON OF ABSOLUTE NUMBER OF PEAKS WITHIN REPLICATES AND RESULTING 
COMPLEXES. n.a = not assessed 
  PEAK NUMBERS COMPLEX NUMBERS 
  Orc2 Orc3 Mcm3 Mcm7 ORC Mcm2-7 Pre-
RC 
HOMER 
repl1 2309 4503 2203 2584 1936 322 329 
repl2 n.a. n.a. 658 767 
repl3 1391 1997 424 405 
T-PIC 
repl1 52366 63976 76032 50795 57597 25529 23896 
repl2 n.a. n.a. 44400 25060 
repl3 84343 72717 53792 57388 
 
 
 
 
 
 
B) A) 
FIGURE 4.13: MOST HOMER PEAKS LOCATE WITHIN THE TOP 10% OF T-PIC PEAKS. REPRESENTATIVE 
EXAMPLE ANALYSIS FOR A) ORC2 AND B) MCM3 IN ONE REPLICATE. Venn diagram of overlap 
between all HOMER-detected peaks with the top 10% of T-PIC-detected peaks. Overall counts 
are indicated. The percentage of overlapping HOMER-detected peaks are specified in brackets. 
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Due to its high sensitivity, T-PIC detected peaks at many known origins of replication 
while HOMER did not (for Mcm4/PRKDC locus, see Figure 4.14, for LaminB2 
(Abdurashidova et al. 2000) and JunB (Fu et al. 2014) origins, Appendix Figure 7 and 
Appendix Figure 8). These observations again confirm the T-PIC program detecting 
peaks of biological relevance. By contrast, HOMER mostly detected strong, highly 
enriched binding sites (example in Figure 4.15). 
The number of detected peaks varied considerably between the different replicates 
(Table 4.1), emphasizing even more the necessity for stringent complex definition. On 
the basis of T-PIC and HOMER peaks, I computed ORC, Mcm2-7 and pre-RC 
according to the settings previously defined on EBV. The final complex numbers are 
listed in Table 4.1. For both approaches, the total number of ORC was 2 to 6-fold 
higher than both Mcm2-7 and pre-RC. This stands in clear contrast to the 3.4-fold 
excess of Mcm2-7 detected in hES cells and likely depends on the “broad” peak-calling 
performed with MACS2 in hES cells. HOMER-defined complex numbers were 
generally 30 to 80-times lower than T-PIC defined complexes.  
Comparison of complex sizes revealed that HOMER complexes were considerably 
narrower than T-PIC ones (for pre-RC, see Figure 4.16 A, ORC an Mcm2-7 in 
Appendix Figure 9). This is mostly due to the HOMER peak-calling algorithm settings 
that produced peaks of around 200 bp. T-PIC peak sizes were more variable, also due 
to the merging process during complex computation.  
When looking at the distribution of ORC, Mcm2-7 and pre-RC complexes, it became 
evident that HOMER-defined complexes represent a subpopulation of T-PIC-defined 
complexes (Figure 4.16 B (pre-RC), Appendix Figure 10 (ORC and Mcm2-7)). This is 
a logic consequence of HOMER peaks being part of the strongest T-PIC peak 
population but also reflects the fact that HOMER-defined complexes (and 
consequently the ones with very strong binding) only built a small sup-population 
within T-PIC-defined complexes. 
After defining ORC, Mcm2-7 complex and pre-RC, the complexes can now be 
correlated with active replication, transcription and histone modifications. 
 
  RESULTS AND DISCUSSION  
63 | 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
IG
U
R
E
 4
.1
4
: 
M
C
M
4
/P
R
K
D
C
 O
R
IG
IN
 I
S
 I
D
E
N
T
IF
IE
D
 B
Y
 T
-P
IC
 B
U
T
 N
O
T
 B
Y
 H
O
M
E
R
 P
E
A
K
-C
A
L
L
IN
G
. 
In
p
u
t:
 g
re
y,
 O
rc
2
: 
re
d
, 
O
rc
3
: 
o
ra
n
ge
, 
M
cm
3
: 
b
lu
e,
 M
cm
7
: 
tu
rq
u
o
is
. 
T
-P
IC
-d
et
ec
te
d
 p
ea
k
s 
ar
e 
re
p
re
se
n
te
d
 a
s 
b
ar
s 
ab
o
v
e 
ea
ch
 p
ile
u
p
 p
ro
fi
le
; H
O
M
E
R
-d
et
ec
te
d
 p
ea
k
s 
ar
e 
ad
d
it
io
n
al
ly
 h
ig
h
lig
h
te
d
 b
y 
lig
h
tb
lu
e 
b
ac
k
gr
o
u
n
d
. V
is
u
al
iz
at
io
n
 
in
 I
G
B
. 
[c
h
r8
: 
4
8
8
6
2
1
8
8
-4
8
88
3
2
5
0
].
 
RESULTS AND DISCUSSION 
64 | 
 
 
 
 
A) B) 
F
IG
U
R
E
 4
.1
5
: 
H
O
M
E
R
 P
E
A
K
-C
A
L
L
IN
G
 I
D
E
N
T
IF
IE
S
 S
T
R
O
N
G
 P
E
A
K
S
. 
E
xa
m
p
le
 p
ea
k
-c
al
lin
g 
at
 c
h
r6
: 
2
6
5
1
6
7
1
7
-2
6
5
4
3
9
82
. 
In
p
u
t:
 g
re
y,
 O
rc
2
: 
re
d
, 
O
rc
3
: 
o
ra
n
ge
, 
M
cm
3
: 
b
lu
e,
 M
cm
7
: 
tu
rq
u
o
is
. 
T
-P
IC
-d
et
ec
te
d
 p
ea
k
s 
ar
e 
re
p
re
se
n
te
d
 a
s 
b
ar
s 
ab
o
v
e 
ea
ch
 p
ile
u
p
 p
ro
fi
le
; 
H
O
M
E
R
-d
et
ec
te
d
 p
ea
k
s 
ar
e 
ad
d
it
io
n
al
ly
 h
ig
h
lig
h
te
d
 b
y 
lig
h
tb
lu
e 
b
ac
k
gr
o
u
n
d
. 
V
is
u
al
iz
ed
 i
n
 I
G
B
. 
  RESULTS AND DISCUSSION  
65 | 
 
 
FIGURE 4.16: DIRECT COMPARISON OF HOMER- AND T-PIC-DEFINED PRE-RC. A) PRE-RC SIZES IN 
[KB]. Represented in boxplot: thick line shows the median, the box is the distribution from the 
first to the third quartile, the whiskers indicate the smallest and largest value without being an 
outlier. B) OVERLAPPING PRE-RCS. Venn diagram of overlap between HOMER- and T-PIC-
defined pre-RCs. Overall counts are indicated. The percentage of HOMER-defined pre-RCs 
common with T-PIC-defined pre-RCs is specified in brackets.    
4.2.2 PRE-RCS CORRELATE WITH ACTIVE REPLICATION UNITS 
As pre-RCs represent sites of licensed origins of replication, I first assessed the 
association of origin licensing and active replication. The group of Dr. Olivier Hyrien 
adopted very recently a method for Okazaki-fragment sequencing (OK-seq) on 
human cells to detect replication initiation (Petryk et al. 2016). They also applied this 
method on Raji cells and kindly provided preliminary data on replication initiation and 
replication termination zones. 
Principal of OK-seq is pulse-labeling of Okazaki-fragments with the Thymidine 
analogue EdU and subsequent purification of these fragments (< 200 bp). Fragment 
sequencing allows to distinguish between Watson (leftward moving fork) and Crick 
(rightward moving fork) Okazaki fragments. From this differentiation, replication fork 
directionality (RFD = 
(𝐶𝑟𝑖𝑐𝑘−𝑊𝑎𝑡𝑠𝑜𝑛)
(𝐶𝑟𝑖𝑐𝑘+𝑊𝑎𝑡𝑠𝑜𝑛)
 ) is calculated resulting in a profile of series of 
ascending (AS), descending (DS), and flat segments of different sizes and slopes 
(Figure 4.17 A). AS represent zones of preferential replication initiation, while DS are 
zones of preferential replication termination. The amplitude thereby reflects initiation 
efficiency. A broad initiation zone (AS) represents a zone of preferential replication 
initiation with multiple inefficient initiation sites but only one single origin firing per 
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cell, presumably corresponding to replication units described in the introduction 
(chapter 1.1.5, p. 6f). Computational wavelet detection of AS and DS in Raji cells 
(performed by Benjamin Audit, ENS Lyon) revealed 4639 AS and 2207 DS, covering 
6.6% and 8.6% of the genome, respectively. Thereby, AS were smaller (mean = 37.8 
kb, range from 3.9 to 198.0 kb) than DS (mean = 122,2 kb, range from 4.7 kb to 339.8 
kb) (Figure 4.17 C). 
VISUAL EXAMINATION OF AS, DS AND T-PIC-DEFINED PRE-RC POSITIONS 
REVEALS A PRE-RC ENRICHMENT IN AS 
First visual examination of the co-occurrence of AS, DS and T-PIC-defined pre-RC 
positions revealed a preferential localization of T-PIC pre-RCs within AS, while there 
were less pre-RCs found in DS (IGB visualized example in Figure 4.17 B). To quantify 
this visual observation, I calculated the density of T-PIC pre-RC positions per Mb 
(Figure 4.17 D). While 8.5 events/Mb were observed in AS, only 3.4 events/Mb were 
detected in DS. Additionally, I also considered all genomic regions being neither AS 
nor DS, termed “remaining genome”. With 8 events/Mb, pre-RC density was similar 
to AS.  Interestingly, these results do not indicate preferential pre-RC positioning 
within AS zones of active replication initiation, but rather argue for a specific depletion 
of pre-RCs in DS zones of replication termination.  
On average, 8.5 pre-RCs per Mb were detected within an AS, which results in one 
pre-RC every 100 kb. Concordantly, on average, one origin is activated every 100 kb 
(mean size of a replication unit, Fragkos et al. 2015). However, one would expect to 
also detect the excess of licensed origins, thus anticipating a higher pre-RC density. 
This might possibly be a problem of peak detection, as every peak-calling algorithm 
expects protein binding at a defined region. This prerequisite is given for ORC but for 
Mcm2-7 complexes site specific binding is controversially discussed. Assuming 
Mcm2-7 spreading, Mcm2-7 binding sites might remain undetected. Consequently, I 
chose another approach to unbiasedly detect pre-RC component binding by 
calculating the mean read coverage of every pre-RC component at AS or DS.      
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A) 
B) 
C) D) 
FIGURE 4.17: CORRELATION OF PRE-RC PEAKS WITH ZONES OF REPLICATION INITIATION (AS) AND 
REPLICATION TERMINATION (DS). A) PRINCIPLE OF AS/DS DETECTION BY OKAZAKI-FRAGMENT 
SEQUENCING. Left: Replication fork directionality (RFD) is calculated by the number of Watson 
and Crick strands. Right: Theoretical RFD profiles for an initiation/ termination site (for one 
fixed origin) or zone (multiple inefficient origins). B) VISUAL COMPARISON OF AS AND DS WITH 
PRE-RC (T-PIC) POSITIONS [chr8: 9033838-9569826]. C) COMPARISON OF AS/DS REGION SIZES. 
Represented in boxplot: thick line shows the median, the box is the distribution from the first to 
the third quartile, the whiskers indicate the smallest and largest value without being an outlier. 
D) PRE-RC (T-PIC) DENSITY WITHIN AS/ DS REGIONS AND THE REMAINING GENOME. Density is 
represented as events/Mb. AS (initiation zones) are colored in red, DS (termination zones) 
colored in blue, the remaining genome is represented in grey. 
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COVERAGE OF PRE-RC COMPONENTS IS ENHANCED AT AS AND DECREASED AT 
DS 
Examining pre-RC positions already procured an impression of pre-RC distribution 
in relation to AS and DS. Another way of analyzing the data is to calculate the 
sequencing read coverage at the superimposition of either AS or DS. This has the 
advantage of being independent of any peak-calling algorithms and obtaining a global 
impression of the average situation at all sites simultaneously.   
Coverage was computed as reads per base within a window of 200 kb around AS or 
DS centers for each replicate. From this, I calculated the mean coverage of all three 
replicates for each pre-RC protein. In Figure 4.18, the result of the mean coverage 
analysis at AS or DS is depicted for A) Orc2, B) Orc3, C) Mcm3, and D) Mcm7. All 
four pre-RC proteins showed an enhanced coverage at AS, while coverage was 
depleted from DS. The input is also plotted as a control for intrinsic chromatin 
composition. As sonication does not fragment chromatin uniformly, regions with 
higher accessibility might be underrepresented because of increased destruction 
during sonication, while less accessible regions are slightly overestimated. This is 
possibly the reason for decreasing input coverage at AS and increasing input coverage 
at DS. AS have been shown to reside in rather euchromatic environment (Petryk et al. 
2016), whereas input coverage implies DS being more heterochromatic.  
The coverage increase of target pre-RC proteins of 0.5 to 0.8 reads/base seems slight, 
but accounts for 10% of the mean coverage (assuming a mean coverage of 4.5 
reads/base). One possible reason is the large AS/DS size. Looking at an average of 
all AS ranging from 3.9 kb to 198 kb, also averaged out specific protein binding events. 
Furthermore, increased coverage at AS had an average region width of ~60 kb and 
decreased coverage at DS ~120 kb, which corresponds to the mean AS (37.8 kb) and 
DS sizes (122.2 kb). This observation and the reproducibility of all pre-RC 
components increasingly covering AS together with a specific coverage depletion at 
DS convincingly argues for specificity of these results.  
In conclusion, both T-PIC-defined pre-RC complex distribution and pre-RC 
component coverage analysis revealed an elevated pre-RC binding in replication 
initiation zones (AS), with specific pre-RC depletion in termination zones (DS).  
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When looking at the T-PIC-defined pre-RC complex distribution, pre-RC density was 
2.5-fold higher in initiation zones than in termination zones. Analysis of HOMER-
defined pre-RC positions by trend also resulted in increased density within AS, but 
the total number of 329 HOMER-defined pre-RCs was not elevated enough to make 
a meaningful statement (data not shown).  
AS are broad zones in which replication preferentially initiates from multiple 
inefficient origins (Petryk et al. 2016). Thus, multiple pre-RC sites are expected within 
these zones. However, presence of pre-RCs outside of these zones (DS, remaining 
genome) is not astonishing. These pre-RCs might be part of dormant origins, i.e. 
origins, that are licensed but not activated, unless replicative stress (replication fork 
stalling) makes their activation necessary to complete genome replication (Blow, Ge, 
and Jackson 2011). These observations indicate, that while AS is indeed a zone of 
pre-RC occurrences and DS clearly is depleted from pre-RCs, origin licensing also 
efficiently takes place outside of AS. 
AS and DS together make up only 15.2% of the human genome, mostly due to low 
OK-sequencing coverage, which partly impedes confident zone detection. But also in 
HeLa cells, only 61% of the genome contribute to zones of replication initiation and 
termination. Petryk et al. propose AS as “master initiation zones”, while the rest of the 
genome displays disperse, stochastically firing origins that cannot be detected by their 
method. Indeed, this is in agreement with AS representing replication units. Other 
methods (bubble trap or SNS-seq) detect many active replication events inside and 
outside AS.  
INTENDED IMPROVEMENTS AND FURTHER ANALYSES 
This analysis of correlating pre-RC components and replication initiation/termination 
represents a first impression of relations between origin licensing and activation. 
Further analyses are anticipated to strengthen these results. First of all, the mean 
pre-RC density was calculated for all AS/DS. However, this calculation ignores 
fluctuations. Pre-RC density per single AS/DS needs to be calculated and plotted in a 
FIGURE 4.18: PRE-RC COMPONENT COVERAGE ANALYSIS REVEALED ACCUMULATION AT AS (LEFT) AND 
DEPLETION AROUND DS (RIGHT). A) MEAN ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN 
MCM3 COVERAGE. D) MEAN MCM7 COVERAGE.  Coverage was calculated as number of reads/base 
within a 200 kb window around either AS or DS center.  
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boxplot to be able to draw any final conclusions. If the mean density is influenced by 
outliers, it will be uncovered. Still, Petryk et al. compared HeLa AS to ~13000 Orc1 
sites detected in the same cell line by Dellino et al. 2013. They found Orc1 peak density 
being 2.4-times higher in AS than DS, consistent with my complex densities (pre-RC: 
2.5-fold higher in AS than DS (Figure 4.17); ORC: 2.4-fold (Appendix Figure 18 B, 
G1), Mcm2-7: 3.3-fold (Appendix Figure 18 C, G1)). 
Furthermore, pre-RC components are not necessarily expected in the middle of AS, 
as calculated. On the contrary, HeLa Orc1 sites were mostly enriched at AS borders 
(Petryk et al. 2016). Indeed, the M-shaped pre-RC component coverage profiles could 
result from elevated border distributions (Figure 4.18 A and B). Simple coverage 
calculations at AS/DS aligned at one border will answer this question. Thereby, one 
important feature has to be taken into account: Petryk et al. found AS often to be 
flanked by actively transcribed genes. This and the fact the Orc1 sites were often found 
at AS borders led to the hypothesis, that ORC loads Mcm2-7 helicases at the borders. 
Delimitation by active transcription possibly directs Mcm2-7 spreading towards AS. 
When calculating coverage at AS borders, flanking genes need to be taken into account 
(possibly sorting AS into different classes according to their association with 
transcription). Two results can be expected: i) indeed, ORC is enriched at AS borders, 
ii) Mcm3 and Mcm7 are also enriched at the borders but migrate smoothly in the AS 
direction. Performing the analysis will reveal whether this hypothesis holds true.   
CONCLUSION 
Biologically, pre-RCs are a prerequisite for active replication. Notably, these results 
validate my pre-RC ChIP-seq approach and undoubtedly prove that I successfully 
chipped pre-RC components. While they were nicely associated with AS, the evident 
depletion at DS was unexpected. Petryk et al. did not observe or discuss any similar 
observations. DS are generally larger than AS (Figure 4.17 C) arguing for replication 
initiation being more precise than replication termination, which appears to be more 
random. This observation also indicates that replication fork speeds fluctuate, 
generating more disperse replication termination sites when forks collide. Pre-RC 
depletion in DS indicate little origin licensing within sites of replication termination. 
Termination zones often consist in actively transcribed gene bodies, but have not been 
further characterized so far. Consequently, several questions arise: Which features 
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define replication termination zones? Is there also a link to heterochromatin? Why are 
pre-RCs specifically absent from these zones? Is it actually simply the absence of pre-
RCs that defines a termination zone as termination zone? And how is active 
transcription linked to replication termination zones? The last question will be also 
discussed in the next chapter. 
Detection of active replication by any method (OK-seq or SNS-seq) often links DNA 
replication to active transcription. Conserved AS that are shared between different cell 
types, are often flanked by actively transcribed genes (Petryk et al. 2016). Also SNS are 
often enriched in genes or promoters (Cayrou et al. 2011; Besnard et al. 2012; Picard et 
al. 2014; Cayrou et al. 2015).  Consequently, after correlating pre-RC positions with 
sites of active replication, I was wondering, whether pre-RC ChIP-seq data also 
associate with active transcription.  
 STABLE ORIGIN LICENSING IS ASSOCIATED TO REGULATION 
OF ACTIVE TRANSCRIPTION 
To be able to correlate pre-RC positions with active transcription, I first needed 
information about gene expression in Raji cells. Alexander Buschle and Prof. Dr. 
Wolfgang Hammerschmidt (Research Group EBV Genetics and Vectors, Research 
Unit Gene Vectors, HelmholtzZentrum München) kindly shared their RNA-seq data 
obtained from identical Raji cells.  
4.3.1 PRE-RC COVERAGE WAS INCREASED AT ACTIVE TRANSCRIPTION START SITES 
RNA-seq data reflects gene expression within a cell population. The obtained reads 
from sequencing are mapped against genes and quantified. The experiments were 
performed in triplicates and the mean quantification was considered to estimate gene 
expression. With the support of Tobias Straub (head of the Bioinformatics Core Unit, 
Ludwig-Maximilians-Universität München), actively transcribed genes were arbitrarily 
defined as more than e2 = 7.39; (ln(mean) > 2), meaning that more than 7.39 
sequencing reads per gene define a gene as actively transcribed. This resulted in 10642 
active and 12731 inactive genes. The transcription start sites of these genes were 
extracted and the coverage of the different pre-RC target proteins was computed  
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within a 4000 bp window around active or inactive TSSs.  
As observed in Figure 4.19 (left panel), all targeted members of the pre-RC 
were clearly enriched at active TSSs. Coverage of Mcm3 (Figure 4.19 C, left panel) was 
less prominent than for the other target proteins (Figure 4.20: Orc2: A, Orc3: B, and 
Mcm7: D, left panel), which might originate from the antibody. Pre-RC association 
was clearly dependent on transcriptional activity, as inactive TSSs were not enriched 
in any pre-RC component (Figure 4.19, right panel).       
4.3.2 STRONG HOMER-DEFINED ORC, MCM2-7 AND PRE-RC ASSOCIATED WITH 
ACTIVE TRANSCRIPTION START SITES 
To examine the relation of HOMER- or T-PIC-defined ORC, Mcm2-7 and pre-RC 
to active and inactive TSSs, I calculated the distance of each complex position to the 
next TSS. This resulted in an estimation of the frequency, in which complexes are 
found in vicinity or in distance of TSSs. The distances to active TSSs (colored) and 
inactive TSSs (grey) are represented in the graphs (Figure 4.20: HOMER-defined 
complexes (left panel); T-PIC-defined complexes (right panel)). As for inactive TSSs, 
all HOMER- and T-PIC-defined complexes peaked at 100 kb distance. Considering 
roughly 13000 inactive TSS and a human genome size of 3.1 Mb (hg19), a random 
distribution would result in an average distance of 238 kb. However, as the genomic 
organization is not random, but grouped in gene dense euchromatic and gene devoid 
heterochromatic regions, I propose that ORC, Mcm2-7 and pre-RC distributions 
around 100 kb from the next inactive TSS originate from TSS-independent 
distributions. When looking at the T-PIC-defined complexes, their distribution in 
relation to active TSSs approximate the one of inactive TSSs (Figure 4.20 (right 
panel)), suggesting that T-PIC-defined pre-RC depend only little on transcriptional 
activity. Moreover, Mcm2-7 are even more depleted from active TSS, compared to 
inactive TSS (mean distance from active TSS: 430 kb, mean distance from inactive 
TSS: 186 kb, p-value = 2.2x10-16). 
FIGURE 4.19: PRE-RC COMPONENT COVERAGE ANALYSIS REVEALED INCREASED COVERAGE AT ACTIVE 
TSS (LEFT PANEL) AND UNCHANGED COVERAGE AT INACTIVE TSS (RIGHT PANEL). A) MEAN ORC2 
COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE.  
Coverage was calculated as number of reads/base within a 4000 bp window around TSS. Input was 
plotted as control (grey). 
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FIGURE 4.20: A SUBPOPULATION OF HOMER-DEFINED ORC, MCM2-7, AND PRE-RC WERE CLOSELY 
RELATED TO ACTIVE TSS. Left: HOMER-defined complexes, right: T-PIC-defined complexes. The 
distance of each position was calculated towards the next TSS and is plotted in log10 on the x-axis.  
Y-axis represents the frequency of complexes within a specific distance. 
RESULTS AND DISCUSSION 
76 | 
 
By contrast, HOMER-defined complex distribution in respect to active TSSs is 
bipartite (Figure 4.20 (left panel)). A subpopulation of strong HOMER-defined 
complexes, is located in close proximity (100 – 1000 bp) to active TSSs. This is true 
for ORC, Mcm2-7 and pre-RC, but also for the single replicates of each ChIP (data 
not shown). HOMER-defined complexes represent a population of very strong 
binding sites (Chapter 4.2.1, p. 60). Consequently, the proximity to active TSSs defines 
at least in part strong pre-RC binding.   
Dedicated programs take peak position information and calculate the peak 
proportions in specific genome features, as e.g. promoters, exons, and introns. 
Analysis of the genomic distribution of HOMER- and T-PIC-defined pre-RC with 
the CEAS program (cis-regulatory element annotation system (Shin et al. 2009)) 
confirmed the close association of pre-RCs to proximal promoter regions (see 
Appendix Figure 11). Thereby, HOMER-defined pre-RCs again showed an increased 
association to close promoter regions and was also more depleted from intronic and 
distal intergenic regions compared to T-PIC-defined pre-RCs. Nevertheless, T-PIC-
defined pre-RCs were also slightly enriched in proximal promoter regions, indicating 
that active transcription indeed favors pre-RC positions, independent of the peak-
calling algorithm.  
Promoter activity is amongst others regulated by specific histone modifications. In 
particular, H3K4me3 is known to recruit chromatin remodeling factors that create 
open chromatin which leads to transcription factor binding (Kimura 2013). 
Consequently, most active TSSs are marked by H3K4me3.  
4.3.3 PRE-RC COVERAGE WAS ENHANCED AT H3K4ME3 PEAKS 
With active TSS being marked by H3K4me3, pre-RC components are also expected 
to be enriched at H3K4me3 sites. The group of Dr. Jean-Christophe Andrau 
(Transcription and Epigenomics in Developing T-Cells, IGMM, Montpellier) kindly 
shared their data of H3K4me3 and H3K36me3 peak positions obtained from ChIP-
seq in Raji cells. Indeed, direct comparison of active TSS and H3K4me3 positions 
revealed that 81% of active TSS coincide with H3K4me3 (Figure 4.21). Still, 52.8% of 
all H3K4me3 peaks do not directly overlap with TSS. However, further analysis of the  
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FIGURE 4.21: MOST ACTIVE TSS DIRECTLY OVERLAPPED WITH H3K4ME3. Venn diagram of overlap 
between TSS and H3K4me3. Overall counts are indicated. The percentage of overlapping 
proportions are specified below in brackets.     
genomic distribution of H3K4me3 peaks revealed a close association to all regulatory 
regions upstream of the TSS (promoter, 5’UTR), as well as presumably first introns 
and exons (Appendix Figure 12).  Computational analysis of the mean coverage of the 
single pre-RC proteins (Figure 4.22) indicated an enrichment at H3K4me3 peak 
centers (except for Mcm3 (Figure 4.22 C)). The calculated coverage is more irregular 
than at TSSs because H3K4me3 peaks of different sizes were centered and read 
coverage was calculated in a large 20 kb window (mean size = 2.2 kb, range from 250 
bp to 98.1 kb, see also Appendix Figure 13).  
In contrast to pre-RC enrichments at H3K4me3 peaks, no enhanced coverage was 
observed at H3K36me3 regions (Appendix Figure 15). H3K36me3 is also a histone 
modification associated to active transcription, but is rather found in actively 
transcribed gene bodies (Kimura 2013), more precisely in intronic regions (Appendix 
Figure 14).  This finding specifically links replication licensing to the regulation of 
active transcription, but not to transcriptional activity itself. 
4.3.4 STRONG HOMER-DEFINED MCM2-7 AND PRE-RC ENTIRELY ASSOCIATE WITH 
H3K4ME3 
Already coverage analyses implied a strong association of pre-RC with H3K4me3. 
However, it remained to be tested whether this association is confirmed by a co-
localization of H3K4me3 and HOMER- and T-PIC-defined ORC, Mcm2-7 and 
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FIGURE 4.22: INCREASED COVERAGE OF TARGET PRE-RC PROTEINS AT H3K4ME3 PEAKS. A) MEAN 
ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 
COVERAGE.  Coverage was calculated as number of reads/base within a 20 kb window around 
H3K4me3 peak center. Input was plotted as control (grey).  
pre-RC positions. Indeed, HOMER-defined Mcm2-7 complexes and pre-RCs nearly 
completely overlapped with H3K4me3 positions (88%) and ORC at least to 56,3% 
(Figure 4.23, left panel). In contrast, for T-PIC-defined peaks, ORC positions 
correlated to a higher degree with H3K4me3 peaks (14.4% of all ORC overlaps with 
nearly 50% of all H3K4me3 peaks, Figure 4.23, right panel). Mcm2-7 complexes and 
pre-RCs remained less associated. This result was also confirmed by analyzing the 
distance to H3K4me3 peak center (Appendix Figure 16, left panel). HOMER-defined 
Mcm2-7 and pre-RC completely resided in close proximity to the peak centers (100-
1000 bp), while a subpopulation of ORC remained distant. The distance of all 
A) B) 
D) C) 
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HOMER- or T-PIC-defined complexes to H3K36me3 remained randomly 
distributed. 
 
 
 
FIGURE 4.23: HOMER-DEFINED COMPLEXES NEARLY COMPLETELY OVERLAP WITH H3K4ME3 PEAKS. 
Left panel: HOMER-defined complexes, right panel: T-PIC-defined complexes. Venn diagram of 
the overlap between ORC, Mcm2-7, and pre-RC with H3K4me3 peaks. Overall counts are 
indicated. The percentages of overlapping proportions are specified below in brackets. 
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CONCORDANCE WITH PREVIOUS STUDIES AND FURTHER ANALYSES 
The regulation of transcriptional activity clearly impacts on origin licensing 
efficiencies. The comparison of HOMER- and T-PIC-defined complexes argues for 
the variability of favorable origin licensing features. Strong licensing depends entirely 
on active transcriptional regulation (association to TSS and H3K4me3) and thus 
affects the entire HOMER-defined pre-RC population. Regarding T-PIC-defined 
ORC, Mcm2-7 and pre-RC, licensing positions regulated by active transcription only 
built a sub-population of all T-PIC peaks and further features account for the other 
T-PIC-defined complexes. However, these features confer less localized binding of 
pre-RC components. 
Interestingly, ORC is the only HOMER-defined complex that did not entirely overlap 
with H3K4me3 peaks. This hypothesis is consistent with the fact that ORC also has 
other functions than regulating pre-RC formation, for instance in heterochromatin 
regulation (Giri et al. 2015; Giri and Prasanth 2015). This can be tested by extracting 
the ORC subpopulation not associating with H3K4me3 and comparing these ORC 
positions with known heterochromatin regions.   
The association of active DNA replication and transcription is already widely proven 
(Martin et al. 2011; Besnard et al. 2012; Cayrou et al. 2015; Smith et al. 2016; Kylie et al. 
2016). Furthermore, also both ChIP-seq studies targeting a component of ORC 
(Orc1: Dellino et al. 2013, Orc2: Miotto, Ji, and Struhl 2016), stated a close connection 
to transcriptional activity. Dellino et al. found 71% of all detected Orc1 sites at active 
TSS. Additionally, the authors linked Orc1 sites with high transcription levels to early 
replication, while Orc1 sites with low or undetectable expression levels replicated late 
in S-phase. Thus, their study connects Orc1 sites and transcription with replication 
timing.   
Miotto et al. claim only a moderate association of Orc2 sites and active 
transcription (Pearson correlation 0.33, Miotto, Ji, and Struhl 2016). Considering 
~52000 detected Orc2 sites and roughly 20000 human genes, of which maybe half are 
transcriptionally active, only 1
5
 of all Orc2 peaks could actually correlate with active 
transcription and a correlation coefficient of 0.33 should be judged as good. Re-
analyzing their data and sorting Orc2 peaks for strong and weak enrichments might 
also connect strong Orc2 binding to active TSS. I intend to directly correlate their 
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Orc2 peak positions with my HOMER- and T-PIC defined ORC, Mcm2-7, and pre-
RC, to get an idea of concordance of the experiments. The authors claim that DNA 
accessibility is the main determinant of Orc2 positions. Consequently, they found 
Orc2 in promoters and regions enriched for active chromatin marks (H3K27ac, 
H3K4me1/2/3), consistent with my own results.  
Very recently, Smith et al. compared active replication in different human cell types 
and differentiation states and found mostly conserved replication origins associated 
with H3K4me3 (Smith et al. 2016). Also Cayrou et al. linked active replication to 
histone modifications favoring open chromatin (H3K4me, H3K9Ac, Cayrou et al. 
2015). These findings suggest H3K4me3 being a histone modification that contributes 
to an accessible chromatin environment for strong pre-RC binding and thus efficient 
replication initiation.   
The general question remains whether transcriptional activity positively or negatively 
influences origin licensing and activation. While it is evident that active transcription 
creates a chromatin environment also accessible for replication factors, multiple 
studies mutually exclude high transcription rates and efficient replication 
(Nieduszynski, Blow, and Donaldson 2005; Mori and Shirahige 2007; Lõoke et al. 
2010; Martin et al. 2011). My results imply, that actively transcribed genes are indeed 
devoid of pre-RC components (absent pre-RC coverage at H3K36me3 peaks, 
Appendix Figure 15), while pre-RCs are mostly found at active TSS (Figure 4.19) and 
promoter regions harboring active histone modification marks (H3K4me3, Figure 
4.22). It has been reported that replication initiation events themselves are absent from 
TSS, but enriched in adjacent sequences (Martin et al. 2011). Petryk et al. found early 
replicating initiation zones predominantly flanked by actively transcribed genes, while 
many termination zones overlap active genes. Assuming that ORC is mostly found at 
initiation zone borders (as shown for Orc1, Dellino et al. 2013; Petryk et al. 2016), and 
Mcm2-7 helicases move from their initial loading site, one could hypothesize that 
transcription and RNA polymerase II action promote Mcm2-7 removal from actively 
transcribed genes.    
RNA polymerase dependent Mcm2-7 double-hexamer sliding has indeed been shown 
by Gros et al. 2015 in budding yeast. The authors found that RNA polymerase II can 
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push Mcm2-7 double-hexamers along the DNA, without them losing initiation 
potential. Also in Leishmania major, it has recently been demonstrated that most 
replication initiation sites are found at sites of RNA polymerase II stalling or 
transcriptional termination, arguing for co-migration of Mcm2-7 helicases and the 
transcriptional machinery (Lombraña et al. 2016). Furthermore, Powell et al. 
demonstrated by ChIP-seq studies in Drosophila melanogaster, that Mcm2-7 helicases are 
evenly distributed throughout the genome in G1/S transition, but absent in actively 
transcribed genes (Powell et al. 2015). Thereby, an active transcription process is 
required for Mcm2-7 displacement from gene bodies. The authors propose Mcm2-7 
residing in transcribed genes being displaced by the passage of RNA polymerase II.  
Absence of Mcm2-7 helicases at actively transcribed genes would explain 
active genes being favored zones of replication termination (Petryk et al. 2016). This 
model would situate ORC localizing at accessible regions, like TSS, and thus initiation 
zone boundaries. ORC loads Mcm2-7 helicases, which are subsequently translocated 
by active transcription into gene-adjacent regions, defining replication initiation zones 
detected by Okazaki-fragment sequencing. This RNA polymerase II-dependent 
translocation mechanism would also avoid head-to-head collisions of replication fork 
and the transcriptional machinery, preventing sources of replication fork stalling or 
DNA damage. Moreover, G4 structures might block Mcm2-7 helicase sliding, possibly 
explaining why G4 structures are found enriched at active replication origins (Besnard 
et al. 2012). The mechanism of Mcm2-7 dislocation would include displacement or 
reassembly of nucleosomes and other DNA-binding proteins, which seems laborious 
for the cell and needs further investigation.  
CONCLUSION 
Pre-RC or replication origin association to the regulation of active transcription is 
generally accompanied by early replication timing. My results showing strong pre-RC 
binding at active TSS provoke the speculation whether active TSS are early replicated 
because of strong pre-RC binding. Miotto et al. used mathematical modeling to correctly 
predict replication timing dependent on ORC densities (Miotto, Ji, and Struhl 2016). 
As higher ORC densities presumably also result in more Mcm2-7 helicases, the 
probability of origin firing events increases, resulting in early replication. Replication 
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timing domains are concordant with topologically associating domains (TADs), whose 
borders also might limit the Mcm2-7 helicase sliding to restricted domains.  
Consequently, active chromatin environment positively influences ORC 
binding probabilities, which leads to more Mcm2-7 helicase loading. These helicases 
are translocated from their original binding sites by transcription machineries, which 
is the reason for replication initiation not taking place within genes, but adjacent to 
them. The more accessible chromatin is, the higher ORC/Mcm2-7 densities may 
become, the higher the probability for licensed origins to fire, the earlier replication 
origins are activated.  
 MCM2-7 HELICASES APPROXIMATE ORC IN S/G2 
Origin licensing can only happen in late mitosis/ early G1, when CDK and DDK 
activities are low. After ORC binding to DNA, Cdc6 and Cdt1 are required for further 
Mcm2-7 double-hexamer loading. Once a replication origin is activated, the helicases 
move as part of the replication forks, until replication termination and helicase 
dissociation. 
I chose the S/G2 time-point during the cell cycle as a control for my ChIP 
experiments, assuming that replication complexes either dissociate because of their 
replication activity, or passively, when replication forks move through inactive 
licensing complexes, thereby removing them from DNA (Kuipers et al. 2011). As a 
consequence, and as observed at oriP, I expected less Mcm2-7 binding to chromatin 
sites, resulting in less peak-algorithm defined complexes.  
4.4.1 COMPLEX NUMBER AND SIZES DO NOT CHANGE IN S/G2 
S/G2 pre-RC-ChIPs were performed in parallel to the G1 ChIPs and sequenced 
comparably. I analyzed the data as described previously and performed HOMER and 
T-PIC peak-calling, starting with comparing the number and positions of detected 
HOMER- or T-PIC-defined complexes in G1 and S/G2.  
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FIGURE 4.24: DEFINED COMPLEXES DO NOT DIFFER IN NUMBER OR SIZE WHEN COMPARING G1 VS. 
S/G2. A) HOMER-DEFINED COMPLEXES. B) T-PIC-DEFINED COMPLEXES. Left: Number of defined 
ORC, Mcm2-7 and pre-RC was plotted as indicated in a bar chart in G1 vs. S/G2. Right: Complex 
sizes were potted as boxplot in G1 vs. S/G2. Thick line shows the median, the box is the 
distribution from the first to the third quartile, the whiskers indicate the smallest and largest value 
without being an outlier. Outliers represented by dots.    
For both HOMER-defined complexes, as well as T-PIC-defined complexes, neither 
the peak number nor the peak sizes changed considerably (Figure 4.24, for EBV 
genome, see Appendix Figure 17 A and B). Opposing to what was expected, there 
were even more HOMER-defined strong Mcm2-7 complexes detected in S/G2, 
which consequently resulted in slightly more defined pre-RCs (Figure 4.24 A). As for 
T-PIC-defined complexes, there was a minor reduction in the number of defined 
complexes observed (Figure 4.24 B). Comparing the positions of the defined-
complexes between G1 and S/G2 on the EBV genome revealed a strong conservation 
(Appendix Figure 17 C). Also for the human genome, the majority of the HOMER-
defined complexes in G1 are conserved in S/G2 (> 60%, Figure 4.25, left panel). 
Because more HOMER-defined Mcm2-7 positions were detected in S/G2, many new 
pre-RC sites were also determined.  
A) 
B) 
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Concerning T-PIC-defined complexes, the situation was less pronounced. While there 
was a considerable conservation of ORC and pre-RC positions observed (>55% of 
S/G2 complexes overlap with G1 positions, Figure 4.25, right panel), this was not the 
case for Mcm2-7 (< 30% overlap of S/G2 positions with G1). The reduction of the 
number T-PIC-defined complexes in S/G2 can be explained by a decrease in global 
FIGURE 4.25: COMPARISON OF HOMER- AND T-PIC-DEFINED COMPLEX POSITIONS IN G1 VS. S/G2. 
Left: HOMER-defined complexes, right: T-PIC-defined complexes. Venn diagram of overlap 
between G1-defined ORC, Mcm2-7, and pre-RC with the same complexes defined in S/G2. 
Overall counts are indicated. The percentage of overlapping proportions are specified below in 
brackets. 
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protein binding. This reduced binding resulted in a more dispersed signal that did not 
meet the criteria for significant peak detection. However, observed reduction of 
defined T-PIC complexes was relatively unimportant, as a significant number of ORC, 
Mcm2-7, and pre-RCs were still detected in S/G2, indicating that a considerable 
amount of pre-RC proteins were still bound to DNA at this cell cycle stage. Moreover, 
I detected an increased amount of HOMER-defined Mcm2-7 complexes and pre-RCs, 
arguing for an increased strong binding of Mcm2-7 proteins at defined positions in 
S/G2. 
I further analyzed the association of S/G2 ORC, Mcm2-7 and pre-RC with 
replication, transcription and active histone marks. In G1, pre-RC coverage was 
detected at replication initiation zones and specifically depleted from replication 
termination zones. In S/G2, after passage of the replication forks, I would expect a 
flat signal for both replication zones.  
4.4.2 MCM2-7 COVERAGE AT AS AND DEPLETION FROM DS ARE LESS 
PRONOUNCED 
Coverage analysis is a measure of global changes in binding of the single pre-RC 
components to certain features. A direct comparison of the maximum read coverage 
at AS is shown in Table 4.2, p. 90. While pre-RC coverage at AS decreased in S/G2, 
especially for Mcm2-7 components (for Mcm3: from 0.8 reads/base in G1 to 0.3 
reads/base in S/G2, for Mcm7: from 0.5 reads/base in G1 to 0.3 reads/base in S/G2), 
coverage at DS seems less depleted (Figure 4.26). Also the quantification of T-PIC-
defined ORC, Mcm2-7 and pre-RC densities revealed no major change of ORC 
densities at AS or DS, but a decrease in the remaining genomic regions (Appendix 
Figure 18 B). Mcm2-7 densities however showed an increase at DS, while AS and the 
remaining genome remain unchanged (Appendix Figure 18 C). These density shifts of 
ORC and Mcm2-7 resulted in pre-RC density reductions mostly at the remaining 
genome (Appendix Figure 18 A). These observations indicate T-PIC-defined ORC 
positions to only marginally change within AS or DS, but that the reduction of ORC 
numbers in S/G2 essentially concerned the remaining genome. T-PIC-defined Mcm2-
7 complex densities and Mcm2-7 coverage rather indicate that Mcm2-7 proteins were 
less present at AS and less absent from DS in S/G2. 
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It has already been shown in chromatin binding experiments based on cell cycle 
fractionation by centrifugal elutriation, that ORC still binds chromatin in S/G2, while 
Mcm3 and Mcm7 binding generally decreases (Ritzi et al. 2003). Indeed, while Orc2 
and Orc3 coverage profiles are very similar in G1 and S/G2 (compare Figure 4.18 and 
Figure 4.26), Mcm3 and Mcm7 profiles assimilate Orc2/3 profiles, which involves 
decreased coverage at AS and less depletion from DS.  
Pre-RC ChIP-seq experiments in Drosophila cells showed that minimal Mcm2-7 
double-hexamer loading can occur in absence of cyclin E (main regulator of S-phase 
entry), while maximal loading coincides with G1/S transition. Minimal loading strictly 
depends on ORC, while maximal Mcm2-7 helicase loading during G1/S coincides less 
with ORC positions (Powell et al. 2015). It is possible that my pre-RC coverage profiles 
in S/G2 reflect minimal Mcm2-7 loading, strictly dependent on ORC, which might be 
the reason for both ORC and Mcm2-7 profiles becoming similar. 
ORC generally binds in accessible regions, the reason for ORC being mostly detected 
at TSS or H3K4me3 enriched regions (chapter 4.3, p. 72ff). If minimal Mcm2-7 
double-hexamer loading in S/G2 strictly depends on ORC, I expect an increased 
Mcm2-7 coverage at these accessible regions. 
4.4.3 PRE-RC COVERAGE AT TSS AND H3K4ME3 WAS INCREASED IN S/G2 
When calculating the coverage of pre-RC subcomponents at active TSS, their 
association was generally increased (Table 4.2, Orc2 coverage from 2.9 reads/base in 
G1 to 3.5 reads/base in S/G2, Orc3 coverage from 4.2 reads/base in G1 to 5.1 
reads/base in S/G2, Mcm3 coverage from 1.5 reads/base in G1 to 2.8 reads/base in 
G2, Mcm7 from 3.3 reads/base in G1 to 4.4 reads/base in G2; compare Figure 4.19 
(G1) with Figure 4.27 (S/G2)). This enhancement was more prominent for Mcm3 and 
Mcm7 (> 1 read/base). Enhanced Mcm2-7 binding was also detected by HOMER 
peak-calling. Strong HOMER peaks were shown to preferentially locate close to active  
 
FIGURE 4.26: PRE-RC COMPONENT COVERAGE (S/G2) AT AS (LEFT PANEL) AND DS (RIGHT PANEL). 
A) MEAN ORC2 S/G2 COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. C) MEAN MCM3 S/G2 COVERAGE. 
D) MEAN MCM7 S/G2 COVERAGE.  Coverage was calculated as number of reads/base within a 200 
kb window around AS/ DS region center. Input was plotted as control (grey). 
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transcription sites (Figure 4.20, left panel; Figure 4.23, left panel; Appendix Figure 
11 A; Appendix Figure 16, left panel) consistent with these results.  
H3K4me3 peaks were also more covered by pre-RC components in S/G2 (Table 4.2, 
Orc2 coverage from 2.8 reads/base in G1 to 3.8 reads/base in S/G2, Orc3 coverage 
from 3.3 reads/base in G1 to 4.3 reads/base in S/G2, Mcm3 coverage from 1.5 
reads/base in G1 to 2.5 reads/base in S/G2, Mcm7 from 2.5 reads/base in G1 to 3.2 
reads/base in S/G2; compare Figure 4.22 (G1) with Appendix Figure 19 (S/G2)).  
TABLE 4.2: DIRECT COMPARISON OF MAXIMUM MEAN READ COVERAGE AT REGIONS OF INTEREST 
IN G1 VS. S/G2. Mean read coverage is specified in reads/base.   
 G1 S/G2 Difference 
Initiation 
zones (AS) 
Orc2 0.5 0.4 - 0.1 
Orc3 0.5 0.5 0 
Mcm3 0.8 0.3 - 0.5 
Mcm7 0.5 0.3 - 0.2 
TSS 
Orc2 2.9 3.5 + 0.6 
Orc3 4.2 5.6 + 1.4 
Mcm3 1.5 2.8 + 1.3 
Mcm7 3.3 4.4 + 1.1 
H3K4me3 
Orc2 2.8 3.8 + 1.0 
Orc3 3.3 4.3 + 1.0 
Mcm3 1.5 2.5 + 1.0 
Mcm7 2.5 3.2 + 0.7 
 
When directly comparing HOMER- and T-PIC-defined pre-RC positions overlapping 
with H3K4me3 peaks, it became evident that the S/G2 HOMER-defined pre-RCs 
still mainly overlap with H3K4me3 (Appendix Figure 20, left panel; for ORC and 
Mcm2-7, see Appendix Figure 21). Thereby, also a higher proportion of T-PIC-
defined pre-RCs associated with H3K4me3 in S/G2 (Appendix Figure 20, right 
panel). 
These observations lead to the conclusion that, while HOMER-defined complexes are 
still related to active transcription in S/G2, T-PIC-defined complexes seem also to 
FIGURE 4.27: PRE-RC PROTEIN COVERAGE INCREASED AT ACTIVE TSS IN S/G2. A) MEAN ORC2 S/G2 
COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. C) MEAN MCM3 S/G2 COVERAGE. D) MEAN MCM7 S/G2 
COVERAGE. Coverage was calculated as number of reads/base within a 4000 bp window around 
TSS. Input was plotted as control (grey). Active TSS (left) inactive TSS (right). 
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locate more towards actively transcribed regions in S/G2. This hypothesis was also 
confirmed by analyzing the genomic distribution of HOMER- and T-PIC defined pre-
RCs (Appendix Figure 22).   
These results indicate that the distribution of Mcm2-7 complexes changed in S/G2. 
The enrichment in active replication sites decreased as well as the specific depletion 
from replication termination sites was less detectable. Moreover, the association of 
Mcm2-7 to active transcription notably increased. One possible explanation for these 
observations is Mcm2-7 being loaded on DNA without sliding away from their 
loading site. This possibly reflects an early time point of Mcm2-7 loading and would 
result a higher similarity between ORC and Mcm2-7 helicases in S/G2. 
4.4.4 MCM2-7 HELICASES APPROXIMATE ORC POSITIONS IN S/G2 
To evaluate the relation between ORC and Mcm2-7 peak positions, I calculated the 
Jaccard index as explained in Figure 4.9 A and represented similarities in a heatmap 
(Figure 4.28). For both HOMER- and T-PIC-defined complexes, highest similarities 
were obtained when comparing each complex between G1 and S/G2 (highlighted as 
red boxes in Figure 4.28), consistent with complex positions being conserved for up 
to 80% (as shown in Figure 4.25). Only T-PIC defined Mcm2-7 showed little similarity 
between G1 and S/G2, as expected from previous results. However, similarities 
between ORC (S/G2) and Mcm2-7 (S/G2) increased (green boxes in Figure 4.28) 
compared to ORC (G1) and Mcm2-7 (G1). These results confirm Mcm2-7 positions 
approximating ORC positions in S/G2.      
POSSIBLE REASONS FOR PREMATURE MCM2-7 BINDING AND ANTICIPATED 
VALIDATION 
During my analyses it became evident, that Mcm2-7 peak-calling does not necessarily 
lead to meaningful biologically relevant results. Due to the discussed Mcm2-7 sliding 
process, Mcm2-7 complexes may become undetectable by peak-calling algorithms. 
HOMER detects only accumulations of Mcm2-7, probably reflecting their initial 
loading sites. Apparently, Mcm2-7 helicases are more dynamic in G1 (very low 
number (322) of strong HOMER-defined Mcm2-7), while they seem to be more 
localized in S/G2 (3x more HOMER-defined Mcm2-7 (1002), Figure 4.24 A).  
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FIGURE 4.28: MCM2-7 APPROXIMATED ORC IN S/G2. T-PIC- and HOMER-defined ORC and 
Mcm2-7 complex similarities represented as heatmap of Jaccard indices (G1 vs. S/G2). Dark red 
indicates high similarities while lighter red marks differences. Each complex generally tends to 
cluster together when comparing G1 vs. S/G2 (marked by red boxes). Mcm2-7 similarity to ORC 
increases in S/G2 (green boxes).  
Thereby, most HOMER-defined Mcm2-7 from G1 are conserved in S/G2 (88.5%, 
Figure 4.25, left panel). In contrast, T-PIC is more sensible for detecting protein 
enrichments. It obviously detects HOMER-defined peaks (Figure 4.13, Appendix 
Figure 6), but also identifies regions of lower intensities, presumably sites of Mcm2-7 
helicase spreading. However, this sensible detection can explain low reproducibility of 
detected peak positions, as stochastic Mcm2-7 helicase sliding is not necessarily always 
detected at similar sites.  
Originally, I planned to use ChIP-seq data from the S/G2 cell cycle phase as negative 
control for my experiments. Interestingly, my analyses in S/G2 provided insights in 
previously unknown Mcm2-7 DNA binding processes happening after origin firing, 
and it seems that pre-RC proteins are not completely dissociated from DNA in post-
replicative cell cycle stages. While association of Mcm2-7 to replication units were 
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reduced, ORC and Mcm2-7 were preferentially found at regions of active 
transcription. Thereby, Mcm2-7 showed a higher similarity to ORC positions in S/G2, 
than in G1. Consequently, these results suggest an early origin licensing state, with 
licensing first taking place at accessible regions and Mcm2-7 helicases still localizing 
at their loading sites. 
Origin licensing is generally prevented in G2. Major licensing block is the inhibition 
of the Mcm2-7 chaperone Cdt1 (Ballabeni et al. 2004). Cdk2 (highest expression in 
G2) phosphorylates Cdt1, thereby targeting it for degradation (Blow and Dutta 2005). 
Furthermore, Geminin inactivates Cdt1 during G2 and mitosis. Consequently, 
Mcm2-7 loading can only take place in late mitosis/early G1.  
The observation of Mcm2-7 loading in S/G2 might be explained by an 
elevated contaminating mitotic cell population. Thus, I need to more precisely define 
the exact cell cycle stage of my S/G2 population. Although centrifugal elutriation is 
routinely used in my laboratory and has been extensively characterized (Ritzi et al. 
2003; Papior 2010), FACS analysis (Figure 4.2) is not sufficient to confirm the precise 
cell cycle stage. Expression of Cdt1 itself, as well as cell cycle markers cyclin E (S-
phase), cyclin B (mitosis) and Histone 3 Serine 10 phosphorylation (additional mitotic 
marker) has to be determined by immunoblot, to deduce the portion of mitotic cells. 
Depending on the result, two scenarios are conceivable: i) in my S/G2 population, a 
considerable number of cells already progressed to mitosis, thus allowing origin 
licensing, and ii) my S/G2 population reflects indeed a time-point after DNA 
replication, indicating that residual origin licensing could occur earlier than expected.    
In Drosophila melanogaster, minimal Mcm2-7 loading can occur in absence of cyclin 
E/Cdk2 activity, while the full complement of Mcm2-7 requires cyclin E/Cdk2 kinase 
activity during G1/S transition (Powell et al. 2015). The authors propose loading of 
the full Mcm2-7 complement being dependent on a second wave of Cdc6 expression 
during G1/S transition (Clijsters and Wolthuis 2014), which is stabilized by cyclin 
E/Cdk2 kinase activity. Alternatively, minimal loading of Mcm2-7 helicases 
themselves might promote full Mcm2-7 loading, by a direct Mcm2-7-cyclin E-Cdt1 
interaction (Geng et al. 2007; Powell et al. 2015). These experiments were performed 
in Drosophila Kc and S2 cell lines, treated with several RNAi and chemicals to induce 
cell cycle arrests at precise stages (early G1, G1 phase, and at G1/S transition). These 
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treatments resulted in an unambiguous phenotype, with minimal Mcm2-7 loading in 
mitosis/early G1 and full Mcm2-7 complement in G1/S. Subsequent ORC and 
Mcm2-7 ChIP-seq also clearly revealed ORC and Mcm2-7 co-localization in late 
mitosis/early G1, whereas little overlap was detected in G1/S. Cell cycle fractionation 
has the advantage of performing similar experiments without any chemical 
manipulation that might induce various biases. However, the cell cycle fractions I 
worked with were not as well defined as specifically arrested cells. Still, I observe 
similar phenomena: although I did not detect less loaded Mcm2-7 in S/G2 compared 
to G1, Mcm2-7 positions were more precisely associated to transcriptional regulation 
and approximated ORC. The fact that the amount of detected Mcm2-7 was not 
reduced in my experiments in S/G2 can be explained by diluted cell populations, with 
contaminating G1 and mitotic cell stages. However, closer association of Mcm2-7 to 
transcriptional regulation and ORC argues for an early stage of Mcm2-7 loading, 
before spreading occurs. 
Taken together, pre-RC ChIP-seq results in S/G2 populations suggest that full pre-RC 
formation is necessary for Mcm2-7 helicase loading, preferentially occurring at sites 
of transcriptional regulation. The exact cell cycle stage needs to be further 
characterized by assessing cyclin expression, but a combination of cyclins already 
allowing origin licensing is expected. Mcm2-7 positions differ between G1 and S/G2, 
arguing for Mcm2-7 spreading with onset of G1 phase.    
CONCLUSION 
Pre-RC ChIP-seq experiments in G1 and S/G2 cell cycle stages and their analyses at 
replication initiation/termination zones and regions of active transcription regulation 
allowed to obtain a genome-wide representation of origin licensing dynamics. 
Interestingly, Mcm2-7 helicases emerge to be the sole determinant of replication 
origins (as proposed first in Xenopus (Lucas et al. 2000; Hyrien, Marheineke, and Goldar 
2003; Woodward et al. 2006) and recently also claimed in yeast (Das et al. 2015) and 
Drosophila (Powell et al. 2015)). While pre-RC formation is mandatory for Mcm2-7 
double-hexamer loading, further Mcm2-7 spreading prior to S phase argues for 
replication initiation being independent of complete pre-RC. This scenario would 
explain low redundancies between ORC positions and active replication data (Miotto, 
Ji, and Struhl 2016; Petryk et al. 2016).  
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This study describes the first genome-wide ChIP-seq analysis of ORC and Mcm2-7 
components in humans. Thereby, these components correlated with zones of active 
replication initiation, while being specifically depleted from replication termination 
zones. Actively transcribed genes often constitute termination zones, leading to the 
hypothesis that active transcription relegates Mcm2-7 helicases to gene-adjacent 
regions. In S/G2, the specific depletion from termination zones was less pronounced, 
while association to ORC and active transcription increased. Assuming that S/G2 
populations represent a cell stage allowing early replication licensing, these results 
possibly reflect the initial loading of Mcm2-7 helicases, before spreading occurs. 
Mcm2-7 spreading might only occur with sufficient Mcm2-7 helicases loaded, and 
possibly in presence of cyclin E/Cdk2 activity. Also, chromatin anchorage after 
mitosis might account for Mcm2-7 positions. In eukaryotes, replication timing is 
established prior to origin selection (Rivera-Mulia and Gilbert 2016b). The timing 
decision point coincides with re-organization of chromatin into TADs/replication 
domains after mitosis. If Mcm2-7 helicases were loaded at ORC sites prior to timing 
decision point and spreading took place after chromatin anchorage, Mcm2-7 density 
would be higher in gene dense TADs, while it would be lower in gene poor TADs. 
Assuming that Mcm2-7 dense regions stochastically replicate earlier that Mcm2-7 poor 
regions, this model would link replication timing to regulation of transcriptions and 
chromatin environment. 
Compartmentalization also localizes heterochromatin TADs towards the nuclear 
lamina. Heterochromatin is generally replicated late in S phase, indicating that despite 
a gene-poor environment, efficient origin licensing occurs. In these compartments, 
chromatin accessibility is most likely not the main determinant of ORC binding and 
origin licensing, implicating other mechanisms.  
One possible candidate is H4K20 methylation, as two methylation stages, H4K20me1 
and H4K20me3, have already been shown be relevant for replication regulation. 
However, the exact mechanism of H4K20 methylation action is elusive.   
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 ORC ASSOCIATES WITH H4K20ME3 IN HETEROCHROMATIN 
Cell cycle-dependent regulation of histone 4 lysine 20 monomethyltransferase PR-Set7 
renders H4K20 methylation a promising histone modification to affect DNA 
replication. Furthermore, stabilization of PR-Set7 (by expressing non-degradable PR-
Set7PIPmutant in cells) leads to DNA re-replication, suggesting that origins are re-licensed 
and re-activated within one cell cycle, if correct regulation of PR-Set7 activity is 
hampered (Tardat et al. 2010; Beck et al. 2012). Consequently, H4K20 methylation 
seems to directly link chromatin regulation and replication licensing and/or activation. 
For this reason, I performed H4K20me1 and H4K20me3 ChIPs in parallel to pre-RC 
component ChIPs, to anticipate the role of H4K20 methylation in origin licensing. 
4.5.1 H4K20ME1 IS PRESENT IN ACTIVE CHROMATIN WHILE H4K20ME3 LOCALIZES 
TO HETEROCHROMATIN REGIONS 
In collaboration with Eric Julien (Chromatin and Cancer, IRCM, Montpellier) and 
Jean-Charles Cadoret (Pathology of DNA Replication, Institut Jaques Monod, Paris), 
H4K20me1 and –me3 were recently assessed genome-wide in U2OS cells. This study 
revealed H4K20me1 being a histone modification present in active chromatin regions, 
while H4K20me3 was rather associated with heterochromatin domains (Figure 4.29). 
These analyses were performed by calculating H3K36me3 (active chromatin) or 
H3K9me3 (heterochromatin) ChIP-seq read coverage at H4K20me1 or –me3 peaks. 
Thereby, H4K20me1 sites were increasingly covered by H3K36me3 while H3K9me3 
was enriched at H4K20me3 sites (analysis performed by Jean-Charles Cadoret).   
H4K20me1 and –me3 ChIPs were performed in parallel to pre-RC component ChIPs 
in both G1 and S/G2 Raji cells in triplicates (qPCR validation Figure 4.4). Subsequent 
peak-calling was performed using the HOMER algorithm and the specific “histone” 
setting. This setting takes the possibility into account that histone modification ChIPs 
can result in broader peaks. Only peak positions present in all three triplicates were 
retained. The resulting peaks were around 2000 bp wide for both histone 
modifications, with both H4K20me1 and –me3 ranging from 200 bp to 88000 bp 
(Appendix Figure 23 A).  
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FIGURE 4.29: H4K20ME1 IS PRESENT IN ACTIVE CHROMATIN, WHILE H4K20ME3 CORRESPONDS TO 
HETEROCHROMATIN. Coverage of either H3K36me3 (active chromatin) or H3K9me3 (silent 
chromatin) ChIP-seq reads was calculated at H4K20me1/ -me3 peak sites and plotted as boxplot.  
* indicates statistical significance with p-value < 0.05 (Brustel et al., in preparation).  
H4K20me1 and –me3 positions in either euchromatic or heterochromatic regions 
already suggest mutual exclusivity of both histone modifications. When calculating the 
overlap of H4K20me1 and –me3 peaks, this assumption was confirmed by only ~ 1% 
of overlapping peaks (Appendix Figure 23 B). This result clearly situated both 
H4K20me1 and –me3 individually in their respective chromatin environment, without 
any redundancies. 
4.5.2 ORC PREFERENTIALLY ASSOCIATES WITH H4K20ME3 
Coverage of pre-RC components was calculated at either H4K20me1 or –me3 sites, 
to get a first impression of a direct association of either histone modification with pre-
RC. All pre-RC components Orc2, Orc3, Mcm3, and Mcm7 were not particularly 
enriched at H4K20me1 sites (Figure 4.30). Accordingly, also HOMER- and T-PIC-
defined ORC, Mcm2-7 and pre-RCs hardly overlapped with H4K20me1 (Appendix 
Figure 24).     
H4K20me3 sites however, were significantly enriched in pre-RC coverage, especially 
by Orc2 and Orc3, and to a substantial lesser extend by Mcm3 and Mcm7 (Figure 
4.31). Also when analyzing the overlaps of ORC, Mcm2-7 and pre-RC with 
H4K20me3, especially ORC partially overlapped with H4K20me3, while Mcm2-7 and 
pre-RC showed little association (Figure 4.32). An IGB profile of such an ORC co-
localization with H4K20me3 is shown in Appendix Figure 25. 
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FIGURE 4.30: COVERAGE OF PRE-RC COMPONENTS (G1) AT H4K20ME1 PEAKS. A) MEAN ORC2 
COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE. 
Coverage was calculated as number of reads/base within a 6 kb window around H4K20me1 peak 
center. Input was plotted as control (grey). 
  
A) B) 
D) C) 
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FIGURE 4.31: ORC SHOWED INCREASED COVERAGE AT H4K20ME3 PEAKS. A) MEAN ORC2 COVERAGE. 
B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE. Coverage was 
calculated as number of reads/base within a 6 kb window around H4K20me3 peak center. Input 
was plotted as control (grey). 
 
A) B) 
D) C) 
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FIGURE 4.32: MOSTLY HOMER- (LEFT) AND T-PIC- (RIGHT) DEFINED ORC OVERLAPPED WITH 
H4K20ME3. Left: HOMER-defined complexes, right: T-PIC-defined complexes. Venn diagram of 
overlap between HOMER- and T-PIC-defined ORC, Mcm2-7 and pre-RCs with H4K20me3 
peaks. Overall counts are indicated. The percentage of overlapping proportions are specified 
below in brackets. 
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4.5.3 NO DISTRIBUTIONAL CHANGE WAS OBSERVED IN S/G2  
H4K20 methylation ChIPs analyzed so far were performed in G1 cell cycle stage. As 
PR-Set7 is cell cycle dependently regulated, with degradation during S phase and a 
subsequent decrease of H4K20me1, I was wondering how H4K20 methylation peaks 
and the observed associations were modulated in S/G2.   
In general, detected number of H4K20me1 and –me3 peaks decreased in S/G2 
compared to G1. This observation was more prominent for H4K20me1 (from 7820 
peaks in G1 to 1700 peaks in S/G2), than for H4K20me3 (from 11709 peaks in G1 
to 5560 peaks in S/G2). Thereby, most of the peaks detected in S/G2 overlapped 
with G1 peaks (> 84%, Appendix Figure 26), arguing for a dilution of H4K20 
methylation during replication, which led to weaker ChIP signals, presumably below 
the threshold for peak-calling. This was also reflected by a decrease of H4K20 
methylation coverage at their own respective G1 peaks (Appendix Figure 27). Again, 
H4K20me1 seemed to be more affected than H4K20me3, where no obvious coverage 
change was detected.     
Neither coverage of any pre-RC component, nor peak positions relative to either 
H4K20 methylation changed considerably in S/G2 (data not shown), indicating that 
no major licensing mechanism relies on the cell-cycle distribution of 
H4K20me1/ -me3. 
POSSIBLE MECHANISMS UNDERLYING ORIGIN LICENSING IN 
HETEROCHROMATIN 
Previous reports suggest that PR-Set7 and subsequent induction of H4K20me1 
undoubtedly affects origin licensing and activation. An extensive genome-wide SNS-
seq study correlating active replication with histone modifications claimed H4K20me1 
associating with 50% of initiation sites, being one of the potential key regulators of 
replication (Picard et al. 2014). However, pre-RC coverage at H4K20me1 sites was not 
majorly enriched. This is in line with other genome-wide studies that did not find any 
associations between H4K20me1 and replication (Fu et al. 2013; Cayrou et al. 2015; 
Smith et al. 2016; Miotto, Ji, and Struhl 2016). By contrast, ORC coverage was clearly 
enriched at H4K20me3 sites, Mcm3 and Mcm7 coverage to a lesser extent. This is in 
accordance with ORC directly interacting with H4K20me2/3, most probably through 
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the BAH domain of Orc1 (Kuo et al. 2012; Beck et al. 2012). ORC interaction with 
heterochromatin has already been reported repeatedly in yeast and Drosophila (Micklem 
et al. 1993; Pak et al. 1997; Shareef, Badugu, and Kellum 2003; Leatherwood and Vas 
2003; Shen et al. 2010). Thereby, ORC was attributed a chromatin silencing function 
independent of origin licensing (Dillin and Rine 1997; Leatherwood and Vas 2003). 
Regarding the low Mcm2-7 coverage enrichment, this might be an explanation for 
ORC – but not Mcm2-7 – associating with H4K20me3. However, dynamics of 
Mcm2-7 loading might also be different in heterochromatin and little Mcm2-7 is still 
sufficient for efficient replication initiation. Consequently, I examined whether ORC 
association to heterochromatin H4K20me3 was indeed linked to origin replication 
licensing and activation. 
 H4K20ME3 IS NECESSARY FOR ORIGIN LICENSING AND 
ACTIVATION IN HETEROCHROMATIN 
The association of ORC with H4K20me3 is not necessarily linked to replication 
licensing function of ORC. Mcm2-7 helicases seemed to be less present at H4K20me3 
sites, than ORC (Figure 4.31), eventually arguing for a heterochromatin organization 
function of ORC.  I used the replication of the well-characterized autosomal plasmid 
system of the Epstein-Barr virus latent origin oriP (herein after called FR-DS, 
Hammerschmidt and Sugden 2013) to functionally validate the role of ORC and 
H4K20me3 association. Contrarily to genome-wide analysis or genomic integration 
sites, this model system with defined genetic background allows the analysis of single 
aspects in the replication initiation process. The strategy was to specifically induce 
H4K20me3 at a distinct targeting site on the plasmid and to assess the effect on 
licensing and replication activity by ChIP-qPCR and plasmid abundance. For 
autonomous replication and segregation of FR-DS plasmids, the EBV viral protein 
EBNA1 needs to be expressed by the cells (Figure 4.33 A). By binding of EBNA1 to 
the FR element, plasmids are tethered to the host chromatin conferring mitotic 
stability. EBNA1 binding to the DS element recruits ORC, which leads to the 
formation of an efficient internal origin of replication. Different reporter plasmids 
were generated: Introducing an upstream activation sequence (UAS) of the Gal4-UAS 
  RESULTS AND DISCUSSION  
103 | 
 
targeting system downstream of FR allows the specific targeting of Gal4(-fusion) 
proteins. DS can be removed or replaced by a 300 bp fragment of the human 
endogenous origin oriRDH, proven to also support autonomous plasmid replication, 
however less efficiently than DS (Gerhardt et al. 2006, described as ori6).  
 
A) 
B) 
FIGURE 4.33: SCHEMATIC REPRESENTATION OF EXPERIMENTAL SETUP. A) EBV-DERIVED 
AUTOSOMAL REPORTER PLASMID SYSTEM. Five EBV-derived reporter plasmids are segregated 
throughout cell division by EBNA1-mediated tethering to host chromatin. Introduction of UAS 
sequence allows specific targeting of Gal4(-fusion) proteins. The internal replicator DS was 
removed or replaced by the human endogenous origin oriRDH. DNA fragments amplified by qPCR 
are indicated in red. B) PLASMID ABUNDANCE EXPERIMENTS. Experiments were conducted in 
HEK293 cells stably expressing EBNA1 and the indicated Gal4(-fusion) proteins. 1µg of reporter 
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plasmids were transfected in the cells, kept replicating for 6 days and isolated from the cells by 
the HIRT protocol, specifically enriching for low molecular weight DNA. DpnI digest removes 
bacterial-derived input plasmids and DpnI-resistant plasmids were electroporated in E.coli 
DH10B. Bacterial colony quantification is a direct measure of plasmid numbers. 
 
 
FIGURE 4.34: GENERATION OF HEK293 EBNA1+ GAL4 (-FUSION) CELL LINES. pcDNA3_Zeo 
expression plasmids carrying the Gal4(-fusion) protein cassettes (obtained from E. Julien, IRMB, 
Montpellier) were linearized and transfected into HEK293 EBNA1+ cells. After selection and 
clonal expansion, depicted clones were chosen for further experiments. Ponceau stain is shown 
as loading control, immunoblot was performed using an anti-Gal4 antibody.    
4.6.1 SUV4-20H1 TARGETING UNSPECIFICALLY INDUCES H4K20ME3 
The first and very easy reasoning to define H4K20me3 action in replication processes 
was to simply target the H4K20me2/3 generating histone methyltransferase Suv4-
20h1 to the FR-UAS-oriRDH reporter plasmid. Consequently, either Gal4 or Gal4-
Suv4-20h1 expression cassettes were integrated into HEK293 EBNA1+ cells and their 
expression was tested by immunoblot (Figure 4.34, first two lanes). Interestingly, 
integration of Gal4-Suv4-20h1 resulted in a doublet signal around 120 kDa, suggesting 
a post-translational modification of this fusion protein (expected size ~ 100 kDa). 
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Induction of Suv4-20h1-mediated H4K20me3 was verified by H4K20me3 ChIP 
experiments for the FR-oriRDH and FR-UAS-oriRDH plasmids, followed by qPCR. 
While Gal4 and Gal4-Suv4-20h1 were specifically targeted to UAS (Gal4, Figure 4.35, 
left panel), Gal4-Suv4-20h1 induced H4K20me3 spread over the plasmid, even when 
no targeting site is present (Figure 4.35, right panel, FR-oriRDH vs. FR-UAS-oriRDH). 
Consequently, plasmid abundance experiments did not result in any effect of Gal4-
Suv4-20h1 targeting (Appendix Figure 28), possibly due to heterochromatinization of 
both reporter plasmids.   
Reason for the observed unspecific induction of H4K20me3 can be the heavy 
overexpression of Gal4-Suv4-20h1. Assuming that also the modified, higher migrating  
 
 
FIGURE 4.35: SUV4-20H1 TARGETING TO FR-ORIRDH AND FR-UAS ORIRDH UNSPECIFICALLY INDUCES 
H4K20ME3 ALL OVER THE PLASMIDS. ChIP-qPCR analyses at FR, UAS and oriRDH sequences of 
FR-oriRDH or FR-UAS-oriRDH plasmids transfected in the indicated cell lines. Fold enrichments 
relative to IgG. Data are means ± SEM (n=3).  
form of Suv4-20h1 is functional, expression is doubled compared to Gal4 or 
Gal4-PR-Set7 proteins (Figure 4.34). Although the cell line itself did not exhibit any 
abnormalities concerning cell growth or morphology, it seems that Gal4-Suv4-20h1 is 
inducing H4K20me3 completely independent from targeting to UAS. This renders 
the approach of Gal4-Suv4-20h1 targeting not suitable for our purposes.  
I refrained from producing a lower expressing cell line and decided to instead target 
H4K20 monomethyltransferase PR-Set7 to the plasmids. Induction of H4K20me1 
will be converted in H4K20me2/3 by endogenous Suv4-20h1/2. 
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4.6.2 PR-SET7 TARGETING LEADS TO INDUCTION OF H4K20ME1, CONVERSION 
INTO H4K20ME3 AND PRE-RC FORMATION 
Either FR-oriRDH/ FR-UAS-oriRDH or FR-DS/ FR-UAS-DS reporter plasmids were 
transfected in cell lines expressing Gal4, Gal4-PR-Set7 or a methylation-deficient 
N469A/H470A SET mutant of PR-Set7, Gal4-PR-Set7SETmut (for integrated protein 
expression, see Figure 4.34, lanes 2-4).  
Efficient induction of H4K20me1 by PR-Set7 and conversion to H4K20me3 was 
assessed by ChIP-qPCR. Furthermore, pre-RC formation was followed by the same 
technique, analyzing the specific pre-RC sub-component Mcm3. Indeed, Gal4-PR-
Set7 targeting to FR-UAS-oriRDH plasmid induced H4K20me1, which was 
subsequently converted in H4K20me3 (Figure 4.36).  
 
FIGURE 4.36: PR-SET7 TARGETING TO FR-UAS-ORIRDH LED TO H4K20ME1 INDUCTION, CONVERSION 
INTO H4K20ME3 AND PRE-RC FORMATION. ChIP-qPCR analyses at FR, UAS and oriRDH sequences 
of FR-oriRDH or FR-UAS-oriRDH plasmids transfected in the indicated cell lines. Fold enrichments 
relative to IgG and FR locus. Data are means ± SEM (n=4).  
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This was not observed when Gal4 or the methylation-deficient PR-Set7SETmut were 
targeted to the reporter plasmids. Interestingly, both H4K20me1 and –me3 were also 
detected at oriRDH when PR-Set7 was targeted, presumably due to the close proximity 
of UAS and oriRDH primer positions (154 bp ~ 1 nucleosome). More importantly, 
endogenous Mcm3 as member of the pre-RC was detected at UAS in the Gal4-PR-
Set7 cell line only, demonstrating pre-RC formation after H4K20me1/3 induction 
(Figure 4.36). Similar results were obtained when the respective Gal4, Gal4-PR-Set7 
and Gal4-PR-Set7SETmut cell lines were transfected with oriP reporter plasmids FR-DS 
and FR-UAS-DS (Figure 4.37).  
 
FIGURE 4.37: PR-SET7 TARGETING TO FR-UAS-DS LED TO H4K20ME1 INDUCTION, CONVERSION 
INTO H4K20ME3 AND PRE-RC FORMATION. ChIP-qPCR analyses at FR, UAS and DS sequences 
of FR-DS or FR-UAS-DS reporter plasmids transfected in the indicated cell lines. Fold 
enrichments relative to IgG and FR locus. Data are means ± SEM (n=4).  
It has already been shown that PR-Set7 targeting to a UAS integrated in the human 
genome leads to pre-RC formation (Tardat et al. 2010). I validated the autonomous 
plasmid system by reproducing these results. However, recruitment of pre-RC 
components is not necessarily sufficient for initiation of DNA replication (Blow, Ge, 
and Jackson 2011). Consequently, I assessed origin activity of the plasmids by 
measuring plasmid abundance.  
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4.6.3 PR-SET7 TARGETING ENHANCES PLASMID REPLICATION EFFICIENCIES 
Principal of the plasmid abundance assay is the measurement of reporter plasmid 
replication efficiencies within a fixed time frame (procedure described in Figure 
4.33 B). Shortly, I transfected reporter plasmids (either FR-oriRDH/ FR-UAS-oriRDH 
or FR-DS/ FR-UAS-DS) in Gal4, Gal4-PR-Set7 or Gal4-PR-Set7SETmut cell lines. Cells 
with transfection efficiencies greater 70% were grown for 6d before low molecular 
weight DNA was harvested, DpnI digested and transformed into E.coli. DpnI digest 
removes bacterial-derived input plasmids. The appearance of bacterial colonies from 
DpnI-resistant plasmids is a direct measure of plasmid replication in mammalian cells. 
Because reporter plasmid replication efficiencies varied between cell lines, replication 
efficiencies of the control reporter plasmid without UAS targeting site were arbitrarily 
defined as 1. Replication efficiencies of the UAS-containing plasmids were calculated 
compared to control in each cell line and the result is depicted in Figure 4.38.      
For the FR-oriRDH/ FR-UAS-oriRDH plasmid pair, FR-UAS-oriRDH replicated about 
3.5-times more than control when Gal4-PR-Set7 was targeted to the plasmid (Figure 
4.38 A). This effect was solely attributable to PR-Set7 methylation activity, as no 
effects were observed when either Gal4 or Gal4-PR-Set7SETmut were targeted. Plasmid 
abundance experiments with the FR-DS/ FR-UAS-DS plasmid pair resulted in 2-fold 
enhanced replication efficiencies when Gal4-PR-Set7 was targeted (Figure 4.38 B). 
Replication increase of only 2-fold (compared to 3.5-fold in oriRDH context) might be 
due to the high intrinsic replication competence of DS.  
These results suggest that induction of H4K20me1 by PR-Set7 targeting, subsequent 
conversion into H4K20me3 and pre-RC formation led to replication initiation, in 
addition to intrinsic plasmid replication competences. Indeed, origin competence 
likely involves combination of different features ranging from sequence composition 
to higher-order chromatin structure (Méchali 2010). Thus, these results do not allow 
to distinguish between H4K20me1/3 increased origin activation as an enhancement 
of intrinsic origin activity or of additional origin formation. To pursue this question, 
the same experiments were performed with a reporter plasmid devoid of any 
replication competence. 
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FIGURE 4.38: PR-SET7 TARGETING ENHANCED INTRINSIC PLASMID REPLICATION ACTIVITY. A) 
QUANTIFICATION OF FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. B) QUANTIFICATION OF FR-DS AND 
FR-UAS-DS PLASMIDS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: Control plasmid (without UAS) replication efficiencies 
were arbitrarily defined as 1. Data are means ± SEM (n=4).  
4.6.4 PR-SET7 TARGETING INDUCES PLASMID REPLICATION 
To test whether PR-Set7 targeting can also lead to the induction of DNA replication, 
I removed the DS element from FR-UAS-DS plasmid and assessed the resulting 
replication efficiency compared to the strong replicating FR-DS reporter (Figure 4.39). 
While FR-UAS reporters were hardly detectable in Gal4 and Gal4-PR-Set7SETmut cell 
lines, FR-UAS plasmids clearly replicated in Gal4-PR-Set7 cell lines. The induced 
replication efficiency was about 1/3 as strong as the intrinsic DS activity and 4-fold 
increased to FR-UAS plasmid replication in Gal4 or Gal4-PR-Set7SETmut cell lines. A 
direct comparison of all reporter plasmid replication efficiencies is depicted in 
Appendix Figure 29. 
ChIP experiments equally revealed H4K20me1/me3 being present at UAS, but due 
to the low plasmid abundance, it was challenging to conclusively perform Mcm3 
ChIPs (Appendix Figure 30). Still, pre-RC formation is a prerequisite for replication 
activity.   
A) B) 
RESULTS AND DISCUSSION 
110 | 
 
 
FIGURE 4.39: PR-SET7 TARGETING INDUCED PLASMID REPLICATION. QUANTIFICATION OF FR-DS 
AND FR-UAS PLASMIDS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: FR-DS replication efficiency was arbitrarily defined as 1. 
Data are means ± SEM (n=3). 
In conclusion, induction of H4K20me1/3 leads to origin licensing and activation. 
However, no conclusion can be drawn whether conversion into H4K20me3 is needed 
for these processes.  
4.6.5 REPLICATION LICENSING AND ACTIVATION DEPEND ON H4K20ME3  
There is a lot of evidence that conversion from H4K20me1 to H4K20me3 is indeed 
needed for origin licensing and activation (Beck et al. 2012). Also my pre-RC ChIP-
seq experiments imply the necessity for H4K20me3, as H4K20me1 is only marginally 
covered by pre-RC sub-components (Figure 4.30), while especially ORC seems to 
have a preference for H4K20me3 (Figure 4.31).  
Eric Julien (Chromatin and Cancer, IRCM, Montpellier), a close collaboration partner, 
also investigated the interplay of H4K20me3 and replication origins and showed that 
H4K20me3 is necessary for proper origin licensing. They performed replication 
timing experiments in MEF cells derived from Suv4-20h2 -/-, Suv4-20h1 -/flox, Cre-ER 
embryos. The remaining Suv4-20h1 floxed allele can be deleted by adding 
4-Hydroxytamoxifen (4-OHT), leading to absence of H4K20me2/3 and an increase 
in H4K20me1 (immunoblot 4d after 4-OHT treatment, Figure 4.40, (Schotta et al. 
2008)). Comparing replication timing in wild type MEF and Suv4-20h knock-out MEF 
revealed a delay of 29% of late replication timing regions while some early replicating 
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FIGURE 4.40: ABSENCE OF H4K20ME2/3 IMPAIRS ORIGIN LICENSING AND ACTIVATION IN DEFINED 
DOMAINS IN MEF CELLS. A) REPLICATION TIMING PROFILES ON CHROMOSOME 11 IN SUV4-20H1 
FLOX/-, SUV4-20H1 -/- MEFS, TREATED OR NOT WITH 4-OHT. Lower left panel: immunoblot 
confirmation of H4K20me2/3 absence. Lower right panel: replication timing in region 
[87560863-96672625]. Red arrows indicate delayed late replicating domains, blue arrows point to 
advanced early replicating domains. B) RELATIVE SNS ENRICHMENT of four H4K20me3 late-firing 
origins compared to control early-firing origin. H4K20me3-associated origins from chromosome 
11 were quantified in relation to an early-firing origin in untreated and 4-OHT treated MEF cells. 
Data are means ± SEM (n=3). C) CHIP-QPCR ANALYSIS at the control early-firing origin and at 
four H4K20me3-associated origins from chromosome 11 in untreated and 4-OHT treated MEFs 
A) 
B) 
C) 
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expressing FLAG-tagged Mcm2. Y-axis represents the ration of immunoprecipitate to input. 
(Figure adapted from Brustel et al. in preparation) 
regions were even slightly advanced (red vs. blue arrows, Figure 4.40 A). H4K20me3 
is mostly present in heterochromatin, which is known to be late replicating. Specific 
measurement of origin activity in some of these late replicating domains delayed by 
Suv4-20h1/2 knock-out (H4K20me3-associated origins) revealed severe reduction of 
origin efficiency upon Suv4-20h1/2 knock-out (Figure 4.40 B). Following ChIP-qPCR 
analysis at the same H4K20me3-associated origins showed a prominent decrease in 
pre-RC formation (assessed by Mcm2-FLAG ChIP), when H4K20me2/3 was absent 
(Figure 4.40 C). Consequently, delay of replication timing upon Suv4-20h1/2 knock-
out results from the inability to properly license origins in regions that depend on 
H4K20me3. These regions might instead be replicated passively. These results already 
indicate the necessity of H4K20me3 for origin licensing and activity. To confirm these 
observation using the plasmid system with defined genetic background, I need the 
possibility to precisely block conversion of H4K20me1 to –me3 by inhibiting 
Suv4-20h1/2.  
The inhibitor compound A-196 specifically inhibits Suv4-20h1/2 methylation activity 
and results in a complete loss of H4K20me2/3, with a concomitant increase of 
H4K20me1, while other trimethylated histone states remained unaffected (examined 
by immunoblot, Figure 4.41). To directly evaluate A-196 effect on H4K20me1/3 
induced plasmid replication, I transfected HEK293 EBNA1+ Gal4-PR-Set7 cells with 
FR-oriRDH/ FR-UAS-oriRDH reporter plasmids and directly compared A-196 treated 
with untreated cells. ChIP-qPCR analysis revealed induction of H4K20me1 and 
conversion to H4K20me3 in the untreated cell population, as expected, while A-196 
treated cells were reduced in H4K20me3 (Figure 4.42). Analyzing the presence of 
endogenous Mcm3 revealed failure of pre-RC formation at the UAS in A-196 treated 
cells (Figure 4.42). The incapacity to properly form pre-RCs at the UAS also led to 
reduction of plasmid replication efficiency to the level of the intrinsic origin oriRDH  
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FIGURE 4.41: IMMUNOBLOT CONFIRMATION OF A-196 COMPOUND INHIBITING H4K20ME2/3. 
HEK293 EBNA1+ Gal4-PR-Set7 cells were treated or not with 5µM A-196 for 6d. Indicated 
antibodies were used for detection of the respective histone modification. Ponceau stain of 
histones served as loading control. 
 
 
FIGURE 4.42: PR-SET7 TARGETING IN PRESENCE OF A-196 LED TO REDUCED H4K20ME3 LEVELS AND 
PRE-RC FORMATION COMPARED TO UNTREATED CELLS. ChIP-qPCR analysis at FR, UAS and 
oriRDH sequences of FR-oriRDH or FR-UAS-oriRDH reporter plasmids transfected in HEK293 
EBNA1+ Gal4-PR-Set7 cells treated or not with 5µM A-196. Fold enrichment relative to IgG and 
FR locus. Data are means ± SEM (n=3). 
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(Figure 4.43). In conclusion, experiments using the autonomous plasmid system 
showed that H4K20me3 is definitely needed for proper origin licensing and 
consequently also for replication activity. Furthermore, genome-wide replication 
timing experiments revealed specific heterochromatic regions that depend on 
H4K20me3, while replication in other regions is presumably regulated through 
different mechanisms.   
 
FIGURE 4.43: ENHANCED REPLICATION DURING PR-SET7 DEPENDS ON H4K20ME3. 
QUANTIFICATION OF FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. Plasmid abundance assays in 
HEK293 EBNA1+ Gal4-PR-Set7 cells treated or not with 5µM A-196 as indicated: FR-oriRDH 
replication efficiency was arbitrarily defined as 1. Data are means ± SEM (n=3).  
H4K20ME1 IS LIKELY NOT DIRECTLY LINKED TO REPLICATION ORIGIN 
LICENSING 
Cell cycle regulation of the H4K20 monomethyltransferase PR-Set7 and resulting 
catalyzation of H4K20me1 during late G2/M led to the hypothesis of this histone 
modification being involved in DNA replication regulation. My ChIP-seq experiments 
of H4K20me1 and –me3 revealed both methylation marks being mutually exclusive. 
H4K20me2 was not assessed, as the abundance of this mark argues against a possible 
role in DNA replication regulation (Pesavento et al. 2008). Together with Eric Julien 
(Chromatin and Cancer, IRCM, Montpellier), we identified the conversion from 
H4K20me1 to H4K20me3 to influence origin licensing, origin activation efficiency 
and replication timing, thus representing the first histone modification identified so 
far, that impacts on all levels of DNA replication regulation. Thereby, H4K20me3 
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affects origin licensing, consequently impairing origin formation at the very first step. 
This holds true for artificial induction of H4K20 methylation states on plasmids with 
defined genetic background, as well as for specific genomic loci with less defined 
chromatin context. Nevertheless, in both cases, origin licensing and activation entirely 
depend on the presence of H4K20me3.    
While knock-out of PR-Set7 is lethal in mammalians, absence of both Suv4-20h1 
and -h2 displays only minor cell cycle defects (Oda et al. 2010; S. Wu and Rice 2011; 
Beck et al. 2012; Schotta et al. 2008). Indeed, genome-wide timing experiments only 
revealed a delay of some late replicating domains when Suv4-20h1/2 were missing. 
This indicates that while replication origin licensing and activation is perturbed in 
absence of H4K20me2/3, the concerned regions are still replicated, most likely 
passively. These results imply that the severe phenotype of PR-Set7 knock-out 
presumably depend on other functions than replication regulation. It has recently been 
reported, that unmethylated H4K20 (H4K20me0) marks post-replicative chromatin 
in G2 and is read by the H3-H4 histone chaperone TONSL-MMS22L, which is 
implicated in DNA repair (Saredi et al. 2016). Taken together, this would situate 
H4K20me0/1 and PR-Set7 as cell cycle sensor mechanism, with H4K20me0 marking 
post-replicative chromatin and H4K20me1 identifying G1 chromatin, primed for 
replication. This scenario would explain both the re-replication phenotype when 
PR-Set7 is stabilized – aberrant H4K20me1 in G2 mimics G1 cell cycle stage prone 
for replication – and cell cycle arrest in absence of PR-Set7 – as the cell cannot 
distinguish between pre- and post-replicative chromatin. Consequently, H4K20me1 
might serve as cell cycle stage marker, but is not necessarily directly linked to origin 
licensing and replication initiation. 
HETEROCHROMATIN REPLICATION IS IN PART REGULATED THROUGH 
H4K20ME3 
In contrast, ORC binding to H4K20me3 convincingly connects heterochromatin with 
replication licensing and activation. In genome-wide ChIP experiments, especially 
ORC was detected at H4K20me3 sites, while Mcm2-7 was present to a lesser extent 
(Figure 4.31). Still, functional plasmid abundance experiments proved H4K20me3 
being necessary for successful Mcm2-7 loading and origin activity. This result also 
implies the amount of Mcm2-7 detected by coverage analysis being sufficient for 
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origin licensing. It is possible that an excess of ORC is needed to provide sufficient 
Mcm2-7 loading at inaccessible chromatin sites. Alternatively, the direct binding 
capacity of ORC (through the Orc1 BAH domain, Kuo et al. 2012; Beck et al. 2012) 
might reduce ORC on-and-off rates and stabilize ORC enough for Mcm2-7 
recruitment. Furthermore, ORC might still execute heterochromatin organization 
functions besides origin licensing. Indeed, ORC has been shown bind 
heterochromatic structures in yeast, Xenopus, Drosophila, and mammals. ORC is directly 
interacting with heterochromatic protein 1 (HP1) and depletion of either protein 
reduces chromatin binding capacity of the other. In mammals, ORC also interacts 
with ORC-associated ORCA/LRWD1, which likely facilitates HP1 recruitment to 
heterochromatin (Chakraborty, Shen, and Prasanth 2011). Furthermore, experiments 
combining ChIP-seq and mass spectrometry have shown ORCA/ORC complex to 
directly bind the most prominent repressive histone modifications H3K9me3, 
H3K27me3 and H4K20me3 (Vermeulen et al. 2010). Thereby, it has been proposed 
that ORC/ORCA specifically recruits lysine methyltransferases and are thus necessary 
for heterochromatin establishment and maintenance (Giri et al. 2015). Furthermore, 
ORC/ORCA/HP1 was suggested to facilitate origin licensing in heterochromatin 
(Leatherwood and Vas 2003; Shen et al. 2012), however ORC-heterochromatin 
interaction has already been shown to be separated from licensing functions of ORC 
(Dillin and Rine 1997; Leatherwood and Vas 2003). My results clearly attribute an 
origin licensing function to ORC binding to heterochromatic H4K20me3. Genome-
wide replication timing experiments thereby revealed that defined late-replicating 
domains – characterized by the presence of H4K20me3 in unperturbed cells – depend 
on H4K20me3, while other late-replicating regions did not. These regions might 
represent heterochromatin where replication is regulated through different 
mechanisms. In conclusion, H4K20me3-mediated origin licensing and subsequent 
activation is one mechanism of replication regulation in heterochromatin. 
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5. CONCLUSION 
With this study, I intended to close the gap between extensive analyses of active 
replication initiation and pre-RC positions. Furthermore, I aimed to elaborate the 
relation between H4K20 methylation and regulation of DNA replication.  
 CHROMATIN ACCESSIBILITY IS THE MAIN DETERMINANT OF 
PRE-RC POSITIONING IN ACTIVE CHROMATIN 
I performed ChIP-seq of the two major pre-RC subcomponents ORC and Mcm2-7, 
targeting two subunits of each complex (Orc2, Orc3, Mcm3, and Mcm7) to increase 
validity of the results. Pre-RC ChIP-seq analysis on the EBV genome allowed the 
determination of the most appropriate peak-calling algorithm, by comparing already 
published pre-RC positions on the EBV genome with detected pre-RC positions from 
ChIP-seq. Despite differences in techniques and bioinformatical analyses, the majority 
of T-PIC-defined pre-RCs detected by ChIP-seq coincided with previously 
determined pre-RC positions (Papior et al. 2012). Comparing replicates of the same 
ChIP between each other and the different target pre-RC proteins, relatively little 
variances were observed. ORC, Mcm2-7 and pre-RC positions were concordant and 
even changed only marginally when ChIP-seq was performed in S/G2 cell cycle stage. 
This suggests little dynamics of the chromatinized EBV genome, resulting in delimited 
ORC, Mcm2-7, and pre-RC positions.  
Applying the peak-calling settings determined on the EBV genome on the human 
genome, variances between replicates and between the two pre-RC subcomponents 
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ORC and Mcm2-7 increased. This presumably relies on the definition of a peak as a 
specific accumulation of reads at a defined position, while neighboring regions 
decrease in read numbers. However, ORC and Mcm2-7 ChIPs do not meet these 
requirements. ORC binding has been shown to depend mostly on chromatin 
accessibility, which renders ORC positions extremely flexible and variable from cell 
to cell. Consequently, although the region of ORC binding might accord, the precise 
ORC position fluctuates, which appears as a broad profile from bulk cell ChIP-seq. 
This impedes the definite detection by a peak calling program, resulting in either non-
concordant peaks, or in undetected enrichments due to high read densities, also in 
neighboring regions. For Mcm2-7, this observation is even more prominent, as 
Mcm2-7 translocate after loading, rendering peak-detection impossible. To avoid this 
bias introduced by peak-calling, I additionally relied on the mean sequencing read 
coverage of each pre-RC component within a specific region of interest. Analyzing 
the mean read coverage is independent of any peak-calling algorithm and allows a 
global impression of the average situation at all regions of interest, simultaneously.  
Evaluating pre-RC component coverage at active initiation zones revealed pre-RC 
enrichment within initiation zones, additionally confirming successful pre-RC 
ChIP-seq. For further analyses, it will be interesting to distinguish between initiation 
zones flanked or not by actively transcribed genes. As especially Mcm2-7 positioning 
might depend on transcriptional activity, fundamental differences are expected. 
Interestingly, pre-RC components, notably Mcm2-7, were specifically depleted from 
replication termination zones in G1 phase. This observation was cell cycle dependent, 
as depletion was less prominent in S/G2. Replication termination zones are to a large 
extent comprised of active genes, consistent with the idea of Mcm2-7 helicase 
translocation by active transcription machineries.   
Generally, pre-RC component coverages were enriched at sites of active 
transcriptional regulation, like TSS or H3K4me3 sites, in accordance with previous 
studies. This enrichment was enhanced at an early stage of pre-RC loading 
(corresponding to S/G2 phase in this study, probably representing a later stage of the 
cell cycle; needs to be confirmed), implying that within active chromatin, ORC/ 
pre-RC is first bound to accessible chromatin sites, while Mcm2-7 helicases relocate 
from their initial loading site prior to S phase (G1 cell cycle stage). Consequently, this 
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study also touches genome-wide pre-RC cell cycle dynamics. The excess of Mcm2-7 
compared to ORC situates Mcm2-7 as major determinant of replication initiation.    
Employing both HOMER and T-PIC peak-calling, observations from coverage 
analysis were actually confirmed. Very strong coverage enrichments, as observed at 
active TSSs or H3K4me3, coincide with strong, HOMER-defined peaks. Active 
initiation zones were moderately enriched in coverage, however, also sensitive T-PIC-
defined peaks were preferably detected in replication initiation zones, when compared 
to replication termination zones.  Consequently, although peak-calling might be 
misleading for ORC and Mcm2-7 ChIPs, final conclusions are not significantly altered. 
My original intention was to unite discrepancies in genome-wide studies of active 
replication initiation by providing a comprehensive picture of the regulation of pre-RC 
positioning. In Raji cells, there are no SNS-seq data available, rendering a direct 
comparison of pre-RC ChIP-seq, SNS-seq and OK-seq impossible. Furthermore, the 
pre-RC ChIP-seq analysis in hES cells is too preliminary to draw any final conclusions 
from direct comparisons with SNS-seq. Still, several conclusions emerge from this 
study:  
The major difference between SNS-seq and OK-seq is SNS-seq detecting single 
replication initiation events, while OK-seq detects zones of preferential initiation, 
encompassing multiple inefficient initiation sites. This technique disregards single 
replication origins and correlates with pre-RC coverage analyses, which also do not 
consider single pre-RC positions. Enrichment of ORC and Mcm2-7 within initiation 
zones and depletion of these proteins from replication termination zones provide an 
explanation for the occurrence of preferential replication initiation or termination, 
depending solely on the density of pre-RC proteins, especially Mcm2-7, on DNA. 
Only 20% of SNS overlap with initiation zones and vice versa (Petryk et al. 2016). 
However, replication initiation events also occur outside of initiation zones and 
amount in total to 30000-50000 initiation events per cell. Mapping of more than 
200000 replication initiation sites by SNS-seq (Besnard et al. 2012) presumably 
originates from the large distribution of Mcm2-7, resulting in many different initiation 
sites in a bulk cell population. It might be possible, that the 200000 detected origins 
are the detection limit of the SNS-seq technique, by employing a limited number of 
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cells and a certain size selection of nascent DNA. It might be discussable whether 
many more replication initiation sites could possibly be detected encompassing all sites 
of all cells. 
Single-cell replication initiation experiments might provide answers for that question. 
Combination of various single-cell experiments would reveal whether the final 
number of detected initiation events evens out around 200000 events or continues to 
grow exponentially. Also single-cell pre-RC ChIPs would help to better understand 
the context. However, although single-cell experiments are advancing, both single-cell 
SNS-seq or pre-RC ChIP-seq are not feasible to date. Currently broad pre-RC profiles 
originating from bulk ChIP-seq experiments complicate conclusions about precise 
ORC or Mcm2-7 positions. Knowing the positions in a single cell and extrapolating 
the results would indeed complete the idea of variable ORC and Mcm2-7 positioning.     
In conclusion, this study provided new insights in the regulation of pre-RC positioning 
and implies Mcm2-7 being the main determinant of DNA replication in accessible 
chromatin regions characterized by transcriptional activity.  
 DIRECT ORC-CHROMATIN INTERACTIONS REGULATE PRE-RC 
POSITIONING IN HETEROCHROMATIN 
H4K20 methylation was also assessed in this study, to decipher the role of this histone 
modification in replication regulation. Altering the expression of the Histone 4 Lysine 
20 monomethyltransferase PR-Set7 has severe DNA replication phenotypes. 
Consequently, H4K20me1 was expected to be involved in the regulation of replication 
licensing and/or activation. However, pre-RC displayed no striking association to 
H4K20me1 in euchromatin in ChIP-seq experiments. This result situates PR-Set7 
being a major regulator of the cell cycle rather than DNA replication mechanisms 
themselves. Interestingly, especially ORC associated with H4K20me3 in 
heterochromatin, while binding of Mcm2-7 was less prominent. Because of reported 
roles of ORC in heterochromatin organization, I functionally tested implication of 
H4K20me3 in origin licensing and confirmed that H4K20me3 is necessary for 
Mcm2-7 recruitment and subsequent replication activation, in specific 
heterochromatin domains.   
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Consequently, euchromatin and heterochromatin differ in ORC loading mechanisms. 
While in euchromatin, ORC randomly binds accessible chromatin sites and loads 
multiple Mcm2-7 complexes, in heterochromatin ORC-binding is stabilized by 
specific histone modifications. In my study, H4K20me3 regulates replication in 
specific heterochromatin regions. H4K20me3 is necessary for pre-RC formation 
within these regions and also controls pre-RC activation. Combining my observations 
and current literature led to the proposition of the following model (Figure 5.1): 
A. Euchromatin locates interior of the nucleus, is marked by active chromatin marks 
(like H3K4me3) and is actively transcribed. ORC favors accessible chromatin 
regions (like TSS) and binds these regions. High on- and off-rates of ORC or 
chromatin conformation lead to multiple Mcm2-7 hexamer loading, which are 
translocated by the transcriptional machinery to gene-adjacent regions. Elevated 
Mcm2-7 densities increase activation probability in S phase and lead to early origin 
firing.  
B. Heterochromatin locates closer to the nuclear lamina. ORC binding is impaired 
through less accessible chromatin structure. Consequently, direct interactions of 
histone modifications (like H4K20me3) and ORC mediate ORC association to 
DNA. Stabilization of ORC leads to lower on- and off-rates and less Mcm2-7 
recruitment. However, one Mcm2-7 double-hexamer is theoretically enough for 
replication initiation although reduced firing probabilities situate heterochromatin 
replication in late S phase.   
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Taken together, this work constitutes the first genome-wide ChIP-seq analysis of a 
full set of pre-RC components, as especially Mcm2-7 has not been analyzed so far. It 
situates Mcm2-7 as major determinant of replication initiation in euchromatin, while 
ORC displays the major regulator in heterochromatin. Furthermore, it provided direct 
evidence of replication origin licensing in heterochromatin depending on H4K20me3. 
These results added a piece to the puzzle of human replication regulation. Some 
already existing pieces might require re-evaluation, while future investigations will 
certainly provide other missing elements to complete the picture.   
 
 
 
 
 
 
FIGURE 5.1: MODEL FOR REPLICATION LICENSING MECHANISMS IN EUCHROMATIN AND 
HETEROCHROMATIN. A) OPEN CHROMATIN STRUCTURES AND ACTIVE TRANSCRIPTION MEDIATE 
MCM2-7 LOADING AND TRANSLOCATION. High ORC on- and off-rates lead to excessive Mcm2-7 
loading. Active transcription machineries translocate Mcm2-7 helicases to gene-adjacent regions. 
B) IN HETEROCHROMATIN, H4K20ME3 STABILIZES ORC BINDING. Lower on- and off-rates lead to 
less Mcm2-7 recruitment. 
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APPENDIX FIGURE 1: DIFFERENT REPRESENTATIONS OF INPUT (GREY) AND ORC2 (RED) CHIP-SEQ 
SAMPLES IN IGB AT THE MCM4/PRKDC LOCUS. A) SEQUENCING ALIGNMENT AFTER MAPPING 
AGAINST THE HUMAN GENOME. UTRs of divergent Mcm4 and PRKDC genes are visible as black 
bars, the first PRKDC exon as thicker black bar. [chr8: 48.872.624-48.872.814]. B) DIRECT 
COMPARISON OF SEQUENCING ALIGNMENT AND PROFILE REPRESENTATION. Upper two panels: 
Zoom-out of sequencing alignment from A); Lower two panels: profile representation of the same 
samples. introns = thin lines, arrowheads point to direction of transcription. Thicker black bars 
= exons, thin black bars = UTR. [chr8: 48.862.188-48.883.250]. 
A) 
B) 
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APPENDIX FIGURE 2: HEATMAP REPRESENTATION OF THE JACCARD SIMILARITY INDEX OF T-PIC-
DEFINED COMPLEXES AND PRE-RC (PAPIOR ET AL. 2012) AND SNS (PAPIOR ET AL. 2012). From little 
similarity (light red) to high similarity (dark red).  
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APPENDIX FIGURE 3: VALIDATION OF ES CELL PLURIPOTENCY. A) CELL MORPHOLOGY. Red bar 
represents 100µm. B) FACS STAIN OF PLURIPOTENCY MARKERS OCT4 AND SSEA4. Staining was 
performed according to BD Stemflow Human and Mouse Pluripotent Stem Cell Analysis Kit.  
FACS was calibrated using the corresponding isotype negative control.  
A) 
B) 
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A) B) 
APPENDIX FIGURE 6: MOST HOMER PEAKS RESIDE WITHIN THE TOP 10% OF T-PIC PEAKS. 
REPRESENTATIVE EXAMPLE ANALYSIS FOR A) ORC3 AND B) MCM7 IN ONE REPLICATE. Venn diagram 
of overlap between all HOMER-detected peaks with the top 10% of T-PIC-detected peaks. 
Overall counts are indicated. The percentage of overlapping HOMER-detected peaks are 
specified in brackets. 
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APPENDIX FIGURE 9: ORC AND MCM2-7 COMPLEX SIZES (HOMER VS. T-PIC). A) ORC. B) MCM2-7. 
Represented in boxplot: thick line shows the median, the box is the distribution from the first to 
the third quartile, the whiskers indicate the smallest and largest value without being an outlier. 
Outliers represented by dots.  
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A) B) 
APPENDIX FIGURE 10: OVERLAPS OF HOMER- AND T-PIC DEFINED COMPLEXES. A) ORC B) MCM2-7. 
Venn diagram of overlap between HOMER- and T-PIC-defined complexes. Overall counts are 
indicated. The percentage of HOMER-defined complexes common with T-PIC-defined pre-RCs 
is specified in brackets.   
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A) 
B) 
APPENDIX FIGURE 11: GENOMIC DISTRIBUTION OF A) HOMER-DEFINED PRE-RC AND B) T-PIC 
DEFINED PRE-RC REVEALED ASSOCIATION TO PROXIMAL PROMOTER REGIONS. The genomic 
distribution was calculated using the CEAS program and normalized against the “default” 
genomic distribution of the single criteria (position 0 on the y-axis). Distribution was then 
represented with upwards orienting bars showing % enrichments and downwards oriented bars 
showing % depletion compared to “default” genomic distribution.  
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APPENDIX FIGURE 12: GENOMIC DISTRIBUTION OF H3K4ME3 PEAKS SHOWED CLOSE ASSOCIATION 
TO REGULATORY 5‘ GENIC REGIONS. The genomic distribution was calculated using the CEAS 
program and normalized against the “default” genomic distribution of the single criteria (position 
0 on the y-axis). Distribution was then represented with upwards orienting bars showing % 
enrichments and downwards oriented bars showing % depletion compared to “default” genomic 
distribution.   
Genomic distribution of H3K4me3 peaks 
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APPENDIX FIGURE 13: H3K4ME3 POSITIONS WERE MORE LOCALIZED THAN H3K36ME3. Peak sizes 
in [kb] are represented in boxplots: thick line shows the median, the box is the distribution from 
the first to the third quartile, the whiskers indicate the smallest and largest value without being an 
outlier. Outliers represented by dots.  
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APPENDIX FIGURE 14: GENOMIC DISTRIBUTION OF H3K36ME3 PEAKS SHOWED ENRICHMENT IN 
INTRONS. The genomic distribution was calculated using the CEAS program and normalized 
against the “default” genomic distribution of the single criteria (position 0 on the y-axis). 
Distribution was then represented with upwards orienting bars showing % enrichments and 
downwards oriented bars showing % depletion compared to “default” genomic distribution.   
Genomic distribution of H3K36me3 peaks 
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APPENDIX FIGURE 15: NO ENRICHED COVERAGE OF PRE-RC PROTEINS AT H3K36ME3 PEAKS. A) 
MEAN ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 
COVERAGE.  Coverage was calculated as number of reads/base within a 20 kb window around 
H3K36me3 peak center. Input was plotted as control (grey). 
A) B) 
D) C) 
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APPENDIX FIGURE 16: HOMER-DEFINED ORC, MCM2-7, AND PRE-RC WERE CLOSELY ASSOCIATED TO 
H3K4ME3 AND NOT H3K36ME3. Left: HOMER-defined complexes, right: T-PIC-defined complexes. 
The distance of each position was calculated towards the next H3K4me3 or H3K36me3 peak center 
and is plotted in log10 on the x-axis. The frequency of complexes within a specific distance is plotted 
on the y-axis. 
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A) 
B) 
C) 
APPENDIX FIGURE 17: T-PIC-DEFINED ORC, MCM2-7, AND PRE-RC ARE VERY SIMILAR IN G1 AND 
S/G2 ON EBV. A) COMPLEX NUMBERS. Number of T-PIC-defined ORC, Mcm2-7 and pre-RC was 
plotted as indicated in a bar chart in G1 vs. S/G2. B) COMPLEX SIZES. Complex sizes were potted 
as boxplot in G1 vs. S/G2. Thick line shows the median, the box is the distribution from the first 
to the third quartile, the whiskers indicate the smallest and largest value without being an outlier. 
Outliers represented by dots. C) COMPLEX POSITION OVERLAPS. Venn diagram of overlap between 
G1-defined ORC, Mcm2-7, or pre-RC and the same complexes defined in S/G2. Overall counts 
are indicated. 
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APPENDIX FIGURE 18: COMPARISON OF T-PIC-DEFINED PRE-RC, ORC AND MCM2-7 DENSITIES AT 
AS, DS, AND THE REMAINING GENOME IN G1 AND S/G2. A) T-PIC-DEFINED PRE-RC DENSITIES. 
B) T-PIC-DEFINED ORC DENSITIES. C) T-PIC-DEFINED MCM2-7 DENSITIES. The cell cycle stage is 
represented above/beneath each line, S/G2 densities are represented in darker colors. 
A) 
B) C) 
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APPENDIX FIGURE 19: PRE-RC PROTEIN COVERAGE IN S/G2 AT H3K4ME3 PEAKS IS MORE 
PROMINENT THAN IN G1. A) MEAN ORC2 S/G2 COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. 
C) MEAN MCM3 S/G2 COVERAGE. D) MEAN MCM7 S/G2 COVERAGE. Coverage was calculated as 
number of reads/base within a 20 kb window around H3K4me3 peak center. Input was plotted 
as control (grey). 
A) B) 
D) C) 
APPENDIX 
152 | 
 
 
 
 
 
APPENDIX FIGURE 20: OVERLAPS OF HOMER- (LEFT PANEL) OR T-PIC- (RIGHT PANEL) DEFINED PRE-
RC WITH H3K4ME3 PEAKS IN G1 VS. S/G2.  Left: HOMER-defined complexes, right: T-PIC-defined 
complexes. Venn diagram of overlap between G1- and S/G2-defined pre-RCs with H3K4me3 
peaks. Overall counts are indicated. The percentage of defined pre-RC overlapping with 
H3K4me3 are specified in brackets.  
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APPENDIX FIGURE 21: OVERLAPS OF HOMER- (LEFT PANEL) OR T-PIC- (RIGHT PANEL) DEFINED ORC 
AND MCM2-7 WITH H3K4ME3 PEAKS IN G1 VS. S/G2. Left: HOMER-defined complexes, right: 
T-PIC-defined complexes. Venn diagram of overlap between G1- and S/G2-defined complexes 
with H3K4me3 peaks. Overall counts are indicated. The percentage of defined complexes 
overlapping with H3K4me3 is specified in brackets. 
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APPENDIX FIGURE 22: GENOMIC PRE-RC DISTRIBUTION IN G1 VS. S/G2. A) HOMER-DEFINED PRE-
RCS. B) T-PIC-DEFINED PRE-RCS. The distribution in G1 is plotted in rainbow color. The S/G2 
distribution is overlaid by gray bars.   
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APPENDIX FIGURE 23: H4K20ME1 AND –ME3 POSITIONS ARE MUTUALLY EXCLUSIVE. A) H4K20ME1 
AND –ME3 PEAK SIZES REPRESENTED IN A BOXLOT. Thick line shows the median, the box is the 
distribution from the first to the third quartile, the whiskers indicate the smallest and largest value 
without being an outlier. Outliers represented by dots. B) OVERLAP OF H4K20ME1 AND –ME3 PEAK 
POSITIONS. Venn diagram of overlapping H4K20me1 and H4K20me3 peaks. Overall counts are 
indicated. The percentage of overlapping proportions are specified below in brackets. 
 
A) 
B) 
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APPENDIX FIGURE 24: HOMER- (LEFT PANEL) AND T-PIC- (RIGHT PANEL) DEFINED COMPLEXES 
HARDLY OVERLAP WITH H4K20ME1. Left: HOMER-defined complexes, right: T-PIC-defined 
complexes. Venn diagram of overlap between HOMER- and T-PIC-defined ORC, Mcm2-7 and 
pre-RC with H4K20me1 peaks. Overall counts are indicated. The percentages of overlapping 
proportions are specified below in brackets. 
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APPENDIX FIGURE 26: COMPARISON OF H4K20ME1 AND –ME3 POSITIONS IN G1 AND S/G2. 
A) H4K20ME1. B) H4K20ME3. Venn diagram of overlap between G1 and S/G2 determined 
H4K20me peaks. Overall counts are indicated. The percentage of overlapping proportions are 
specified below in brackets. 
A) B) 
  APPENDIX  
159 | 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX FIGURE 27: H4K20ME1 AND –ME3 COVERAGE AT H4K20ME1 AND –ME 3 PEAKS (G1 VS. 
S/G2). Coverage was calculated as number of reads/base within a 6 kb window around 
H4K20me1/-me3 peak center. H4K20me1 coverage in green, H4K20me3 coverage in violet, 
S/G2 coverages colored lighter.  
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APPENDIX FIGURE 28: SUV4-20H1 TARGETING HAS NO EFFECT ON PLASMID REPLICATION. 
QUANTIFICATION OF FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. Plasmid abundance assays in 
HEK293 EBNA1+ Gal4/ Gal4-Suv4-20h1 cell lines as indicated: FR-oriRDH replication efficiency 
was arbitrarily defined as 1. Data are means ± SEM (n=3). 
  APPENDIX  
161 | 
 
 
  
APPENDIX FIGURE 29: DIRECT COMPARISON OF ALL REPORTER PLASMID REPLICATION EFFICIENCIES 
RELATIVE TO FR-DS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: FR-DS replication efficiency was arbitrarily defined as 1. 
Data are means ± SEM (n=4). 
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APPENDIX FIGURE 30: PR-SET7 TARGETING TO FR-UAS LED TO H4K20ME1 INDUCTION AND 
CONVERSION INTO H4K20ME3. ChIP-qPCR analysis at FR and UAS sequences of FR-UAS 
reporter plasmids transfected in the indicated cell lines. Fold enrichment relative to IgG. Data are 
means ± SEM (n=3). 
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